Towards more efficient screening of pharmaceutical cocrystals by Issa, N.
1Towards more Efficient Screening of
Pharmaceutical Cocrystals
Nizar Issa
A thesis submitted to the University of London in partial fulfilment
of the requirements for the degree of Doctor of Philosophy
University College London
2011
Department of Chemistry
University College London
20 Gordon Street
London, WC1H 0AJ
United Kingdom
2Declaration
I, Nizar Issa, confirm that the work presented in this thesis is my own.
Where information has been derived from other sources, I confirm that
this has been indicated in the thesis.
Signiture:……………………………………………………
3Academic Acknowledgements
I would like to sincerely thank my academic supervisors Professor Sally Price
and Professor Derek Tocher, for their enthusiasm, encouragement and continued
support. Working with them over the past few years has been both a privilege and an
absolute pleasure.
I also wish to thank my industrial supervisor Dr Royston Copley for his
guidance, source of inspiration and many valuable discussions. I am grateful for his
help in indexing the cells to provide data in Table 5-5 and facilitating my student
placement at GSK; working there was a truly unforgettable experience.
Dr Sarah Barnett assistances in teaching me the art of crystallography and
applying it to solve crystal structures has been central to many of the determined
cocrystal structures, I would like to thank her for her patience and endless advise as
well as for solving the crystal structure of the complex cocrystal 4-aminobenzoic
acid•phenazine (figure 5-8).
Much of the computational work wouldn’t have been realized without the
contributions of Dr Panos Karamerzanis and Dr Gareth Welch. Their nonstop efforts
in designing, implementing, updating and debugging of the computational programs
have been of immense importance to this thesis of which I am extremely grateful. Dr
Gareth Welch is also thanked for his kind contribution in performing the caffeine
search (figure 4-2).
Dr Doris Braun and Mr Sharmarke Mohamad are thanked for the many
endless late night discussions, assistance in various experimental and crystallography
4work. Mr Martin Vickers is thanked for his assistance using the powder
diffractometer.
I would also like to express my gratitude to past and present members of
Professor Sally Price’s group: Dr Louise Price, Dr Robert Lancaster, Dr Ashely
Hulme, Dr Antonio Torrisi, Dr David Coombes, Miss Anastia Ntantou, Dr
Kostantinous, Dr Emiliana D’Oria, Dr Mathew Habgood, Mr Miguel Ardid and Mr
Peter Norwood.
Finally, I would like to thank GlaxoSmithKline for a generous Ph.D.
studentship and giving me the opportunity to partake in a work placement that
exposed me to the practical world aside from the academic domain.
5Personal Acknowledgements
First and foremost I would like to thank my parents for their love, guidance
and encouragement. You have both been superb and I hope this makes you proud. A
special thanks to my sisters, your warmth and support was always there when I
needed it most. I am also grateful to my brother in law for the many times he picked
me up following late night research in the labs.
To my friends Jude Jumblat, Alexia Issa, David Brown, Genevieve Jacobs-
Brown, Mehran Allybacus, Gracy Aoun, Ghina Elbizri, Reiss Williams, Lauren
Woods and Antoine Zougeib, thank you so much for the emotional support,
camaraderie and fun times. You all have been amazing.
I would also wish to extend my gratitude to my colleagues at Chelsea &
Westminster Hospital, in particular to Melanie Davy for providing me with a job
whenever I needed it.
And finally, I would like to thank the good people of UCL for making my
time here so enjoyable and memorable.
6Abstract
Pharmaceutical cocrystals are formed between active pharmaceutical
ingredients (APIs) and coformers that are biologically safe. Cocrystals are of
considerable relevance to the pharmaceutical industry as they offer the ability of
optimizing the physical properties of an API whilst retaining its biological function.
However, producing cocrystals is experimentally challenging and often results in
undesired forms. The objective of work presented herein is to investigate a more
effective screening approach.
Assuming that the formation of cocrystals is thermodynamically driven, we
tested whether a contemporary computational methodology can account for the
formation of 26 known cocrystals. By comparing their calculated lattice energies with
the sum of their components we found the majority of cocrystals to be
thermodynamically more stable, implying that this computational method is sufficient
and could be applied to the prediction of cocrystal formation.
An experimental screening procedure for the formation of succinic acid and
4-aminobenzoic acid cocrystals was explored. Grinding and hot stage microscopy
experiments provided a rapid indication of cocrystal formation. For systems showing
an indication of cocrystal formation, more extensive screening was carried out using
slow solvent evaporation with a diverse variety of solvents to grow single crystals for
X-ray structural determination. The results produced 4 novel cocrystals.
Finally a multistage computational process was used to generate lattice energy
landscapes for succinic acid•2,2´-bipyridine and succinic acid•1,4-dicyanobenzene
cocrystals and their components. Analysis of these landscapes rationalized why only
one of these cocrystals had been formed in the experimental screening.
This thesis shows that computational methods can be used as a
complementary technique to experimental screening of cocrystals. The calculations
could have been performed prior to the experimental work and so have the potential
to narrow down experimental investigations to the most promising candidates.
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Chapter 1. Introduction to Pharmaceutical Cocrystals and their
Applications
1.1 Introduction
The pharmaceutical industry invests significant resources in identifying novel
active pharmaceutical ingredients (APIs) with suitable physiological profiles that
could later be formulated into drugs. However, to be considered for commercial use,
an API’s physiochemical properties, which are generally dependant on the dosage
form, must be controllable and adhere to the guidelines set up by the regulatory
authorities such as the Food & Drug Administration (FDA).
Most commonly, an API is formulated in the solid state, i.e. tablets and
capsules, as its chemical stability is generally greater in this form than in
solution[1,2]. Furthermore, solid state formulation provides a more practical means of
packaging, processing and handling of the API, as well as being the preferred choice
of drug intake for most patients.
An API can exist in a variety of solid state forms, which include: polymorphs;
solvates; hydrates; salts; cocrystals and amorphous forms (figure 1.1). Each form
exhibits unique physiochemical properties that can profoundly influence the
bioavailability, stability, manufacturability and other performance characteristics of
the formulated API [2-4]. Such diversity offers the opportunity of tuning key
physiochemical properties of the pharmaceutical product without compromising the
physiological activity of the API as the molecular structure is preserved.
Nowadays, the pharmaceutical industry apply a rigorous process termed ‘the
due diligence process’ of solid form selection, which precedes the pre-clinical stage.
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During this process, solid state characterization is carried out to determine the range
of solid forms an API can potentially have, and to identify the one with optimal
physiochemical properties [5,6]. Additionally, studies aimed at establishing the
relative thermodynamic stabilities of the possible forms are conducted. Ideally, the
thermodynamically most stable form is chosen for drug development, as it minimizes
the possibility of unexpected form changes that may occur due to slight variations in
the manufacturing process or during storage of the drug. A form change during
production can have serious ramifications on the drug’s relative bioavailability or
physical integrity. This is exemplified in the well publicized case of the drug ritonavir
(Norvir®)[7,8], which during its launch was formulated as form I, the only known
polymorph at the time. After approximately two years into production, the marketed
form consistently converted into a thermodynamically more stable polymorph: form
II, which exhibited a significantly reduced bioavailability[7]. This led to the
withdrawal of the drug from the market, and a new formulation had to be developed,
costing the company millions of pounds and limiting patient access to this vital
therapeutic product.
Currently, most drugs are formulated as salts, these are multi-component solid
forms that consist of a stoichiometric ratio of negatively charged anion and a
positively charged cation, and it is estimated that about half of all medicines are
marketed in this form[9,10]. Generally, salts have a higher bioavailability than single
component forms of the API or its hydrates, and are biologically safer than solvates.
However, this solid form is limited to APIs that possess a suitable (basic or acidic)
ionisable site for proton transfer.
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To assist in the screening of salts, current salt screening practices require
knowledge of the pka values of the ionisable groups. For a set of complementary
counterions, a difference in the pka values by ≥3 is generally expected to favour salt
formation[11], although empirical evidence[12,13] suggest that there is no universal
pka value for which salt formation is guaranteed for all acid-base pairs.
Recently, optimization of an API’s physiochemical properties by
cocrystallization has become an attractive alternative to salt formation[14,15].
Cocrystals have the advantage that they can be formed regardless of the API’s
ionisable status. Instead, their formation relies on complementary functional groups
between the API and a biologically safe partner molecule, termed the coformer, to
allow for hydrogen bonding or other form of interactions in the solid. The number of
biologically safe coformers that can be incorporated into cocrystallization is more
extensive than the number of acids or bases which can be used in the production of
salts[16]. Thus cocrystallization can afford a greater crystal form diversity than
salts[17]. Pharmaceutical cocrystals also represent an opportunity to patent and
market clinically improved crystal forms of existing APIs, possibly as novel drug
formulations[2].
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Figure 1.1: Solid state classifications.
1.1.1 What is a cocrystal?
Cocrystals have been known for some time, and an early example is that of
the quinhydrone cocrystal which was reported in the eighteenth century as a
‘derivative of quinhydrone’ [18]. However, it wasn’t until 1988 that the term
‘cocrystals’ was first used [19], to which the exact definition remains a subject of
topical debate [20-23].
In this thesis the operating definition of a cocrystal is ‘a stoichiometric
multicomponent crystal in which all its components are neutral and solid under
ambient conditions when in pure form’[24]. This definition distinguishes cocrystals
from other solid forms such as solvates and hydrates which have at least one pure
component in the liquid state. Furthermore, the criterion that all components are solid
under ambient conditions has important practical considerations as cocrystals can be
produced via solid state methods such as grinding and hot stage microscopy.
To be classified as a pharmaceutical cocrystal, the components must comprise
of an API and a coformer that is considered biologically safe. Some of the early
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examples of pharmaceutical cocrystals are those of barbiturates (central nervous
system depressants) with 4-oxy-5-nitropyridine, 2-ethoxy-5-acetaminopyridine, N-
methyl--pyridone and -aminopyridine, which were reported in a 1934 French
patent[25].
1.2 Potential applications of pharmaceutical cocrystals
Pharmaceutical cocrystals represent a strategic opportunity for the
optimization of key physiochemical properties of an API whilst retaining its
molecular structure, and hence its physiological activity-as there are no making or
breaking of the API’s covalent bonds. These multicomponent systems have gained
recent prominence in a flurry of research reports that demonstrate their potential
utility to the pharmaceutical industry, examples of which are described in the
following subsections.
1.2.1 Improved bioavailability of an API
It is imperative that the bioavailability profile of a drug satisfies the regulatory
authorities’ requirements: a very low bioavailability could render a drug ineffective
whereas a very high one could make it toxic. The bioavailability of an API is mainly
dependant on its solubility and dissolution rates[26], which in turn, are dependent on
the formulation of the API. For instance, the solubility difference between
polymorphs of an API is typically less than a factor of 10, whereas an amorphous and
a crystalline form of an API differ in solubility by several hundreds times[26,26,27].
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In the context of pharmaceutical cocrystals, the bioavailability is the most
studied physiochemical property of an API, and there have been numerous reports
describing an improvement to this property upon cocrystallization[28-32].
Indomethacin, a non-steroidal anti-inflammatory drug (NSAID), is an example of a
pharmaceutical product with low bioavailability. It has two known polymorphic
forms:  and [33,34], the latter of which is thermodynamically stable at room
temperature[35]. Attempts to formulate indomethacin in an amorphous form with
improved bioavailability were ineffective as the amorphous form displayed a
tendency to transform to the stable polymorph of indomethacin[36]. However,
cocrystallization with saccharin produced a stable solid form with enhanced
bioavailability properties which could be utilized pharmaceutically[37].
Another API whose bioavailability is improved upon cocrystallization with
saccharin is the anticonvulsant drug carbamazepine (Tegretol)[38]. Carbamazepine is
known to have five anhydrous polymorphs[39-43], a dihydrate[44], a host of
solvates[45-50] and cocrystals[51-54], as well as two ammonium salts[55]. However,
it is the carbamazepine•saccharin cocrystal that displayed a particular superiority to
the current marketed form in terms of its bioavailability profile, and exhibits
equivalent physiochemical stability to all known polymorphs of carbamzepine[38].
1.2.2 Increased resistance to hydrate formation
The stability of an API in the presence of atmospheric moisture is of concern
to the pharmaceutical industry. A conversion of an API into a hydrate form could
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bring about undesired physiochemical properties such as low bioavailability and can
also implicate the processing, formulation, packaging and storage of the API[56,57].
Various manufacturing methods such as aqueous granulation, spray drying,
aqueous film coating and crystallization may bring the API into contact with water,
thus providing the opportunity for hydrate formation[58]. Even after an API has been
formulated into a drug product, an opportunity for hydration could still exist. For
example, if hydrated excipients are used, water redistribution within the dosage form
could occur resulting into hydration of the API itself. Also if the storage environment
is humid, a hydrate could be formed[56]. Thus special requirements are needed for
the manufacture and handling of APIs that are hygroscopic, which could be difficult
and expensive to maintain. Alternatively, cocrystallization could be used to solve this
problem as in the case of caffeine and theophylline: a central nervous system
stimulant and a bronchodilator respectively. Both APIs are stable below a certain
critical relative humidity levels, but at higher relative humidity levels they transform
into hydrate forms[59-61]. However, upon cocrystallization with dicarboxylic acids
such as oxalic acid, non-hygroscopic cocrystals were produced that can resist
hydration under extreme relative humidity levels [62,63].
1.2.3 Improved compaction properties for tabletting
An understanding of an API’s mechanical properties such as its
compressibility is essential for its development into a tablet form. Excipients are
sometimes added to the formulation to enhance the tablet quality of the drug.
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Paracetamol (Panadol®), an analgesic and antipyretic drug, has three known
polymorphs: the most stable is form I and the least stable is form III which has not
yet been fully characterized[64-66]. Form II is the only polymorph which exhibits the
necessary compaction properties for direct tabletting as it exhibits parallel molecular
stacking, making it more favourable with respect to plastic deformation[67,68].
However, its lower stability makes it an impractical option for commercial use,
therefore, the current marketed form of paracetamol comprises of form I and
excipients that prevent chipping and disintegration of the tablet [69-72].
Recently, attempts[67] were made to produce alternative solid forms of
paracetamol that are pharmaceutically acceptable, thermodynamically stable and
share similar compaction properties to form II of paracetamol. This was achieved by
cocrystallization, as salt formation was unattainable due to the lack of acidic and
basic functionalities on the paracetamol molecule. Several paracetamol cocrystals
containing a biologically safe coformer were produced, such as
paracetamol•theophylline cocrystal[73], all of which displayed superior compaction
properties to form I.
1.2.4 Formulation of two APIs into one dose
The ability to formulate two pharmacologically complementary APIs into a
single dosage is also of interest to the pharmaceutical industry, as this could
potentially save resources in manufacturing, packaging, storing and may provide a
more convenient dose for patients.
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An example of a cocrystal that contains two APIs is that of
sildenafil•acetylsalicylic acid. Sildenafil (Viagra®) is a drug used for the treatment of
erectile dysfunction and pulmonary arterial hypertension, and acetylsalicylic acid
(aspirin), a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and
inflammation, reduce fever (antipyretic) and for the treatment of cardiac diseases
(antiplatelet). This cocrystal has been patented[74] for the treatment of cardiac
diseases and male erectile dysfunction. It has also displayed favourable
physiochemical properties which include higher dissolution rates to the marketed salt
form of sildenafil.
1.3 Conclusion
The solid state landscape of pharmaceutically relevant forms has expanded
since the emergence of pharmaceutical cocrystals. Significant physiochemical
properties of an API such as its bioavailability, stability and processability features
can be considerably improved upon cocrystallization, thus allowing for optimal drug
formulation.
Although the commercial utility of pharmaceutical cocrystal is not yet
common, this comes as no surprise given the lengthy and laborious process
associated with drug research and development which includes both scientific and
legal complications. However, it is very conceivable that drugs marketed in this solid
form will become readily available at some stage in the future, and there are signs of
optimism with the pharmaceutical cocrystals Depakote® (used for the treatment of
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manic episodes of bipolar disorder, and comprise of sodium valproate•valproic acid)
already sold in the pharmaceutical market.
1.4 Thesis outline
Work presented in this thesis combines both computational modelling of the
organic solid state and experimental studies to investigate more efficient and effective
methods of screening for pharmaceutical cocrystals. There is an emphasis on
theoretical work, examining the ability to predict the formation and structure of these
multicomponent systems. This could assist future experimental endeavours targeting
cocrystals by focusing the screens to a set of coformers computationally identified to
have a high tendency to form cocrystals.
Chapter 2 describes both standard and novel experimental methods used in the
screening of cocrystals, beginning with a description of the crystal engineering
guidelines that are routinely used in the selection of suitable coformers to be included
in such experimental screens. It also briefly describes how cocrystallization is
induced during nucleation and the crystal growth process, as well as highlighting the
challenges in producing these solid forms due to the potential influence of kinetic
factors that can prevent their formation in preference to other undesired products such
as solvates.
Chapter 3 describes the theoretical basis of computational modelling,
beginning with a brief introduction of the origin of intermolecular forces and the
approximations used to model them. This is followed by describing a multistage
computational methodology, used in latter parts of the thesis, for the generation of
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lattice energy landscapes. The potential uses of these lattice energy landscapes are
also described, including crystal structure prediction, solid state characterization and
rationalization of some experimental observations.
Chapter 4 investigates whether the formation of cocrystals can be
computationally predicted by comparing the calculated lattice energies of 26 known
cocrystals against the weighted sum of their components. Central to this work is the
assumption that cocrystallization is a thermodynamically driven process.
In chapter 5, an extensive experimental procedure, which combines both
conventional and novel techniques targeting cocrystals, is designed and tested in its
ability to produce these multicomponent solid forms more efficiently. 4-
Aminobenzoic acid and succinic acid are used as cocrystallizing agents and attempts
are made to cocrystallize them with compounds of biological relevance.
Chapter 6 builds on the experimental screens performed in chapter 5 by
investigating computationally why some systems produced cocrystals and others did
not. Such rationalizations are achieved by analysing the generated lattice energy
landscapes and computed crystal structures of both the binary systems and their
constituents. Results of this study are also used to elucidate whether crystal structure
prediction can provide a more efficient complement for future experimental screens
of cocrystals.
Finally, chapter 7 provides an overall conclusion to the work presented in this
thesis and identifies areas that can benefit from further research.
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Chapter 2. Crystal Engineering and Experimental Methodologies
for Screening of Cocrystals
2.1 Introduction
Traditional methods of producing cocrystals utilize crystal engineering
guidelines (sections 2.2.0-2.2.2) to select suitable coformers with complementary
regions of interactions by hydrogen bonding. These are then used in solution based
crystallization screens of cocrystals (sections 2.3.0-2.3.4). During the course of this
thesis, screening for cocrystals by grinding or hot stage microscopy methods (sections
2.4.0-2.4.2) have become more widespread [1-15]. These novel techniques are
considered to be more efficient in producing cocrystals as well as being
environmentally friendly (green chemistry) given their little to no inclusion of
solvent. Depending on the nature of the sample produced, there are various
characterization techniques (sections 2.5.0-2.5.3) available to determine whether
cocrystallization is successful, the most recognised ones being single crystal X-ray
diffraction, powder X-ray diffraction and infrared spectroscopy.
This chapter provides general descriptions of the screening methods and
characterization techniques used in the experimental study in chapter 5. It also briefly
describes how cocrystallization is induced during nucleation and the crystal growth
process, as well as highlighting the kinetic factors that can prevent the formation of
cocrystals in preference to other undesired forms such as solvates, hydrates and
crystallization of the individual components separately.
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2.2 Designing cocrystals by crystal engineering
2.2.1 Crystal engineering
The term crystal engineering was coined in 1955[16], and was first used in
studies seeking to define crystals able to react in the solid state by topochemical
reactions[17]. It has since expanded into the field of supramolecular chemistry, which
deals with the interaction of molecules in a crystal through non-covalent bonds such
as hydrogen bonding[18]. Crystal engineering has been defined as the understanding
of intermolecular interactions in the context of crystal packing and the utilization of
such understanding in the design of new solids with desired physical and chemical
properties[19].
Crystal engineering is often based on surveying existing structures stored in
the Cambridge Structural Database[20] to identify robust supramolecular synthons.
These are molecular recognition units between complementary functional groups[21],
which are categorized into two groups[22]:
(1) Supramolecular homosynthon: where there are intermolecular interactions
between the same functional group, for example the interaction between
carboxylic acid···carboxylic acid or amide···amide (figure 2.1:I-II)
(2) Supramolecular heterosynthon: where there are intermolecular interactions
between different but complementary functional groups, for example the
interaction between carboxylic acid···amide or carboxylic acid··· pyridine
(figure 2.1:III-IV).
Due to the prevalence of carboxylic acid moieties in organic molecules and active
pharmaceutical ingredients, they are one of the most heavily studied functional
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groups in crystal engineering [19,23-29]. Statistical analysis[30] of structures with
this moiety in the CSD found that they often pack forming the supramolecular
homosynthon I. However, in the presence of competing functional groups such as
amide or pyridine groups, supramolecular heterosynthons III and IV were found to be
more favoured[31-33].
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Figure 2.1: Examples of supramolecular synthons.
Such empirical information on complementary functional groups and their
likely supramolecular synthons is a prerequisite for the designing of cocrystals as
they facilitate the selection of appropriate coformers, which are later used in
experimental screens targeting these multicomponent solid forms.
2.2.2 Hydrogen bonding
Due to their strength, directionality and relative abundance[19] hydrogen
bonds are the most studied form of intermolecular interaction in crystal engineering.
They have been defined as interactions that direct the association of a covalently
bound hydrogen atom with one or more other atoms, groups of atoms or molecules
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into an aggregate structure that is sufficiently stable to make it convenient for the
chemist to consider it as an independent chemical species[34].
Strong hydrogen bonds occur when the hydrogen atom is polarisable and is
covalently bonded to an electron-withdrawing donor atom, such as nitrogen, and
interacts with a partially negatively charged and comparatively less polarisable
acceptor atom, such as oxygen[35]. For weak hydrogen bonds, the hydrogen atom is
covalently bonded to a weak electron-withdrawing donor atom such as carbon, and
interacts with an acceptor group such as the π-electron cloud of an aromatic ring.
The Donor···Acceptor distance is often used to assess the strength of the hydrogen
bond. For strong hydrogen bonds, this distance is usually less than the sum of the van
der Waals radii of the donor and acceptor atoms[35]. The Donor···Acceptor distance
is considered rather than the H···Acceptor distance as the location of the hydrogen
atom may not be accurately established in structures solved from X-ray diffraction
data.
Analysis of crystal structures in the CSD resulted in the construction of empirical
rules (Etter’s rules[36]) that can help predict the likely supramolecular synthons of
molecules with a limited number of functional groups[36]. These rules are:
 All good hydrogen donors and acceptors are used in hydrogen bonding.
 Six membered ring intramolecular hydrogen bonds form in preference to
intermolecular hydrogen bonds.
 The best hydrogen donors and acceptors remaining after intramolecular
hydrogen bond formation form intermolecular hydrogen bonds to one another.
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Furthermore, a graph set notation was developed to describe the observed
supramolecular synthons between molecules[36] (figure2.2) in the form:
G ab (n)
where G is the descriptor of the hydrogen bond pattern and is represented by one of
the following: C=infinite chain, D=discrete finite set, R=ring pattern,
S=intramolecular hydrogen bond pattern. The superscript a is the number of
acceptors in the repeat unit and the subscript b is the number of donated hydrogens in
the repeat unit. The size of the pattern, i.e. the number of atoms in the repeating unit,
is presented by n.
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Figure 2.2: Example of graph set assignments[36].
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2.3 Traditional cocrystallization screens
2.3.1 Solution based crystallization
Once suitable coformers have been selected, the traditional approach is to then
carry out solution based crystallization screens of cocrystals, such as slow solvent
evaporation or slow cooling methods. In these experiments, a saturated solution is
prepared in specimen tubes with a 1:1 stoichiometric ratio of components (assuming
the targeted cocrystal is of 1:1 stoichiometry) and a solvent (or a solvent mixture) in
which both components exhibit similar solubilities. This solubility condition is a
major limitation of screening by solution crystallization. Examination of the phase
diagram[37] leads to the conclusion that even if a cocrystal (1:1) is stable,
crystallization from solvents in which the components have very different solubility
will lead to a component crystallizing out before the cocrystal (figure 2.3).
Coformer A Coformer B
Solvent I
0% 50% 100%
100%0%
0%100%
Coformer A Coformer B
Solvent II
0% 50% 100%
100%0%
0%100%
Figure 2.3: Ternary phase diagram for coformers A and B in different solvents at a given
temperature in concentration %[37]. (a) In solvent I, the solubilities of the coformers are
approximately equivalent leading to a symmetrical ternary phase diagram. A stable cocrystal of
a 1:1 stoichiometry is most likely to form under conditions described by the shaded region. (b) In
solvent II, the solubilities of the coformers are considerably different resulting in an
unsymmetrical ternary phase diagram. Under these conditions, the coformers are likely to
crystallize separately.
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For slow solvent evaporation methods, the solvent is left to evaporate slowly
under ambient laboratory conditions. This causes the solution to become
supersaturated which induces crystallization of potential cocrystals (figure 2.4). To
control the rate of solvent evaporation, lids with pierced holes are placed over the
tubes.
Saturated solution Supersaturation Crystallization of cocrystals
Figure 2.4: Representation of slow solvent evaporation crystallization. The saturated solution is
exposed at the top of the specimen tube allowing slow solvent evaporation under ambient
conditions. This causes supersaturation which induces crystallization.
For slow cooling methods, the saturated solution is sealed and stored at low
temperatures that are higher than the freezing point temperature of the solvent. This
also causes the solution to become supersaturated and potentially induces
crystallization of the cocrystals.
It is also possible to combine the two techniques together, so that slow solvent
evaporation is performed at low temperatures. This approach is often utilized in
pharmaceutical applications to increase product yield [38].
2.3.2 Supersaturation
At a given temperature there is a maximum amount of solute (coformer and
cocrystallizing agent) that can dissolve in a solvent. At this point the solution is
saturated and is in equilibrium. This is associated with the stable zone in figure 2.5
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[39]. For crystallization to occur, it is a prerequisite that supersaturation is reached.
This occurs when the amount of dissolved solute is greater than the equilibrium
saturated value (shaded region in figure 2.5), and is achieved by either increasing the
solute concentration as the solvent is allowed to evaporate (slow solvent evaporation),
or by reducing the temperature which is proportionally related to the solubility of the
solute (slow cooling).
So
lub
ili
ty
cu
rv
e
M
eta
sta
ble
cu
rv
e
Stable Zone
Labile zone
Metastable zone
Temperature
C
on
ce
nt
ra
tio
n
Slow cooling
Slow solvent evaporation
C
on
ce
nt
ra
tio
n
Figure 2.5: Achieving supersaturation (grey region) by slow cooling and slow solvent
evaporation. Nucleation is expected to occur beyond the metastable zone[39].
Unlike the solubility curve which is fixed for a given solvent, the metastable
curve can shift depending on kinetic factors. Under fast rates of cooling or solvent
evaporation the metastable curve shifts away from the solubility curve, giving rise to
a wide metastable zone. Conversely, under slow rates of cooling or solvent
evaporation the metastable curve shifts towards the solubility curve, giving rise to a
narrow metastable zone [40,41]. The former situation favours the formation of
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metastable crystals, whereas the latter favours the formation of the most
thermodynamically stable crystals.
A major limitation of producing cocrystals by solution based experiments is
the requirement for the solution to be supersaturated with respect to the cocrystal, so
it crystallizes out before either pure component.
2.3.3 Nucleation and crystal growth
Crystallization is considered as a two stage process: nucleation followed by
crystal growth[42]. Whilst thermodynamics define the stability domains of different
crystal structures, kinetics control the crystallization pathway which may lead to the
formation of metastable crystal structures[43].
Nucleation is classified as either primary: nucleation is induced without pre-
existing crystals of the crystallizing product; or secondary: nucleation is induced by
pre-existing crystals of the crystallizing product which are already present or are
deliberately added as seeds[44] (secondary nucleation of cocrystals by seeding is
described in section 2.3.4). Primary nucleation itself is subdivided as either
homogenous: where the nuclei of the crystallizing product occur spontaneously; or
heterogeneous: where the nuclei of the crystallizing product occur at interfaces or
surfaces such as dust particles or the walls of the container[45].
The driving force behind spontaneous nucleation is a lowering of the free
energy (Gtotal), which is a function of the volume free energy (Gvolume) that favours the
assembly of molecular clusters, and the surface free energy (Gsurface) that favours the
disassembly of molecular clusters[46]:
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Gtotal = Gsurface + Gvolume
Classical nucleation theory assumes that prior to nucleation, molecules assemble
themselves into clusters with varying dimensions. Those with a radius below a certain
‘critical’ value (r < rc) are disfavoured and contribute by increasing the free energy, as
the Gsurface term dominates over the Gvolume term. Consequently, these clusters have
a tendency to disassemble. However, clusters that exceed the ‘critical’ radius value (r
> rc) are favoured and contribute by lowering the free energy term, as the Gvolume
term dominates the Gsurface term. Such clusters are called nuclei, which may
continue to grow into crystals (figure 2.6).
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Figure 2.6: Plot of free energy of cluster during molecular aggregation that leads to nucleation
once the activation energy barrier (Gc) is overcome [45]. When the radius of the clusters is
equal to the critical radius, the free energy is equal to the activation free energy of the critical
cluster (Gtotal = Gc).
This process of producing competing clusters, where small crystals dissolve and
larger ones grow further is known as Ostwald ripening[39].
42
It has been postulated that crystallization progresses from nucleation to the
equilibrium state through stages (Ostwald’s Rule of Stages[47]), where the
thermodynamically stable form does not crystallize directly (although there have been
observations that contradict this argument [43,48,49]). The form that crystallizes first
will correspond to the cluster with the lowest free energy barrier and may be
metastable. This form has the closest free energy value to the original state that is in
solution[50]. The metastable form is preferred at this stage because it exhibits the
fastest crystal growth rate as a result of its lower free energy barrier to nucleate. If the
crystallization conditions allows, this form may undergo a phase mediated
transformation producing a form with a lower free energy, which itself may transform
into another form with an even lower free energy, and so on. This sequence is
repeated until the thermodynamically most stable form is produced. If on the other
hand the crystallization conditions do not allow such transformation, then the product
is trapped, and the result is a kinetically stable product. This could, for example, arise
from solvent effects, where different polarities and hydrogen bonding characteristics
of the solvent are believed to promote or inhibit the assembly of some clusters and
subsequently influence the crystallized product[51-53].
As kinetic factors control the crystallization process, crystallization may not
necessary produce the thermodynamically most stable product[54], giving rise to
polymorphism and concomitant crystals. The form eventually produced is determined
by a combination of the relative nucleation rates and relative crystal growth rates
under the crystallization conditions[49].
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2.3.4 Seeding effect
To produce good quality single crystals for an X-ray structure determination
or to bias the crystallization process, seeds can be added to solution based
experiments to promote secondary nucleation (in this study seeds were collected from
grinding experiments that indicated potential cocrystallization). As long as the seeds
do not undergo a solution mediated phase transformation, these then become new
centres for crystal growth and are defined as ‘secondary nuclei’[55].
Seeding enables crystal growth to start at lower supersaturation levels, as it
narrows the metastable zone width, and prevents random nucleation at higher
supersaturation levels. The point of introducing these seeds is critical if they are to
have the desired effect: if added too early, before the solution is supersaturated they
will dissolve; and if added at a point where nucleation without seeding (primary
nucleation) has already begun, their effects will be reduced[38] (figure 2.7).
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Figure 2.7: Seeding effect on the metastable zone width. Seeding narrows the metastable zone
and promotes crystal growth at more moderate supersaturation levels.
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2.4 Novel cocrystallization methods
2.4.1 Grinding
The formation of cocrystals by neat grinding has been known for some
time[56]. However, its application as a viable screening method for cocrystals has
only recently become extensively utilized[4,5,10,57]. The efficiency of this method
can be improved further by the addition of few drops of solvent, which catalyze the
cocrystallization process[11,58,59].
There are various advantages of neat and solvent assisted grinding over the
traditional solution based experiments such as the simplicity of the experimental set-
up, rapidity in producing cocrystals, being environmentally friendly (as little or no
solvent is used), and the reduced possibility of producing undesired products (e.g.
solvates). Furthermore, these methods can make accessible cocrystal forms that may
not be obtainable from solution based experiments, for example, because of solubility
differences of the components or solvent–solute interactions[11]. However, as these
methods produce a microcrystalline sample, structural determination by single crystal
X-ray diffraction can not be performed. Instead structural characterization is carried
out using powder X-ray diffraction techniques in combination with other
characterization techniques such as infrared spectroscopy.
The addition of solvent drops during grinding is expected to speed the rate of
cocrystallization[8,58]. However the mechanism of doing so remains
unclear[11,12,60,61]. It has been proposed [8] that the inclusion of a few drops of
solvent can improve the diffusion rate of components by providing additional degrees
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of orientational and conformational freedom at various interfaces, as well as
enhancing the opportunity for molecular collision.
2.4.2 Hot Stage Microscopy
The hot stage microscopy technique has similar advantages to grinding over
the solution based methods: the results are rapidly obtainable; the method avoids the
formation of undesired products and is considered environmentally friendly. However
its use is often limited to coformers with comparable melting points, to avoid
molecular decomposition of one coformer before the other has melted.
This method is based on the contact (or mixed fusion) approach [62,63],
which involves the melting of one coformer (the one with the higher melting point)
between two microscope slides, which is then allowed to solidify. A second coformer
is introduced between the same microscope slides and allowed to melt, consequently
dissolving a proportion of the first coformer at the region where they meet. This
region is known as the zone of mixing. The system is then cooled down to room
temperature and fully solidified, before being heated up again until all the
components melt. This is monitored using a microscope with crossed Polaroid filters.
If cocrystallization is achieved, a distinct new morphology with a different melting
point to its components would be identified within the zone of mixing.
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2.5 Characterization techniques
2.5.1 Single crystal X-ray diffraction
Single crystal X-ray diffraction techniques represent a powerful
characterization tool for establishing the solid state structure and determining whether
a cocrystal has been formed. In this method, crystals of a suitable size and quality are
exposed to a beam of monochromatic X-ray radiation with a wavelength comparable
to the interatomic distances. As the radiation interacts with electrons in the crystal, it
is diffracted and recorded by an X-ray detector. The diffracted data is collected in the
form of a series of images for different crystal orientations and these are analyzed to
solve the 3-dimensional structure of the crystal.
2.5.2 Powder X-ray diffraction
In this technique, a powder sample is exposed to a beam of monochromatic X-
ray radiation, which is diffracted and recorded by an X-ray detector. The diffracted
data is processed and an X-ray powder pattern is plotted. For samples produced using
grinding methods, this technique has been traditionally utilized in the detection of
cocrystals and in some cases used to solve their crystal structures[10,64-66].
However, due to practical purposes and the exclusive availability of an Infrared
spectrometer in our laboratories, vibrational spectroscopy was used instead as a
viable alternative for the characterization of ground samples.
Nevertheless, the application of the PXRD technique was exploited in chapter
5 section 5.4.1 to test the ability of novel crystallization methods to effectively
reproduce cocrystals previously made via solution based crystallization. This was
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achieved by the fingerprinting approach where powder patterns of the ground samples
were compared against the simulated powder patterns of their known cocrystals
generated by the CSD program Mercury[67].
2.5.3 Infrared spectroscopy
Infrared spectroscopy is based on the fact that molecules absorb specific
frequencies of electromagnetic radiation characteristic of their structure. An infrared
spectrum is obtained by irradiating a sample with the full range of IR frequencies
(4000-659 cm-1) and determining what fraction of the incident radiation is absorbed at
a particular energy. The energy at which any peak in an absorption spectrum appears
corresponds to the vibrational frequencies of the sample molecules[68].
In this study, infrared spectroscopy is used to detect possible cocrystallization.
Several signals that indicate potential cocrystallization can be found when comparing
the IR spectra of the pure components with that of the potential cocrystal sample
caused by new hydrogen bonds between the two coformers. The most prominent ones
are shifts in the bands associated with vibrations of the hydrogen bond donor and
acceptors groups, such shifts are located outside the fingerprint region (i.e. in the
frequency range 4000-1300 cm-1).
The vibrations of the hydrogen bond (DonorH···Acceptor) itself can also be
found in the IR spectrum[69]. However as these bonds are weak, their absorption
bands are typically found in the complicated fingerprint (low frequency) region,
where, due to the nature of the compounds studied, assignment is very difficult.
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Therefore in this study, analyses of the IR spectra are confined to the 4000-1300 cm-1
frequency range.
2.6 Conclusion
This chapter has described the commonly used methods for screening of
cocrystals and the standard characterization techniques. It has also demonstrated that
cocrystallization is a difficult process to control due to the varied kinetic factors that
take place during the nucleation and the crystal growth processes.
A cocrystal is designed using crystal engineering guidelines, which are based
on the selection of coformers with complementary functional groups. However,
experimental attempts targeting that cocrystal are often unsuccessful as kinetic factors
may promote the formation of other forms such as solvates or the crystallization of
the pure components separately. Furthermore, the targeted cocrystal may be
thermodynamically unfavoured, thus making extensive screens aimed at producing it
unnecessary and wasteful of labour and chemical recourses. This underlines the need
for more efficient screening methods for cocrystals.
In the next chapter, computational methods are described. These are used in
the latter parts of this thesis where their viability as complementary tools to
experimental screening of cocrystals is investigated.
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Chapter 3. Computational Modelling of Organic Crystal Structures
3.1 Introduction
The terms hydrogen bonding, Van der Waals interactions and π-π interactions
are all descriptions of intermolecular forces, whose origin stems from electrostatic,
induction, dispersion and short range forces. Although weaker than the weakest
covalent bond[1], they are responsible for various properties of a molecule such as its
crystal structure, morphology, solubility and melting point. Understanding the nature
of these intermolecular forces is fundamental to deriving accurate models for
computational simulations of the organic solid state.
In the initial sections of this chapter, the origin of intermolecular forces and
the approximations used to model them are discussed. This is followed by describing
a multistage computational process for generating putative crystal structures and
calculating their lattice energies, which is used throughout the theoretical work
presented in this thesis. This computational methodology has been specifically
designed to address the added complexity of calculating multicomponent systems
with conformational flexibility such as cocrystals[2]. In the final sections of the
chapter, the subject of data analysis and manipulation is discussed, followed by a
description of recent computational studies on cocrystals.
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3.2 Intermolecular forces
Kitaigorodskii’s close-packing principle states that in order to minimize
empty space in a crystal structure, the molecules are stacked in such a way whereby
the bumps in one are inserted into the hollows of another, producing a dense crystal
structure[3]. This is accompanied by stabilizing intermolecular interactions such as
hydrogen bonds between molecules with complementary functional groups, as
described by the crystal engineering guidelines in chapter 2. This manner of stacking
results in a lowering of the intermolecular energy as the enthalpy gain outweighs the
loss of entropy due to the ordering of molecules. The gain in enthalpy is caused by
intermolecular forces between molecules that are both attractive and repulsive[4].
Optimum stability is achieved by attaining a balance between these forces. In the case
of two spherical molecules, this is reached at the equilibrium distance of separation
between two molecules, re, where the intermolecular energy, U(r), has a minimum
value (–) as presented graphically in figure 3.1[5]. For non-spherical molecules, the
intermolecular energy, U(r,Ω), will depend on the relative orientation of the
molecules (Ω) as well as their separation distance (r) [6].
The intermolecular forces are classified as either long range: where there is
negligible overlap of the electron densities of the molecules and the energy of
interactions behaves as an inverse power of the separation distance; or as short range:
where there is considerable overlap and the energy decreases exponentially.
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Figure 3.1: Intermolecular energy, U(r), as a function the intermolecular separation, r, between
two spherical molecules. The energy minimum (-ε) occurs at the equilibrium distance of
separation (re).
3.2.1 Long range forces
For molecules separated by relatively large distances, the electron density
overlap is negligible, and the electron densities are assumed to belong to individual
molecules. At such long range separations there are three contributors to the
intermolecular energy which are dependent on the symmetry of the molecules:
(i) The electrostatic forces arise from the Coulombic interactions
between the positively charged nuclei and negatively charged electrons of one
molecule with the corresponding charges on another molecule[6]. Such interactions
can be attractive or repulsive. They are defined by the undistorted and isolated
electron distribution of the molecules[7]. They depend strongly on the separation and
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relative orientation of the molecules[8] and are very important in the formation of
hydrogen bonds.
(ii) Induction (polarization) forces arise from the distortion of charge
distribution on a molecule due to the electric field of surrounding molecules. For
example the electric field of a molecule with a permanent dipole distorts the charge
distribution of a nearby non-polar molecule producing an induced dipole moment
within it. This induced dipole then interacts with the permanent dipole to lower the
overall energy[7].
The magnitude of the induced dipole depends not only on the strength of the
permanent dipole, but on the polarizability of the molecule whose charge density is
being disturbed. Polarizability is the ease with which the electron distribution in a
molecule can be distorted. Generally, the larger the number of electrons and the more
diffuse the electron cloud in the molecule the greater the polarizability[9].
(iii) Dispersion (London) forces are a universal form of interaction that
arises from instantaneous dipoles in the molecule which are caused by the
fluctuations of the non-static electron density. At any instant a temporary dipole
moment can occur, which can induce a temporary dipole moment in a neighbouring
atom and so on[9]. As with polarization forces, this interaction is an attractive one,
and thus, reduces the overall energy.
For molecules where electrostatic and induction contributions are absent, for
example spherical molecules such as argon, dispersion is the only form of long range
interaction.
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3.2.2 Short range forces
For short range separations, the electron density overlap is significant, and the
most important contributors to the overall energy are due to exchange-repulsion and
charge transfer forces, as described below:
(i) Exchange-repulsion forces are split into two components. The first
results from the exchange of electrons between the two molecules. This component is
always attractive[10]. The second component is the repulsion and is derived from the
Pauli Exclusion Principle that prohibits the simultaneous existence of electrons in the
same region. By definition, this component is always repulsive in nature and
dominates the attractive exchange forces[8].
(ii) Charge transfer forces arise when charge is transferred from the
occupied orbitals of one molecule to the unoccupied orbitals of another[8]. If the
charge transfer is large then it describes covalent bonding interaction. It must
therefore be very small in intermolecular interactions, and is generally neglected.
3.2.3 Modelling the intermolecular forces
Modelling all these intermolecular interactions is extremely difficult and
computationally expensive. Therefore, for simplicity and to reduce the computational
costs, two approximations are used to sum the intermolecular forces and evaluate the
lattice energy of crystal structures. The first is the pairwise-additivity approximation,
which assumes that the energy of a system is simply the sum of all two-body
interactions in that system. For example, a system comprising of molecules A, B and
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C, the potential is expressed as the sum of two-body interactions of the pairs
AB+AC+BC [5].
Not all the intermolecular terms are described by the pairwise-additivity
approximation. Electrostatic interactions are strictly pairwise-additive, whereas the
dispersion and repulsion are approximately so. However, induction is implicitly a
many-body interaction and not pair-wise additive [5].
The second approximation is the atom-atom approximation, and assumes that
the interaction between molecules is the sum of all interactions between their
constituent atoms[8] so that the intermolecular energy as a function of the separation
distance (r) and relative orientation (Ω) of the molecules is:
U(r,Ω) = 
 BkAi
ikik rU
,
)(
where atom i belongs to molecule A and atom k belongs to molecule B, and they are
separated by distance rik. This approximation allows for the intermolecular potential
model to be transferable between organic molecules.
In work presented in this thesis only the dispersion, repulsion and electrostatic
interactions are modelled explicitly. The dispersion and repulsion contributions are
modelled together using empirically fitted models which are considered transferable.
By contrast, the electrostatic contribution is derived from the ab initio calculated
wavefunction and is only specific to the molecule(s) being investigated.
The remaining non-additive terms, the induction and charge transfer, are
neglected. Although some of these effects may be absorbed in the empirically fitted
models of the dispersion and repulsion terms.
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3.2.4 Empirical potentials: dispersion-repulsion potentials
The dispersion and repulsion terms are modelled together using the empirical
FIT potentials [11] that are considered transferable and where the atoms are assumed
to be spherical. These are described by the Buckingham potentials, where the
repulsion is represented by the exponential based term and the dispersion is
represented by the inverse 6th power term:
6)exp()( 
ikIKikIKIKikIK
rCrBArU
rik is the separation between atoms i (of type I) and k (of type K) respectively. This
potential depends on the parameters A,B and C to describe the interaction between
each type of atom pair, which are derived from experimental data of organic crystal
structures[12].
For heteroatomic interactions, the combining rules are used:
2
1
)( KKIIIK AAA  , )(2
1
KKIIIK BBB  , 2
1
)( KKIIIK CCC 
where I and K are different atomic types.
For carbon, non-polar hydrogen and nitrogen atoms, the parameters were
derived from fitting to azahydrocarbons crystal structures[11], and for the oxygen
atom from fitting to oxohydrocarbons crystal structures[13]. The polar hydrogen
atom parameters were derived from a wider range of organic crystal structures, which
included nucleic acid bases, non-linear optic materials, azabenzenes, nitrobenzenes
and other simple molecules [14]. The distinction between polar and non-polar
hydrogen atoms is necessary to account for the smaller effective van der Waals radius
of protons involved in hydrogen bonding[12].
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Once the dispersion-repulsion contributions are calculated, they are summed over all
intermolecular atom-atom distances to a defined cut-off of 30 Å.
Although these crystal structures were primarily used to derive the empirical
potentials for the dispersion and repulsion contributions, other intermolecular
interactions are also absorbed as they are present to some extent in the sample
crystals.
3.2.5 Modelling the electrostatic energy
In this thesis, two methods which approximate the electron density of the
molecule have been used to model the electrostatic contribution to the lattice energy
and these are discussed below.
1) The point charge method is a crude and computationally cheap approach
which assumes that the charge density of the molecule can be described by
superimposing spherical atomic electron densities. Although widely used, this
method is limited in terms of accuracy, as it cannot represent the electrostatic fields
due to non-spherical features such as lone pairs or π electrons[12].
There are a number of ways of obtaining these atomic charges.
Experimentally, X-ray diffraction data can be used as an experimental source to
derive them. This involves the integration of the three-dimensional map of the charge
density produced from the diffraction experiment to yield the atomic charges.
However, this procedure requires numerous approximations and assumptions which
reduces its reliability [15]. Alternatively, and as used in this study, they can be
derived from an ab initio calculated wavefunction of the molecule[12]. This involves
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the CHELPG scheme (an acronym for CHarges from ELectrostatic Potentials using a
Grid based method), whereby the atomic charges are fitted to reproduce the molecular
electrostatic potential at a number of points outside the van der Waals radius of the
molecule[16].
2) The distributed multipole analysis (DMA) method is a more elaborate
method where the atomic charge distribution is modelled using a series of multipoles
comprising of the charge, dipole, quadrupole, octopole and hexadecapole[5]. These
are fitted directly at each nuclear site. Thus non-spherical features in the atomic
charge distribution such as lone pairs or π electrons are accounted for. These are
critical in evaluating the relative stabilities of crystals that differ subtly in the
geometries of their hydrogen bonding and π-π stacking arrangements[17]. In this
method, the distributed multipoles are derived from an ab initio wavefunction of the
molecule using the program GDMA2 [18] by a distributed multipole analysis[19].
Short-range multipole interactions converge rapidly and are summed directly
between all atoms in molecules whose centre of mass are within 30 Å. However long-
range interactions which include the charge-charge (r-1), charge-dipole (r-2) and
dipole-dipole (r-3) terms are evaluated using the Ewald summation method [20].
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3.3 Computational methodology
The intermolecular energy of a crystal (Uinter) is the sum of all long and short
range intermolecular interactions described above, and for rigid molecules it defines
the lattice energy: Elattrigid=Uinter [21], i.e. the difference in energy between the
molecules in a static lattice at 0K and when infinitely separated. For flexible
molecules, the lattice energy is defined as Elattflex=Uinter+Eintra, where Eintra is the
conformational intramolecular energy penalty that the molecule must pay for
changing its conformation from the most stable gas phase conformation to one that
allows better intermolecular interactions in the crystal[22].
Designing a computational methodology for the generation of putative
structures and calculating their lattice energies requires a balance between the
accuracy of the model and the computational costs. Typically, thousands of structures
are produced, covering a range of possible space groups. However it is the low lying
energy structures that reflect physical reality and are of greater interest, hence more
emphasis on the accuracy is required when modelling them. To address the accuracy
and computational cost problem, the methodology used in this thesis is a multistage
one[2], where the accuracy of the modelling is improved at subsequent stages and the
number of minimized structures is progressively cut down as the high energy ones are
discarded (figure 3.2).
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Figure 3.2: Workflow of the computational methodology used. In stages I-III the molecules are
held rigid in the unit cell during optimization, whereas in stage IV they are allowed to relax.
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3.3.1 Stage I: Ab initio optimization of the molecular conformation
It is assumed for simple organic molecules, as those studied in this thesis, that
the molecular conformation in the gas phase is a good approximation to those in
all solid forms [4]. The use of an experimental molecular conformation from a
known polymorph could unfairly bias the computational results, thus for a
credible computational study, an ab initio optimization is performed to obtain the
optimized (gas phase) molecular conformation. This is achieved through the
following 3 step process:
 Step I: An experimental structure† defined by its cell parameters, symmetry
operations and fractional atomic coordinates is converted into a Cartesian
representation using the utility program NEIGHCRYS[24], which also
standardizes any X-H bond length solved from X-ray diffraction to average
values derived from neutron data[25].
The Cartesian coordinates of the molecule, defined by an axis system, are then
used in the ab initio calculations to obtain the wavefunction of the
experimental molecular conformation. This is performed using the quantum
package GAUSSIAN03[26] with the 6-31G(d,p) basis set and MP2 (Moller-
Plesset 2nd order) level of theory. This basis set and level of theory is
maintained throughout the computational work presented in this thesis.
The distributed multipoles are then derived directly from the ab initio
calculated wavefunction using the program GDMA2. These are inputted,
along with the empirical FIT potentials, into the program DMACRYS [27]
† The experimental crystal structure is taken from the Cambridge Structural Database (CSD)[23] in the
.res format. If multiple structures of the same compound are stored in the database the one with the
lowest R-factor (%) is used with preference to the structures solved using neutron diffraction.
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which is used to calculate the lattice energy with the molecule(s) held rigid
within the unit cell. The lattice energy is optimized using a modified Newton-
Raphson method.
 Step II: the experimental conformation is ab initio minimized to obtain the
optimized molecular conformation, this is achieved using GAUSSIAN03.
 Step III: this step is similar to that of step I, however the experimental
molecular conformation is replaced with the optimized molecular
conformation (from step II) using the computer program OptimalPaste [28].
The lattice energy minimized crystal structure containing the ab initio
optimized conformation is referred to as ExpMinOpt.
The ExpMinOpt structure is used as a preliminary test to confirm whether the
computational model is likely to be adequate for the generation and
optimization of putative structures in the following stages. This is done by
comparing it against the experimental structure, as found in the CSD, using
the root mean square overlay of all the non-hydrogen atoms in a 15 molecule
coordinate cluster [27] (RMSD15) as implemented in the program
Mercury[27,29]. An RMSD15 value below 0.5Å suggests that the model is
sufficient.
The ExpMinOpt structure is simulated as a static entity at absolute zero
whereas the experimental structure is solved at a higher temperature, and as
such, some discrepancy between the two will always be present. This is due to
the differences in the cell dimensions, which are induced by the likely
thermal expansions [27].
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3.3.2 Stage II: Generation and optimization of putative structures
using a cheap electrostatic model (CrystalPredictor)
The program CrystalPredictor [30] utilizes a global optimization search
algorithm, and is used to generate randomly a large number of hypothetical crystal
structures containing the ab initio optimized molecular conformation in the following
15 space groups: P1, P

1 , P21, P21/c, P21212, P212121, Pna21, Pca21, Pbca, Pbcn,
C2/c, Cc, C2, Pc and P2/c. These space groups have been specifically chosen due to
their prevalence in the CSD for organic crystals [23,31].
The generated hypothetical structures are then minimized using the FIT
empirical potentials and CHELPG point charges. The lattice length and angles are
restricted to a fixed range to avoid the consideration of deformed cells [30].
The resulting minimized crystal structures are then processed using the
program ANALYSE[32] to ensure that only unique structures are carried forward to
the next stage. ANALYSE compares the lattice energies, densities, and the minimum
intermolecular distances between each distinct pair of atom types to eliminate
duplicate structures[30].
3.3.3 Stage III: Rigid-body refinement using a more realistic
electrostatic model (DMACRYS)
A selection of the lowest energy structures from stage II are forwarded for
refinement using the program DMACRYS. This process is analogous to that in stage
I step I, and calculates the lattice energy: Elattrigid=Uinter, with the electrostatic
contribution modelled anisotropically. For molecules with a rigid structure, the
calculation is complete at this point.
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To eliminate duplicate structures, the program CLUSTER[33] is used. This
process is similar to that performed using ANALYSE, but with an additional
comparison of the simulated X-ray powder patterns.
3.3.4 Stage IV: relaxed body refinement (CrystalOptimizer)
The lattice energy of flexible molecules is defined as Elattflex=Uinter+Eintra.
Calculating Elattflex requires a combined approach of minimizing the intermolecular
lattice energy (Uinter) and the intramolecular lattice energy (Eintra). Such calculations
are achieved using the program suite CrystalOptimizer[34] which couples
DMACRYS with GAUSSIAN03 and GDMA2.
From stage III, a limited number of the lowest energy structures with some
degree of flexibility are forwarded for relaxed body refinement. The flexibility is
defined by a set of torsion angles which allows for conformational change (for
example figure 3.3). Other degrees of flexibility such as bond lengths and bond
angles are not expected to deviate significantly from the values given when the
molecule is ab initio optimized in isolation with the flexible torsion angles
constrained to the conformation in the crystal.
C2 C3
C4
C5C6
C1N1
H1
H2
 
C7
O1
O2 H3


Figure 3.3: The ﬂexible torsion angles for 4-aminobenzoic acid varied in the generation of crystal
structures and lattice energy minimizations are labeled and are defined as: =H1-N1-C1-C6,
=H1-N1-C1-H2, =O1-C7-C4-C3 and =H3-O2-C7-C4. Torsion  is an improper dihedral
determining the amine group pyramidalization
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CrystalOptimizer performs a ‘simplex minimization’ of Elattflex by optimizing
the intermolecular component (Uinter) of the lattice energy for each conformation
generated by varying the flexible torsion angles in a series of ‘on-the-fly’ ab initio
calculations of the isolated molecule to provide the intramolecular energy (Eintra),
and the corresponding distributed multipoles. This form of refinement leads to
improved hydrogen bonding between molecules as it allows for small changes in the
conformation of NH2 or OH groups[2].
3.4 Analysis of lattice energy landscapes
The process of generating and minimizing the lattice energy of putative
crystal structures is termed the ‘search’. The search is computationally more
demanding for flexible structures with more than one molecule in the asymmetric unit
(i.e. cocrystals) than for rigid structures with only one molecule in the asymmetric
unit, as a considerably greater number of crystal structures are generated. This is due
to the increased dimensionality arising from the additional need to calculate the
relative orientation of the components[35]. Structures generated in the search that are
sufficiently low in energy are of practical importance [36], typically these structures
are up to 10-20 kJ/mol less stable than the most stable computed structure (the global
minimum structure). These low energy structures define the lattice energy landscape.
The lattice energy landscape and hence the search results are summarized on scatter
plots of lattice energy against the density.
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3.4.1 Identifying the experimental structure on the lattice energy
landscape
To identify the experimental structure on the lattice energy landscape, manual
comparisons of the lattice energies, cell parameters and simulated powder X-ray
patterns are made between the ExpMinOpt structure (produced in stage I step III) and
the low lying lattice energy structures produced in the search. The ExpMinOpt
structure is the only version of the experimental crystal structure that can be directly
compared with the generated putative structures as it has been energy minimized
using the same intermolecular potential and molecular conformation.
If the search is extensive enough, the experimental structure (ExpMinOpt)
should be found in the lattice energy landscape. The experimental structure should be
located within the plausible energy range of polymorphism from the global minimum
structure. If not, the method of evaluating the relative energy of structures is probably
inadequate.
3.4.2 Interpretation of lattice energy landscapes for polymorphism
Several types of landscapes are possible, in the simplest case, the known
crystal structure is thermodynamically favoured (i.e. found at the global minimum)
and is separated from the rest of the computed structures by a large energy gap (figure
3.4a). This is an ideal scenario for confident crystal structure prediction, as the errors
due to the approximations are insignificant in comparison to the energy gap
separating this structure from all other computed structures, indicating that
polymorphism is highly unlikely. An example of this is Yellow Pigment 74 [37],
where the known form was found at the global minimum, 12 kJ/mol lower in energy
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than the next most stable structure, and had a close-packed structure which is
preferred to all other computed structures.
Such a ‘monomorphic’ lattice energy landscape is rarely encountered, more
commonly the global minimum is separated from the rest of the computed structures
by a smaller energy gap that is too small to rule out potential polymorphism.
Another possible scenario is where the experimentally known form is located
above the global minimum structure but the energy difference is very small (figure
3.4b). This could be attributed by the approximations used in the model, and
consequently minor changes to the way the energy is calculated could result in a
significant reordering of the computed and experimentally known structures. It may
also be conceivable that the ordering of these structures is in fact correct, and that the
global minimum structure could be produced experimentally under different
laboratory conditions. For example, the generation of the lattice energy landscapes for
progesterone and 5-fluorouracil identified their only known forms (at that time) to be
higher in energy than the global minimum. Subsequent experimental attempts
targeting the global minimum structure using a different crystallization set up were
successful[38,39]. For the pharmaceutical industry, it would be vital to find this
polymorph or risk it appearing unexpectedly and disrupting the production
process[40].
A final example is where the lattice energy landscape is a congested one with
many crystal structures about the low energy region (figure 3.4c). Such a range of
equi-energetic structures could imply that the molecules cannot pack well with
themselves and are susceptible to polymorphism, disorder or difficulty in
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crystallizing, as illustrated in the case of caffeine [41]. It has been hypothesized[42]
that compounds with these attributes present good candidates for coformers, as an
alternative more preferred packing mode might become available upon
cocrystallization.
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Figure 3.4: Examples of lattice energy landscapes. (a) Ideal scenario, where the experimental
structure is the global minimum. (b) The experimental structure may not be thermodynamically
most stable. (c) The experimental structure is among a range of low energy structures. In all
cases the experimental structure is shown in red.
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3.4.3 Motif generation: the advantage of computational modeling over
crystal engineering for the design of cocrystals
Analyzing the structures on the lattice energy landscape in terms of their
hydrogen bonding motifs, will often show that there is a prevalent motif amongst the
low lying energy structures which would have been expected from crystal
engineering guidelines [43,44]. This confirms that the prevalent motif represents a
strong, stabilizing interaction [45]. However in some cases, the low energy structures
may adopt a different packing style to that expected from crystal engineering, for
example the lowest energy and experimental structure of alloxan [46] does not
contain the conventional hydrogen bonds seen in the higher energy structures. Such
uncommon molecular packing cannot be predicted by crystal engineering, but can by
computational modeling where all the collective molecular interactions are
considered rather than focusing on a set of chemically intuitive synthons.
This computational ability has been used to rationalize why formic acid
crystallizes with catemeric hydrogen bonds whereas most carboxylic acids, including
benzoic acid, form R 22 (8) dimers[46]. Analysis of the lattice energy landscapes found
that all the low energy structures for benzoic acid had a R 22 (8) motif, whereas both
motifs were found for formic acid. This suggested that catemers could only form
between molecules with small substituents on the acid group, as the steric bulk of the
aromatic ring prevented catemer formation[47,48].
In a recent study, structural analyses of both experimental and computed
structures have been used to establish and rationalize the optimum packing style of a
series of structurally related steroid cocrystals[49]. In this study, crystal engineering
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concepts were limited as the coformers investigated did not contain hydrogen bond
donor or acceptor functional groups.
3.4.4 Combining computational and experimental data to solve crystal
structures
Results from the search can assist in determining the crystal structure for
cases where structural determination by single crystal X-ray diffraction could not be
achieved (possibly due to the lack of quality single crystals to perform the diffraction
experiment) or where structure solution from powder X-ray diffraction (PXRD) is
ambiguous. The process involves comparing the simulated PXRD patterns of the
generated structures with one obtained experimentally to identify an equivalent
match. This approach has helped in determining the crystal structure of various
organic compounds[50-52].
It is hoped that searches, combined with periodic ab initio calculations could
also be used to define the structure of multicomponent systems as either salts or
cocrystals in cases where the hydrogen atom is difficult to locate by X-ray
diffraction[53].
3.5 Previous and simultaneous work on crystal structure prediction of
cocrystals
3.5.1 Cambridge Crystallographic Data Centre blind tests
There has been steady evidence of significant improvements in the field of
crystal structure prediction, as exemplified by successes in the international blind
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tests of crystal structure prediction (CSP) organized by the Cambridge
Crystallographic Data Centre (CCDC)[54-57]. These exercises challenge the
capability of academic groups and commercial companies to predict the crystal
structures of organic molecules which have been determined experimentally but
remained unpublished, with nothing more than a molecular diagram and the
crystallization conditions. The assumption that most of the participants use is that the
lowest energy computed structure (the global minimum) on the lattice energy
landscape plot is the most likely experimental crystal structure, and structures with
competitive energies are potential polymorphs [3]. Figure 3.5 shows the molecules
used in the past four blind tests and a summary of results. The rate of success of these
blind tests has varied according to the complexity of the molecules and the type of
methods used.
In the fourth blind test (2007)[57], a cocrystal was put forward for
investigation to test those computational methods that had developed the ability to
model structures with more than one molecule in the asymmetric unit. Two very
different approaches were successful in correctly predicting the cocrystal structure.
The first used a hybrid method[58] that combines the density functional theory
calculations with an empirical van der Waals correction by means of the programs
GRACE1.0[59] and VASP[60-62]. This method considers all 230 space groups and is
computationally very expensive. The other method used a random search technique
implemented in the UPACK program package[63] in 13 space groups. This approach
is similar to the methodology used in this thesis, although a different search program
was used.
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VIII Rigid‡
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4/14
II Rigid
1/8
V Rigid
4/15 IX Rigid
1/15
XIII Rigid
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III Flexible
1/11
VI Flexible
0/11
XIV Flexible
3/12
X Flexible
0/12
VII Flexible
1/4 XI Rigid†
0/13 XV Cocrystal
2/12
Figure 3.5: Summary of results from the first four CCDC international blind tests for CSP of
organic molecules. X/Y indicates that there were X correct predictions, as determined by a
reasonable root mean square overlay of all non-hydrogen atoms in a 15 molecule coordinate
cluster (RMSD15), from the Y participating entries. ‡ Crystallographic details of molecule VIII
were accidentally revealed prior to the results submission deadline, consequently it was not
treated as a ‘blind’ test molecule and was replaced by molecule XI.
A partial attempt to predict the cocrystal XV was made using
CrystalPredictor, but technical problems were discovered just prior to submission.
The experience of the 2007 blind test was used to improve the approach used in this
thesis. Note that the blind test only identifies which structure the cocrystal can adopt,
not whether it will actually form, i.e. the order of stability of the cocrystal with
respect to its components (sections 3.5.2) is not investigated.
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3.5.2 Lattice energy comparison of cocrystals and their components
In the following chapters, a novel approach for the structure prediction of
cocrystals and the likelihood of their formation is investigated. This is based on
lattice energy comparisons of cocrystals and their individual components. Central to
this approach are the assumptions that cocrystals are thermodynamically more stable
than their components and that relative thermodynamic stability can be equated to
relative lattice energies. This is a similar approach to that used to investigate the
stoichiometries of multi-component systems (section 3.5.3). In order to predict the
formation of a cocrystal, the lattice energy landscapes for both the components and
the cocrystal need to be calculated and compared. If a cocrystal (of given
stoichiometry) is to be found, it should be the most stable cocrystal structure in its
lattice energy landscape, and be more stable than its components.
Results from this work have paved the way for other computational studies
aimed at rationalizing experimental observations of cocrystals. For example in a
recent experimental study[64,65], attempts made to form cocrystals between
carbamazepine and the coformers isonicotinamde, nicotinamide and benzamide
where successful. However cocrystals with picolinamide did not form despite the
structural similarity of this coformer with the other pyridine carboxamides.
Computational modeling[35] supported these experimental results, as the observed
cocrystals were found to be more stable than their components, whereas the
hypothetical cocrystal, carbamazepine•picolinamide, was predicted to be too high in
energy. Structural analysis of the hypothetical cocrystal, found fewer hydrogen bonds
than anticipated using the crystal engineering guidelines.
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3.5.3 Predicting the formation and stoichiometry of multicomponent
systems
It has been stated that multicomponent systems will usually form in an
‘expected’ stoichiometry that is consistent with the number of hydrogen bond donor
and acceptor groups present [66]. However, for complex components such as API’s,
where the number of donor and acceptor groups is high, more than one stoichiometry
may be possible. Stoichiometric preferences are difficult to forecast and can vary
within a related group of structures. For example both 1:1 and 1:2 stoichiometries are
known for caffeine:acetic acid solvate[67], whereas only a 1:2 stoichiometry is
observed for urea:acetic acid solvate[68]. Computational methodologies can be used
to understand these stoichiometric uncertainties by predicting the preferred ratio on
energetic grounds, as exemplified in the study of theobromine:acetic acid solvate[51]
and caffeine:monosubstituted hydrobenzoic acids cocrystals[69]. A major finding of
these comparisons is that the relative stabilities of different stoichiometries are often
small, comparable to polymorphic energy differences.
81
3.6 Outline of computational projects‡
In chapter 4, and to a lesser extent in chapter 5, a contemporary computational
model will be tested for its ability to account for the formation of known cocrystals
on thermodynamic grounds. This will be achieved by calculating and comparing the
lattice energy of a number of known cocrystals against the weighted sum of their
components.
In chapter 6, a full search is performed to generate lattice energy landscapes
of two binary systems and their components. Only one of these produced a cocrystal
following the extensive experimental screens described in chapter 5. This study will
test the ability of computational modeling to predict the crystal structure of the
cocrystals and their components as well as calculate their relative stabilities.
The overall objective of these projects is to investigate the viability of
computational modeling as an efficient and effective tool in the screening of
cocrystals, and whether they could be applied synergistically with experimental
studies for the discovery of novel cocrystals.
‡ The computational projects described in the next parts of this thesis were performed concurrently to
the multicomponent system studies described in this chapter.
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Chapter 4. Can the Formation of Crystals be Computationally
Predicted? Comparison of Lattice Energies
4.1 Introduction
In chapter 2, the standard approach of producing cocrystals was described:
this typically involves the selection of compounds with complementary functional
groups, as inferred by crystal engineering guidelines, to be used in extensive and
varied experimental screens of cocrystals. However, despite this comprehensive
approach, cocrystallization attempts are rarely successful[1,2]. This has led to the
development of other methods of cocrystal screening such as the use of ternary phase
diagrams[3], which if symmetrical, may suggest the formation of a
thermodynamically favoured cocrystal [3]. Although phase diagrams present a more
advanced way of determining the existence of cocrystals than the crystal engineering
guidelines, they are difficult and time consuming to construct and are specific to each
binary system as they are only applicable to the experimental conditions they were
derived from such as temperature and choice of solvent.
Recently, there have been considerable advances in the ability to predict
crystal structures from the chemical diagram as evidenced by the international blind
tests [4-7] organised by the Cambridge Crystallographic Data Centre, which in
2007[3], included a cocrystal for the first time. This exercise stipulates that the most
stable structure in the search corresponds to the experimentally known form (section
3.5.1). Thus, assuming that cocrystallization is a thermodynamically driven process;
i.e. cocrystals are more stable than the sum of their components, it should be possible
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to computationally predict their formation. Hence, future experimental endeavours
targeting cocrystals need only to focus on a smaller set of promising candidates,
thereby considerably reducing labour and consumption of chemical resources e.g.
APIs.
This chapter, therefore, investigates whether the formation of cocrystals can
be computationally predicted by comparing the lattice energies of 26 known
cocrystals against the weighted sum of their components using a methodology that
could be feasibly applied in a search so as to provide a genuine prediction.
In keeping with the pharmaceutical theme of this thesis, the cocrystals studied
have at least one component of pharmaceutical relevance.
4.2 Method
4.2.1 Coformer and cocrystal selection
The choice of cocrystallizing agents studied was limited to those approved by
the FDA as ‘generally recognized as safe’ (GRAS) for internal administration, that
were also computationally feasible, i.e. had a limited flexibility and contained only
carbon, hydrogen, oxygen and nitrogen in common functional groups. The
Cambridge Structural Database (CSD)[8] (September 2007) was searched for
cocrystals of these compounds, including their partner molecules, which obeyed the
computational restrictions. Another requirement, was that the crystal structures of
both the cocrystals and at least one polymorph of the component molecules were
reasonably well determined (R-factor <10%), with no disorder and had the proton
positions determined. Generally all polymorphs with a sufficiently well determined
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crystal structure have been considered. When there were multiple entries for a
polymorph in the CSD, the crystal structure with the lowest R-factor determined at
the lowest temperature, with a preference for any neutron determinations, was used.
Succinic acid and 4-aminobenzoic acid were chosen as they had a significant
number of cocrystals that could be studied. Caffeine was also included, despite fewer
suitable cocrystals, as it is rather unique amongst possible pharmaceutical coformers
due to its inability to hydrogen bond to itself, and thus, increases the diversity of this
study.
Caffeine belongs to a group of stimulants called xanthines and is often
included in analgesic preparations.[9] It crystallizes from aqueous solution as a
monohydrate[10], and under ambient temperature and atmospheric pressure may
convert to the -anhydrous form, which in turn converts to the -anhydrous form
above 155 C[11]. Only powders[12]and disordered crystals[13,14] of caffeine have
been obtained. The high temperature  polymorph is dynamically orientationally
disordered[13,15] and high in symmetry (Z=1/3), whereas a tentative solution from
powder[12] for the low temperature  polymorph gave a Z=5 structure. Calculations
of the crystal energy landscape of caffeine[16] rationalized the problems of growing
an ordered crystal structure in terms of there being a range of nearly equi-energetic
structures, where the caffeine molecules stack in different modes each with varying
ways of packing. Since there is no ordered crystal structure suitable for the
computational modeling of caffeine, the lowest energy structure found in a
computational search was used to estimate its lattice energy. The caffeine cocrystals
considered in this study are presented in table 4.1.
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Table 4-1: Structures of molecules which cocrystallize with caffeine, defining the crystal
structures used in this study. The CSD reference code of the pure component structures above
and the cocrystal structures below the dotted line. The intramolecular degrees of freedom that
were optimized within the lattice energy minimization are indicated. All structures are Z'=1, and
cocrystals stoichiometries 1:1 unless otherwise indicated by S=caffeine:partner. Known
crystallization conditions for the cocrystals are given with SSE denoting slow solvent
evaporation.
N
N
N
N
CH3
O
CH3
O
CH3
Caffeine
No ordered structure in CSD, use lowest energy
computed structure generated in a search
NN
H H
OO
CH3
CH3
O
Barbital
Form I, DETBAA11[17], 3R
Form II, DETBAA04[18], C2/c,
Z'=0.5
O H
OOH
O
Oxalic acid
α-form, OXALAC06[19],
Pbca, Z'=0.5
β-form, OXALAC04[20],
P21/c, Z'=0.5
O
O
H
O
O
H
Maleic Acid
Form I, MALIAC12[21], P21/c
Metastable form II,
MALIAC13[21], Pc
CAFBAR20[22], 1P , S=1:2 GANXUP[23], P21/c,
Z'=1.5, S=1:0.5
SSE using chloroform and
methanol
GANYEA[23], P21/n
SSE using dichloromethane.
O
O
O
O
H
H
Glutaric acid
Form III, GLURAC02[24], C2/c, Z'=0.5
β-form - GLURAC04[19], C2/c, Z'=0.5
H
O O
O
H
O
Malonic acid
α-form, MALNAC03[25], Pbcn, Z'=0.5
β-form, MALNAC02[26], 1P
Form II, EXUQUJ[27], 1P
Form I, EXUQUJ01[27], P2/c
SSE using chloroform (precipitate concomitantly)
GANYAW[23], Fdd2, Z'=1.5, S=1:0.5
SSE using chloroform and methanol
Succinic acid has been extensively studied as a cocrystal former, exploiting
the tendency of the carboxylic acid group to form a doubly hydrogen bonded R22(8)
motif with amides and amino-pyrimidines as well as with itself. Overall, 27
cocrystals have been reported, but for a significant number of these, the crystal
structure of the partner molecule was not available, or could not be modeled by the
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chosen computational method. Succinic acid has two polymorphs:  and  with the
latter being more stable at room temperature[24]. However, both are based on chains
of molecules linked by R22(8) carboxylic acid dimers. Table 4.2 displays the succinic
acid cocrystals considered in this study, many of which are 1:2 cocrystals with
succinic acid on a centre of symmetry.
4-Aminobenzoic acid has been described as one of the most versatile acids for
cocrystal formation, as it has the potential for hydrogen bonding through carboxylic
acid and amino groups[28]. Indeed, the search of the CSD gave 23 cocrystals of 4-
aminobenzoic acid, though only 12 were suitable for this computational study, as
shown in table 4.3. 4-Aminobenzoic acid is an API associated with vitamin B[9] . It
has two polymorphic forms: the commercially available α-form with a long fibrous
needle morphology; and the β-form which has a prismatic morphology[29]. The
solvent used during crystallization influences the type of motif formed[29], with the
R22(8) carboxylic acid dimers crystallizing in the  form with relative ease from a
range of solvents (predominantly alcohols) although often with twinning and
disorder[29-31]. The  form[32] has a distinctive R44(12) hydrogen bond motif
(figure 4.1) and has only been reported as crystallizing from water or ethyl acetate,
often concomitantly with the  form[29,33], although the application of controlled
sonication has been shown to promote the  form[34]. These polymorphs are
enantiotropically related, with a transition temperature of 25 °C, below which the
form is the thermodynamically stable polymorph[29]. At the transition temperature
the enthalpy of the form is about 5.5 kJ mol-1 lower than the  form, and the
entropy is about 19 J mol-1 K-1 lower[29].
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Table 4.2: Structures of molecules which cocrystallize with succinic acid, defining the crystal
structures used in this study. The CSD reference code of the pure component structures above
and the cocrystal structures below the dotted line. The intramolecular degrees of freedom that
were optimized within the crystal energy minimization are indicated, with double arrows
representing the independent rotation of two fragments around the same single bond. All
structures are Z'=1, and cocrystal stoichiometries 1:1 unless otherwise indicated by S=succinic
acid:partner. Known crystallization conditions for the cocrystals are given with SSE denoting
slow solvent evaporation.
O
O
H
O
O
H
Succinic acid
α-form, SUCACB07[35], 1P
β-form, SUCACB03[36], P21/c
O
NH
H
Benzamide
Form I, BZAMID05[37], P21/c
Metastable form II,
BZAMID06[38], Pba2, Z'=0.5
N
O
NH
H
Isonicotinamide
Form I, EHOWIH[39], P21/c
Form II, EHOWIH02[40],
P21/c, Z'=2
N O
H
2-Pyridone
PYRIDO04[41], P212121
BZASUC[42], P21/c, Z'=1.5 , S=
0.5:1
Slow Cooling using Nitromethane
LUNNUD[43], 1P , Z'=1.5,
S=0.5:1
SSE using ethanol
NISTAK[44], P21/n, Z'=1.5, S=0.5:1
SSE using water
N
N
N
H
H
2-Aminopyrimidine
AMPYRM01[45], Pbca
NN
H
H
H
H
O
Urea
UREAXX02[46], m24 1P ,
Z'=0.25
N
N
Phenazine
α-form, PHENAZ04[47], P21/n,
Z'=0.5
β-form, PHENAZ11[48], P21/n
SERMOR[49], P21/n
SSE (solvent unknown)
VEJXAJ[50], P21/c, Z'=1.5,
S=0.5:1
SSE in ethanol
WOQBOT[51], P21/n
N
O
N
N
N
2,5-Bis(4-Pyridyl)-1,3,4-oxadiazole
ODACIF01[52], C2/c, Z'=0.5
N
N
(E)-4,4'-Diazastilbene
AZSTBB[53], P21/a, Z'=0.5
GAWLOG[54], 1P , Z'=1.5, S=0.5:1
Recrystallization using methanol and water
UMINOT[55], 1P
SSE using acetone: ethanol (2:1)
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Figure 4.1: The hydrogen bonding motifs in α and β 4-aminobenzoic acid. In the α form (left),
the two crystallographically independent molecules are each hydrogen bonded to an equivalent
molecule, with O(-H)···O distances of 2.64 and 2.61 Å. The carbonyl group of one molecule
hydrogen bonds to the NH2 group of the other molecule, with a N(-H) ···O distance of 2.98 Å.
The NH2 group of the second molecule is not involved in hydrogen bonding. The hydrogen
bonds in β (right) are O(-H) ···N, 2.75 Å, and N(-H) ···O, 3.05 Å.
The cocrystals of 4-aminobenzoic acid considered in this study are presented
in table 4.3, the majority of which are based on the R22(8) carboxylic acid dimer.
Computational modeling of the 4-aminobenzoic acid•carbamazepine cocrystal only
considered the thermodynamically most stable polymorph of carbamazepine, as
carbamazepine was previously investigated using very similar computational
methodologies to those used in this thesis, and the results correctly predicted form III
as the most stable polymorph[56-58].
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Table 4.3: Structures of molecules which cocrystallize with 4-aminobenzoic acid, defining the
crystal structures used in this study. The CSD reference code of the pure component structures
above and the cocrystal structures below the dotted line. The intramolecular degrees of freedom
that were optimized within the crystal energy minimization are indicated, with double arrows
representing the independent rotation of two fragments around the same single bond. All
structures are Z'=1, and cocrystal stoichiometries 1:1 unless otherwise indicated by S=4-
aminobenzoic acid:partner. Known crystallization conditions for the cocrystals are given, with
SSE denoting slow solvent evaporation.
HO
O
N
H
H
4-Aminobenzoic acid
α-form, AMBNAC0131, P21/n, Z'=2
β-form, AMBNAC04[32], P21/n
H O
O
NO2
4-Nitrobenzoic acid
Form II, NBZOAC02[59], P21/c
Form I, NBZOAC04[60], A2/a
N
N
2,2-Bipyridine
BIPYRL04[61], P21/n, Z'=0.5
NN
4,4'-Bipyridine
HIQWEJ02[62], 1P ,
Z'=2
DAQYOK[63], P21/c
SSE using 1:2:3
CHCl3/Hexane/2-Propanone
DAQYUQ[63], P21/c, Z'=1.5,
S=1:0.5
SSE using methanol
UDUZOI01[64], P21/n,
Z'=1.5, S=1:0.5
SSE using methanol
N
N
N
H
H
2-Aminopyrimidine
AMPYRM01[45], Pbca
NN
H
H
H
H
O
Urea
UREAXX02[46], m24 1P , Z'=0.25
N
N
N
N
H
H
2-Amino-4-(4-
pyridyl)pyrimidine
OCATOB[65], P21/c
LEWPUY[66], P21/n
SSE using ethanol
NUHYEU[67], Pnab, Z'=1.5,
S=1:0.5
SSE using ethanol
OCATUH[65], P21/c
SSE using ethanol
N
H
H
O2N
4-Nitroaniline
NANILI22[68], P21/n
NO2
O
O
H
4-Nitrophenylacetic acid
SEMTAF01[69], Pbca
N
N
N
H
H
O
O
CH3
CH3
2-Amino-4,6-
dimethoxypyrimidine
AFUYIJ[70], C2/c
RILJEB[71], P21/c
SSE using ethanol
RILJOL[71], P21/a
SSE using ethanol
IFACUO[72], P21/c
SSE using methanol
NO2O2N
NO2
1,3,5-Trinitrobenzene
Form I, TNBENZ11[73], Pbca,
Z'=2
Form II, TNBENZ12[73], Pca21,
Z'=2
Form III, TNBENZ13[73], P21/c
N
H
H
N
4-Aminobenzonitrile
monoclinic - BERTOH[74], P21/c
orthorhombic - BERTOH01[75],
P212121
N
H
H
O
Carbamazepine
Form III,
CBMZPN10[76], P21/n
WIKTEP[77], C2/c
Crystallizes from water
WOCVIT[78], P21/c
SSE using ethanol
XAQRAJ[79], C2/c,
Z'=1.5, S=0.5:1
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4.2.2 Computational methodologies
Nearly all the molecules in this study have some degree of flexibility as
indicated by their torsion angles in figures 4.1-4.1. These torsion angles, as well as
the cell parameters, position and orientation of each independent molecule were
varied to minimize the lattice energy (Elattflex); which is the sum of the intermolecular
lattice energy (Uinter) and the conformational energy penalty (Eintra) required to
improve the intermolecular interaction such as hydrogen bonding.
The calculations of Uinter were performed using the program DMAREL§ [80]
which is an older version of DMACRYS (section 3.3.3), whereas that of Eintra were
performed using the program DMAflex§ [57], an older version of CrystalOptimizer
(3.3.4). These calculations are equivalent to the stage IV computational methodology
described in section 3.3.4 and uses the same empirical repulsion-dispersion potentials
[81-83] and models the electrostatic contribution anisotropically using the program
GDMA2 [84].
Each minimization was carried out using the space group symmetry of the
experimental structure, or the space group which contained whole molecules in the
asymmetric unit. The rigid-body second derivatives of Uinter were used to confirm that
the optimization had converged to a minimum rather than a transition state. The final
value of Eintra was evaluated at the HF 6-31G(d,p) level relative to the globally
optimized molecular structure at the HF level. The quality of the reproduction of
crystal structure was evaluated by the optimal root mean square overlay of all non-
§At the time of performing lattice energy calculations in this chapter, the programs DMAflex and
DMAREL were used. These were later replaced by the programs CrystalOptimizer and DMACRYS
respectively, which apply the same principles as their superseded programs.
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hydrogen atoms in a 15 molecule coordination sphere[85] (RMSD15) calculated by
Mercury[86].
The lattice energies of each cocrystal, Elattcocry, were compared with the
weighted sum of the lattice energies of the crystals of the components, Elattsum, which
is defined for a cocrystal with m molecules of the coformer and n of the partner
molecule by Elattsum= (mElattcoformer+ nElattpartner), to give the lattice energy in kJ mol-1
for the cocrystal.
The lack of a reliable crystal structure for caffeine meant that the lattice
energy for this coformer was taken as that of the most stable crystal structure found in
a search for ordered caffeine crystal structures, using the same model for DMAflex
lattice energy minimization. A CrystalPredictor[87] search (stage II [section 3.3.2])
for Z=1 structures in the common tetragonal, orthorhombic, monoclinic and triclinic
space groups was performed with the ab initio optimized structure of caffeine held
rigid. All the 2300 unique structures found in this search within 25 kJ/mol of the
global minimum were then reminimized (stage III [section 3.3.3]) using the
distributed multipole electrostatic model instead of the point charge model. The most
stable of these structures were then minimized by DMAflex to optimize the
conformation of the methyl groups (indicated on Table 4.1) to be consistent with the
other lattice energy evaluations. Keeping the methyl groups in their gas phase
conformation until the final DMAflex refinement is a reasonable approxiamation, as
methyl groups often rotate quite freely at room temperature, even within the crystal.
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4.3 Results
4.3.1 Caffeine
The relative lattice energies of caffeine proved surprisingly sensitive to the
optimization of the methyl torsion angles (Figure 4.2a). Methyl rotations
corresponding to small intramolecular energy penalties of up to 3.1 kJ mol---11 were
more than compensated for by the improved intermolecular lattice energy resulting
from an increase in density (the methyl groups were also significantly rotated from
the gas phase conformation in all the experimental cocrystal structures.) The most
stable structure has a lattice energy of -112.07 kJ mol-1, which was used as the
caffeine energy, Elattcoformer, in determining the relative thermodynamic stability of
caffeine cocrystals. In this global minimum structure, the caffeine molecules stack in
sheets that comprise of anti-parallel columns with respect to the direction of the 6-
membered ring, each column is inverted over the next layer as these sheets stack on
each other (figure 4.2b).
The majority of the caffeine cocrystals are predicted to have a lattice energy
within 5 kJ mol-1 of the sum of the components, with the majority being more stable
(Figure 4.3). This is despite the greater intramolecular lattice energy penalty for all
the caffeine cocrystals (Table 4.4), implying that the partner molecules are more
conformationally distorted in the cocrystals than when crystallized by themselves.
However, the caffeine molecules are not stacked in the cocrystals in the ways seen in
the disordered structures or the lattice energy landscapes[16] of pure caffeine,
therefore, the cocrystal structures are not determined by a preferred self-association
stacking mode of caffeine.
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Figure 4.2: Results of the caffeine search. (a) The effect of optimising the methyl rotations on the
low energy crystal structures of caffeine found in a search for Z´=1 crystal structures. The red
symbols denote the lattice energy minima (Elattrigid=Uinter) when caffeine is held rigid in the ab
initio optimised conformation. The blue symbols indicate energy minima obtained from the
DMAflex optimization of the three methyl torsion angles, i.e. Elattflex=Uinter+Eintra. The dashed
lines connect the low energy DMAflex optimized structures to their starting positions following
rigid body optimization. (b) The packing of caffeine molecules in the global minimum structure
forms sheets that are based on anti-parallel columns with respect to the direction of the 5-
membered ring, as indicated by the direction of the arrows. The caffeine molecules are also
inverted above each other as indicated by the colour codes (the methyl group bonded to the 5-
membered ring of caffeine is pointing upwards for molecules coloured blue and black, and
pointing downwards for those coloured grey and red).
101
With the exception of barbital, all the cocrystals with caffeine are with
dicarboxylic acids produced in a study aimed at forming a cocrystal that is less
susceptible to hydration than caffeine[23]. Only the oxalic and malonic acids have
the expected hydrogen bonds to two caffeine molecules to give a 2:1 ratio in the
cocrystal, with the maleic acid and both polymorphs of the glutaric acid cocrystals
being 1:1, (though there is NMR evidence for a 2:1 caffeine•maleic acid
cocrystal)[23]. The calculated relative stabilities of these five cocrystals (Figure 4.3)
follow the same trend as their critical relative humidity[23]. The less stable glutaric
acid•caffeine cocrystal, form I (EXUQUJ01), converts readily to form II (EXUQUJ),
which then readily dissociates to caffeine hydrate and glutaric acid, which is
consistent with the low calculated stability of this cocrystal and instability of its
polymorph. In both the conformational polymorphs the glutaric acid is highly
distorted, which is reflected in the high intramolecular energy penalty (Table 4.4).
The particularly high stability of the oxalic acid•caffeine cocrystal
(GANXUP), Figure 4.3, is probably a reflection of poor modeling of pure oxalic
acid[88], particularly the catemeric  form, and the wrong relative stability of the two
polymorphs. The metastable form II polymorph of maleic acid[21] is calculated to be
more stable than form I, and the relative orientation of the sheets is poorly reproduced
for form I, as in the computational study that investigated this polymorphism[21]. In
the cocrystal, the maleic acid is distorted relative to the gas phase and pure
component structures, straining the intramolecular hydrogen bond to improve the
interaction with caffeine. This experimental observation is reproduced but
overestimated by the minimized structures.
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Table 4-4: Lattice energies and quality of reproduction for caffeine systems.
Cocrystal former
Cocrystal
former
CSD code
Z
Crystal
RMSD1
5 (Å)
∆Eintra
(kJ mol-1)
Lattice energy
(kJ mol-1)
Caffeine - 1 - 1.72 -112.07
Caffeine +
coformer
lattice energy
(kJ mol-1)
Cocrystal
CSD code
Ratio
**
Crystal
RMSD1
5 (Å)
∆Eintra
(kJ mol-1)
Caffeine
∆Eintra
(kJ mol-1)
Partner
Lattice energy
(kJ mol-1)
Barbital (form I) DETBAA04 1 0.107 0.53 -97.71 -209.78
Barbital (form II) DETBAA11 1 0.119 1.73 -98.02 -210.09
CAFBAR20 1:2 0.134 1.21 4.07; 1.48 -309.28
Oxalic acid (-form) OXALAC04 1 0.430 0.00 -95.23 -207.30
Oxalic acid (-form) OXALAC06 1 0.122 0.03 -90.85 -202.92
GANXUP 2:1 0.181 1.09 0.01 -340.14
Maleic acid (form I) MALIAC12 1 0.524 0.58 -93.59 -205.66
Maleic acid (form II) MALIAC13 1 0.215 0.32 -94.98 -207.05
GANYEA 1:1 0.144 2.12 1.88 -202.81
Glutaric acid (form III) GLURAC02 1 0.256 3.95 -105.71 -217.78
Glutaric acid (-form) GLURAC04 1 0.260 3.98 -105.73 -217.80
EXUQUJ 1:1 0.175 0.53 5.37 -218.11
Glutaric acid (form III) GLURAC02 1 0.256 3.95 -105.71 -217.78
Glutaric acid (-form) GLURAC04 1 0.260 3.98 -105.73 -217.80
EXUQUJ01 1:1 0.336 0.04 5.53 -213.13
Malonic acid (-form) MALNAC02 1 0.386 0.14 -97.83 -209.90
Malonic acid (-form) MALNAC03 1 0.295 0.66 -99.54 -211.61
GANYAW 2:1 0.263 0.75 1.49 -324.66
** Stoichiometeric ratio in cocrystal
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Figure 4.3: The relative stability of the caffeine cocrystals to the sum of the component energies. The cocrystal and the partner crystal structure are
denoted by the CSD refcodes (table 4-1), with each system separated by a vertical line. To make the lattice energies comparable, the lattice energies for
a 2:1 stiochiometry are divided by 2 to correspond to one formulas unit of caffeine, i.e. refer to a 1:0.5 cocrystal.
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4.3.2 Succinic acid
The comparison of the lattice energies of the cocrystals of succinic acid (table
4.5) with the lattice energies of their components, considering both succinic acid and
any partner polymorphs (figure 4.4), show that the cocrystal is more stable for the
majority of cases. The cocrystal is clearly more stable than the most stable
combination of components by more than 10 kJ mol-1 for 2,5-bis(4-pyridyl-1,3,4-
oaxadiazole (GAWLOG), 4-4’-diazastilbene (UMINOT), and phenazine
(WOQBOT). The preference for cocrystallization is highest for the partner molecules
in which succinic acid hydrogen bonds to an aromatic nitrogen in a molecule
incapable of hydrogen bonding to itself.
There is a smaller energetic preference when the partner molecule hydrogen
bonds to itself in the pure phase. 2-Pyridone and isonicotinamide show an R22(8)
amide···amide homodimer motif which is linked by succinic acid in the cocrystal. 2-
Aminopyridine has a more planar amine group in the R22(8) carboxylic
acid···pyrimidine hydrogen bond in the cocrystal than in the complex N-H···N 
hydrogen bonding in the pure component. Indeed, the only cocrystals that are not
more favorable than the components are those where the cocrystal forms the R22(8)
carboxylic···amide motif between succinic acid and urea or benzamide.
The order of the two polymorphs of succinic acid has been predicted
correctly, with an energy difference of 6.69 kJ/mol-1, this is partially due to
conformational distortion in the less stable  polymorph. The calculated order of
stability of the polymorphs of phenazine is correct[48], and for isonicotinamide is
consistent with their melting points[40]. The relative polymorphic stability of
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benzamide is correct, but the reproduction of the highly metastable form II is
poor[38]. The modeling of urea also proved problematic as the high symmetry
structure proved to be a transition state between lower symmetry lattice minima. The
poor reproduction of the cocrystal of succinic acid with urea (VEJXAJ) includes an
extremely large intramolecular energy penalty for conformational distortion, which
also contributes to this cocrystal being wrongly predicted as unstable.
Hence, the calculations successfully rationalize the formation of the succinic
acid cocrystals, with the exception of urea and benzamide, but the energetic
advantage of the cocrystal is modest unless the partner molecule lacks a hydrogen
bond donor.
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Table 4-5: Lattice energies and quality of reproduction for succinic acid.
††When two values are given, the original symmetry of the cocrystal about the centre of a molecule was not retained during optimization.
Cocrystal former
Cocrystal
former
CSD code
Z
Crystal
RMSD15
(Å)
∆Eintra
(kJ mol-1)
Lattice
energy
(kJ mol-1)
Succinic acid (-form) SUCACB07 2 0.309 1.56; 0.49 -105.21
Succinic acid (-form) SUCACB03 1 0.152 0.85 -111.90
-SA
+ coformer
Lattice
energy
(kJ mol-1)
-SA
+ coformer
Lattice
energy
(kJ mol-1)
Cocrystal
CSD code
Ratio
Crystal
RMSD15
(Å)
∆Eintra
(kJ mol-1)
SA
∆Eintra
(kJ mol-1)
Partner††
Lattice
Energy
(kJ/mol-1)
Benzamide (form I) BZAMID05 1 0.168 0.16 -94.41 -199.62 -206.31
Benzamide (from II) BZAMID06 2 0.481 1.00; 0.70 -78.85 -184.06 -190.75
BZASUC 1:2 0.469 0.57 1.68; 0.61 -289.65
Isonicotinamide
(form I)
EHOWIH 1 0.163 2.01 -96.53 -201.74 -208.43
Isonicotinamide (form
II)
EHOWIH02 2 0.228 0.45; 0.20 -103.37 -208.58 -215.27
LUNNUD 1:2 0.213 0.17 0.93 -323.24
2-Pyridone PYRIDO04 1 0.244 0.10 -78.74 -183.95 -190.64 NISTAK 1:2 0.149 0.25 0.06 -271.31
2-Aminopyrimidine AMPYRM01 1 0.218 2.16 -84.06 -189.27 -195.96 SERMOR 1:1 0.384 1.07 0.14 -199.08
Urea UREA 1 0.687 0.18 -84.09 -189.3 -195.99 VEJXAJ 1:2 0.662 1.13 6.52; 4.99 -243.82
Phenazine (-form) PHENAZ04 1 0.626 0.01 -101.35 -206.56 -213.25
Phenazine (-form) PHENAZ11 1 0.127 0.14 -99.73 -204.94 -211.63
WOQBOT 1:1 0.189 0.75 0.04 -228.48
2,5-Bis(4-pyridyl)-
1,3,4-oxadiazole
ODACIF01 1 0.205 0.13 -120.76 -225.97 -232.66 GAWLOG 1:2 0.252 0.87 1.23 -366.88
(E)-4,4´-Diazastilbene AZSTBB 1 0.193 0.14 -112.18 -217.39 -224.08 UMINOT 1:1 0.525 0.16 0.29 -236.88
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Figure 4.4: The relative stability of the succinic acid cocrystals to the sum of the component energies. Comparisons with respect to the  and  forms of
succinic acid are represented by the red and grey bars respectively. The cocrystal and the partner crystal structure are denoted by the CSD refcodes
(table 4-2), with each system separated by a vertical line.
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4.3.3 4-Aminobenzoic acid
The two polymorphs of 4-aminobenzoic acid are reproduced reasonably well
(table 4.6), with the  form being correctly predicted to be the most stable. However,
the energy difference between the two polymorphs is unreasonably large at almost 20
kJ mol-1, and the O(-H)···N hydrogen bonds in the  form have shortened by 0.126 Å
(figure 4.1). The excessive stability for this unusual hydrogen bonding motif appears
to be an artifact of the computational model: the relative energies of the two
polymorphs are very sensitive to the modeling of the electrostatic interactions and
choice of repulsion-dispersion potential. Hence, the overestimate of the stability of
the  form relative to the experimental enthalpy difference of 5.5 kJ mol-1
dramatically affects the relative stability of the cocrystals (figure 4.5) calculated from
the energies in table 4.6.
The polymorphic energy differences for 4-nitrobenzoic acid, trinitrobenzene
and 4-aminobenzonitrile are all within a more reasonable 6 kJ mol-1, but there is no
experimental information for comparison.
All 4-aminobenzoic acid cocrystals, except that with carbamazepine
(XAQRAJ), are predicted to be more stable than the sum of the partner and 
polymorph lattice energies (figure 4.5), but only two cocrystals are marginally stable
relative to the  form. This can be seen due to the errors in the computational model:
if the energy of the  form is estimated from that of the  form and the experimental
enthalpy difference[29], then eight of the cocrystals are more stable.
The two cocrystals with the two isomers of bipyridine form cocrystals with 4-
aminobenzoic acid that are very stable relative to the weighted sum of their
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component energies. Of these two molecules, which are incapable of hydrogen
bonding to themselves, the 4,4'-bipyridine forms the more stable cocrystal despite
being significantly more conformationally distorted in the cocrystal than in its pure
solid form (table 4.6).
The problems in the modeling of urea and 4-aminopyrimidine already noted
for their cocrystals with succinic acid, also affect the relative stability of the
cocrystals with 4-aminobenzoic acid. The high stability of the 4-aminopyrimidine•4-
aminobenzoic acid cocrystal (LEWPUY) can be attributed to the planarity of the
amine group in the cocrystal R22(8) hydrogen bonding motif, relative to its
computationally overestimated pyrimidality in the pure aminopyrimidine. The urea
cocrystal stability suffers from large conformational distortion penalties. All the other
amides, which form an R22(8) hydrogen bonding motif with the carboxylic acid group
of 4-aminobenzoic acid are predicted as somewhat more stable than the partner and 
polymorph. However, this motif is not energetically distinguished from the 4-
aminobenzoic acid R22(8) homodimer observed in the cocrystals with nitroaniline,
trinitrotoluene and aminobenzonitrile. This competition between R22(8) homo and
heterodimers, is evident in the only marginally unstable cocrystal with
carbamazepine, which is a complex structure containing both the carbamazepine
amide homodimer and the heterodimer with aminobenzoic acid.
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Table 4-6: Lattice energies and quality of reproduction for 4-aminobenzoic acid systems.
Cocrystal
former
CSD code
Z'
Crystal
RMSD15
(Å)
∆Eintra
(kJmol-1)
Lattice energy
(kJ mol-1)
4-Aminobenzoic acid (a-form) AMBNAC01 2 0.395 1.79, 1.55 -100.43
4-Aminobenzoic acid (b-form) AMBNAC04 1 0.361 1.97 -120.52
-ABA
+ coformer
lattice energy
(kJ mol-1)
-ABA
+ coformer
lattice energy
(kJ mol-1)
Cocrystal
CSD code
Ratio
Crystal
RMSD15
(Å)
∆Eintra
(kJ mol-1)
ABA
∆Eintra
(kJ mol-1)
Partner
Lattice
energy
(kJ mol-1)
4-Nitrobenzoic acid (form II) NBZOAC02 1 0.147 0.63 -105.40 -205.83 -225.92
4-Nitrobenzoic acid (form I) NBZOAC04 1 0.159 0.88 -108.06 -208.49 -228.58
DAQYOK (1:1) 0.224 0.76 0.51 -211.47
2,2-Bipyridine BIPYRL04 1 0.167 0.00 -86.48 -186.91 -207.00 DAQYUQ (2:1) 0.242 0.39 0 -327.18
2-Amino-4,6-dimethoxypyrimidine AFUYIJ 1 0.464 3.39 -98.09 -198.52 -218.61 IFACUO (1:1) 0.54 0.80 2.17 -207.96
2-Aminopyrimidine AMPYRM01 1 0.218 2.16 -84.06 -184.49 -204.58 LEWPUY (1:1) 0.231 1.49 0.28 -205.14
Urea UREAXX02 1 0.687 0.18 -84.09 -184.52 -204.61 NUHYEU (2:1) 0.484 5.83; 4.60
‡‡ 2.39 -287.08
2-Amino-4-(4-pyridyl)pyrimidine OCATOB 1 0.635 4.05 -120.05 -220.48 -240.57 OCATUH (1:1) 0.189 0.81 4.53 -227.20
4-Nitroaniline NANILI22 1 0.17 1.80 -92.30 -192.73 -212.82 RILJEB (1:1) 0.229 0.65 0.36 -200.28
4-Nitrophenylacetic acid SEMTAF01 1 0.276 0.85 -110.63 -211.06 -231.15 RILJOL (1:1) 0.461 0.85 2.01 -215.80
4,4-Bipyridine HIQWEJ02 2 0.238 1.30; 0.50 -89.86 -190.29 -210.38 UDUZOI01 (2:1) 0.351 1.50 10.53 -336.39
1,3,5-Trinitrobenzene (form I) TNBENZ11 2 0.338 2.05; 2.05 -95.85 -196.28 -216.37
1,3,5-Trinitrobenzene (form II) TNBENZ12 2 0.232 0.59; 0.58 -90.32 -190.75 -210.84
1,3,5-Trinitrobenzene (form III) TNBENZ13 1 0.807 0.77 -93.46 -193.89 -213.98
WIKTEP (1:1) 0.358 0.34 1.97 -203.09
4-Aminobenzonitrile (monoclinic) BERTOH 1 0.826 0.03 -86.53 -186.96 -207.05
4-Aminobenzonitrile (orthorhombic) BERTOH01 1 0.194 0.32 -89.86 -190.29 -210.38
WOCVIT (1:1) 0.359 0.85 0.01 -199.66
Carbamazepine (form III) CBMZPN10 1 0.183 1.12 -127.72 -228.15 -248.24 XAQRAJ (1:2) 0.383 3.42 2.22; 0.14 -355.27
‡‡The Original symmetry of the cocrystal about the centre of urea was not retained during optimization
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Figure 4.5: The relative stability of 4-aminobenzoic acid cocrystals to the sum of the component energies. Comparisons with respect to the  and 
forms of 4-aminobenzoic acid are represented by the red and grey bars respectively. The cocrystal and the partner crystal structure are denoted by the
CSD refcodes (table 4-3), with each system separated by a vertical line. To make the lattice energies comparable, the lattice energies for a 2:1
stoichiometry are divided by 2 to correspond to one formulas unit of 4-aminobenzoic acid, i.e., 1:0.5 cocrystal.
112
4.4 Discussion
The cocrystals investigated were chosen on the basis of including a
pharmaceutically acceptable coformers and the availability of crystal structures for
cocrystal and partner molecules that were suitable for computer modelling. For
succinic acid and caffeine, the majority of cocrystals are predicted by lattice energy
minimization to be more stable than the component crystal structures but often by
quite a small margin relative to polymorphic energy differences and errors in the
computational model. For 4-aminobenzoic acid, the majority of cocrystals are
predicted to be more stable than the kinetic α form but not the β form because its
stability is seriously overestimated by the specific computational model used. The
lack of cases where the cocrystal is considerably more stable than the component
crystals correlates with a lack of cocrystals sampled in this study which are hydrogen
bonded but comprised of two components that are incapable of hydrogen bonding in
their pure homogenous form. However, it is notable that the most energetically
favoured cocrystals of succinic acid and 4-aminobenzoic acid are with partners that
lack hydrogen bond donors. In the majority of cases, where both partners have
hydrogen bond donors and acceptors, there is no clear energetic preference for
cocrystals that contain a synthon used in qualitative crystal engineering, such as
the R22(8) carboxylic acid···amide motif, over those with more complex hydrogen
bonding motifs.
In the case of caffeine, the pharmaceutically acceptable coformer with no
hydrogen bond donors, the modest thermodynamic driving force for cocrystallization
is relative to the lowest energy static crystal structure found in a search. Caffeine has
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resisted all attempts to produce such an idealized ordered structure, so in reality,
cocrystallization is in competition with a process that results in a disordered structure
which will be entropically stabilized to some extent.
It is also tempting to speculate that crystallization of 4-aminobenzoic acid
cocrystals is in competition with the formation of the α form, since the solvents used
to grow these cocrystals do not nucleate the β polymorph§§. Unravelling the role of
kinetics[89,90] in cocrystallization will be difficult without a more accurate
understanding of the thermodynamics of cocrystal formation. If the β polymorph of
4-aminobenzoic acid had not been found, this study would have concluded that
almost all its cocrystals were thermodynamically stabilized relative to the
components. However, this structure revealed problems with the accuracy of the
chosen model for lattice energies and had a significant effect on the conclusions that
could be drawn from this study. Other modelling problems were observed for urea,
benzamide, oxalic acid, and maleic acid. All these systems are known to be
challenging to model either for reasons of transferability or sensitivity to the proton
positions. The repulsion−dispersion atom−atom potential used had been empirically
fitted to a modest sample of crystal structures[82], and so the limited range of
intermolecular contacts sampled is unlikely to include the unusual hydrogen bonding
in the β polymorph of 4-aminobenzoic acid (Figure 4.1) or the unique contacts in
oxalic acid[88] and urea (whose functional groups will also be atypical in their charge
distribution). The modelling of the hydrogen bonding of the NH2 group is very
sensitive to the degree of pyramidalization[91], for which, the intramolecular energy
penalty can be significantly reduced with an increased quality of wave
§§ The cocrystal with trinitrobenzene may be an exception as WIKTEP was crystallized from water.
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function[92]. Similarly, since intramolecular induction is included in the ab initio
calculation of ΔEintra but intermolecular induction is not explicitly modelled in Uinter,
the lattice energy differences between crystals where the degree of intramolecular
hydrogen bonding changes is poorly modelled[93]. This applies to maleic acid and
may affect the modelling of some amine groups. Hence improving the quality of the
wave function used for ΔEintra and the electrostatic model, including intermolecular
induction[58], and using nonempirical model potentials[88,94] specific to the actual
molecule have all been shown to improve the reliability of the relative lattice energies
for molecules similar to those used in this study. Indeed, theoretically motivated
changes to the computational model have been shown to improve the relative stability
of the 4-aminobenzoic acid polymorphs to reasonable agreement with experiment
[95]. Using more accurate models for all the cocrystals studied was beyond the
computational resources available because of the cost of hundreds of wave function
evaluations for each minimization. However, this study has demonstrated that
predicting the stability of cocrystals relative to their components is more demanding
of accuracy than initially hoped.
A second limitation is the use of calculated lattice energies, which nominally
correspond to 0 K. A more reasonable definition of thermodynamic stability relative
to the infinitely separated molecules would be at ambient or the crystallization
temperature. Hence, this study ought to be comparing the heats of sublimations and
needs to evaluate the assumption that –Elatt=Hsub.
Results of this study (Table 4.4–4.6) have shown that the intramolecular
energy difference between the components and cocrystals can vary by a few
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kilojoules per mole, and the differences in the packing and hydrogen bonding motifs
means that the entropy and zero-point energy differences will also be sensitive to the
specific cocrystal system. Hence, this concludes that relatively few of the studied
cocrystals of pharmaceutically acceptable coformers systems have such enhanced
lattice energy stability relative to the components that we do not need to carefully
define the term ‘relative thermodynamic stability’ and strive to minimize the errors in
the modelling.
With such a conclusion, any biases to the sampled collection of cocrystals
needs to be considered. A requirement to have high-quality structural determinations
of both the cocrystal and constituents lacks consistency with the interest in
cocrystallization to provide well behaved solid forms of difficult to crystallize active
pharmaceutical ingredients. Caffeine provides a counter-example: all other structures
were experimentally determined by single crystal diffraction. The observation that
polymorphic systems are more likely to be good cocrystal formers[40] implies that
cocrystallization gives a way of solving the problem a molecule has in packing by
itself. Certainly, polymorphism, disorder, and solvate (and by implication cocrystal)
formation are common when the computed crystal energy landscape shows that there
are many almost equienergetic crystal structures for a molecule[96,97]. Results
presented in this study indicate that the lattice energy landscapes of cocrystals will
often have the most stable structures close in energy to the weighted sum of the
components, Elattsum, and may well have many structures in this region.
A second bias is that all of the studied cocrystals were grown from solution,
the majority by slow solvent evaporation, implying a restriction to systems where
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both components have a similar solubility on the ternary phase diagram. Thus, the
cocrystal comparison is even more limited by the requirement for crystal structures
than the comparison of hydrate lattice energies with the sum of the anhydrate and ice
energies[98], which also found that the relative stabilization of the multicomponent
system was often within the errors in the modelling. Hence, conclusions of this study
are limited by the availability of suitable crystal structures. Future computational
studies could use cocrystals that have been formed by grinding, solution calorimetry
to quantify the thermodynamic stability differences, and systems where extensive
experimental effort has failed to produce a cocrystal (chapter 6). However, given the
number of cocrystals which have not adopted the hydrogen bonding motif expected
from qualitative crystal engineering, there is definitely a role for computer predictions
to determine which of a series of coformers can or cannot pack in a particularly
stabilizing way with an API that has difficulty in crystallizing with itself.
4.5 Conclusion
Many cocrystals of three pharmaceutically accepted coformers have been
shown to be more stable than the sum of the lattice energies of the component
structures. However, the cocrystals are rarely so dramatically stabilized that the
formation of the cocrystal can be confidently predicted. Nevertheless, it will be more
reliable than the qualitative design of cocrystals by crystal engineering approaches, as
quantifying the relative energies by crystal structure modelling allows the
compromises between all the interactions to be automatically taken into account.
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Unfortunately, the differences between the lattice energies of the cocrystals
and the sum of the components are often sufficiently small that all the usual concerns
about the approximations used in evaluating the relative energies of crystals
apply[99]. This study clearly demonstrates that it cannot be assumed that the errors in
the three lattice energies will cancel, and careful thought needs to be given as to
whether the energies of all three structures are likely to be adequately modelled by
the chosen method of evaluating the crystal energy. A further concern is that even if
highly accurate relative energies were available, cocrystal formation will be
influenced by kinetic factors. With an awareness of these caveats, computational
searches for the low-energy crystal structures of cocrystals and their components, and
comparison of their relative lattice energies (as investigated in chapter 6) should
prove a useful complement to the experimental design and understanding of
cocrystals.
In the next chapter, an elaborate experimental strategy is designed targeting
cocrystals comprising of 4-aminobenzoic acid or succinic acid and coformers
incapable of hydrogen bonding in their homogenous state. This is to expand on
findings made in this study, where a greater thermodynamic stability was calculated
for cocrystals of this nature. The experimental strategy combines grinding, hot stage
microscopy and solution based crystallization techniques in an attempt to enhance the
efficiency of screening for these multicomponent forms. Lattice energy calculations
are carried out for systems that yielded cocrystals of computational feasibility, to
theoretically establish their relative magnitude of stability.
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Chapter 5. Experimental Multistage Screening Strategy for
Pharmaceutical Cocrystals
5.1 Introduction
Conventionally, screening for cocrystals has focused on solution based
experiments such as slow cooling and solvent evaporation methods. These techniques
are favoured as they provide the opportunity of producing suitable crystals for
structure determination by single crystal X-ray diffraction experiments. However,
they are often limited by differences in solubility of the cocrystal components and
solvent-solute interactions which may inhibit cocrystallization and result in undesired
solid forms such as solvates and hydrates. These experiments can also be time
consuming to perform, with some requiring months for completion. Furthermore, the
solvent dependency of these screens can be problematic as many solvents are harmful
and environmentally damaging, thus, special safety requirements are needed during
their handling.
Recently, the use of novel cocrystal screening techniques such as grinding and
hot stage microscopy (HSM) has become widespread [1-15]. These methods have a
reduced propensity of forming undesired solids such as solvates as there is little to no
inclusion of solvents. This lack of solvent use also makes them environmentally
friendly and cheaper to set up. Another key advantage of these methods is their
rapidity in producing results, with typical experimental duration lasting for few hours.
However, structure determination by single crystal X-ray diffraction is not feasible as
crystals of necessary dimensions and quality are unattainable. Instead, structure
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determination is limited to techniques such as powder X-ray diffraction whose results
may be ambiguous.
Work presented in this chapter is aimed at designing and testing an
experimental procedure with improved efficiency for searching for cocrystals by
combining both conventional and novel screening techniques. The targeted cocrystals
comprise of either 4-aminobenzoic acid or succinic acid and coformers that are
incapable of hydrogen bonding in their homogenous state. The screening of these
cocrystals is motivated by findings made in chapter 4, where lattice energy
calculations on such binary systems (figure 5.1) found a greater thermodynamic
driving force for cocrystallization in comparison to systems whose components are
capable of hydrogen bonding in their pure homogenous state. To further examine this
thermodynamic relationship, lattice energy calculation is performed on cocrystals
produced in this study that are computationally feasible.
(a)
(b)
Figure 5.1: Examples of the targeted 4-aminobenzoic acid and succinic acid cocrystals. Both
cocrystals exhibit COOH···Naromatic heterosynthon interactions (a) 4-aminobenzoic acid•4,4-
bipyridine and (b) succinic acid•2,5-bis(4-pyridyl)-1,3,4-oxadiazole.
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5.2 Selection criteria for coformers
Using an internal GSK database of registered and available compounds, a
series of coformers were chosen that have hydrogen bond acceptors but no donors.
These molecules were chosen as they have some pharmaceutical relevance, i.e. APIs
or biological building blocks. The other criterion was that they needed to be
computationally feasible, i.e. have limited flexibility and contain only carbon,
hydrogen, oxygen and nitrogen in common functional groups. A further limitation
was that the compounds could be safely handled in the available facilities. Table 5.1
displays the compounds selected.
Table 5-1: The compounds used in this study and their Cambridge Structural Database (CSD)
reference codes where available.
O
O
H
N
H
H
4-Aminobenzoic Acid
form, AMBNAC01[16]
 form, AMBNAC04 [17]
O
O
O
O
H
H
Succinic Acid
form, SUCACB07[18]
 form, SUCACB03[19]
Cocrystallizing agents
N
N
2,2´-Bipyridine
BIPYRL04 [20]
N
O
N
Metyrapone
BIHYEW10[21]
CH3
N
O
O
-Methyl--Nitrostyrene
VESYOH[22]
N
N
1,4-Dicyanobenzene
Monoclinic, TEPNIT06[23]
Triclinic, TEPNIT11[24]
N
N
Bifonazole
O
N O
N
N
N
N
1-(5-Nitro-2-Pyridyl)Benzotriazole
N
N
N
N
1-(2-Pyridyl)Benzotriazole
N
N
CH3
CH3
O
Antipyrine
ANTPYR10[25]
O
Diphenylcyclopropenone
DPCYPO[26]
N
N
Phenazine
form, PHENAZ04[27]
 form, PHENAZ11[28]
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5.3 Method
5.3.1 Experimental strategy
The experimental methodology comprises of two stages (scheme 5.1). In stage
I, attempts are made to produce cocrystals by grinding the two components
(neat/solvent assisted) and/or by HSM to cocrystallize from the melt. These methods
are considered environmentally friendly [9,29] as there is little or no inclusion of
solvent and have a reduced possibility of solvation. They also provide a quick
indication of potential cocrystal formation. If a system displays strong indications of
cocrystallization, either by a change in the vibrational spectrum from that of the pure
components or by observation of a new phase under the microscope, then more
extensive screening using the slow solvent evaporation technique is performed in
stage II to try and grow suitable single crystals of the new product for X-ray structure
determination. This was done with and without seeding from the ground sample
obtained in stage I.
Whilst the techniques used in stage I are usually expected to be the most
effective means of cocrystal screening[4,14], this needed to be validated by testing it
on known cocrystals of 4-aminobenzoic acid and succinic acid. In addition, a few
slow solvent evaporation experiments were set up for systems that displayed weak
indication of cocrystallization to test the effectiveness of Stage I screens, since its
conceivable that a cocrystal may only be formed when a solvent is included as it can
play an active part in the nucleation step.
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Scheme 5.1: Summary of experimental strategy
5.3.2 Safety precautions
The availability of materials of sufficient purity from the GSK compound
bank was confirmed by NMR and mass spectrometry. All other materials were
purchased from the Aldrich Chemical Company (Poole, UK, generally 99% purity)
and were used as purchased in all cocrystallization screening experiments. All of the
materials used were categorized as irritants and harmful. Particular care was required
for 4-aminobenzoic acid which had the added risk of being a potential skin sensitizer.
Therefore, all experimental work was conducted in a fume cupboard with suitable
protective clothing being worn as well as gloves and safety spectacles. Weighing of
samples as well as vibrational analysis was conducted in an air controlled
environment where the instruments were placed in an extractor cabinet to reduce the
possibility of inhalation.
Stage I
Attempts to form cocrystals by
grinding (neat/solvent assisted)
and/or HSM
Stage II
Strong indication of
cocrystallization
Weak indication
of cocrystallization
Extensive slow solvent evaporation screens
(with and without seeding from stage I)
Limited slow solvent evaporation screens
132
5.3.3 Grinding experiments
Equimolar quantities of the cocrystallization agent (4-aminobenzoic acid or
succinic acid) and the biologically useful compound (table 5.1) were combined in a
stainless steel grinding jar (1.5ml) with one grinding ball (5mm in diameter), and
ground together for 60 minutes at a frequency of 30Hz on a Retsch MM200 grinding
mill. An IR spectrum of the ground material was then collected at 4 cm-1 spectral
resolution with a spectrum range of 4000-650 on a PerkinElmer SpectrumOne FT-IR
Spectrometer cm-1. This was compared with a previously collected IR spectrum of the
pure components taken under the same grinding conditions. If weak indication of
cocrystallization were observed (within the limits of experimental error) the sample
was ground for a further 60 minutes at the same frequency after the addition of a few
drops of solvent, and the IR spectra were compared as before. The IR spectra were
collected at 4 cm-1 spectral resolution with a spectrum range of 4000-659 cm-1 on a
PerkinElmer SpectrumOne FT-IR Spectrometer cm-1.
5.3.4 Hot stage microscopy experiments
The hot stage microscopy (HSM) experiments were conducted on a LINKAM
hot stage (THMS 600) with a temperature controller TMS 93 using the contact (or
mixed fusion) method[30,31] as described in chapter 2 section 2.4.2.
In cases where the considered combinations had a significant difference in their
melting point, the cocrystal screens using this method were unsuccessful as heating at
elevated temperatures led to the decomposition of the component with the lower
melting point.
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5.3.5 Slow solvent evaporation experiments
In most cases, 40 mg of the biologically useful compound was dissolved in
solvent(s) to give a saturated solution. An equimolar amount of 4-aminobenzoic acid
or succinic acid was separately dissolved in the same solvent(s) to give a saturated
solution. The two solutions were then combined in a specimen tube with pierced
holes in the plastic lid and left to evaporate at room temperature. In cases where the
sample from the grinding experiment indicated possible cocrystallization, a few
grains from that sample were used to seed a parallel experiment.
5.3.6 X-ray powder diffraction
Powder X-ray diffraction data were collected at room temperature on a Stoe
StadiP transmission geometry diffractometer using Ge ‹111› monochromated Cu-K1
radiation ( = 1.54056 Å) operating at 40 kV and 30 mA. Diffraction patterns were
collected from a sample flame-sealed in a 0.5 mm diameter borosilicate glass
capillary and measured with a linear position sensitive detector (nominal aperture
4.5° 2θ), which was scanned from 5 to 40° in 2θ, with steps of 0.2° and a count time 
of 140 s per step.
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5.3.7 Single crystal X-ray diffraction
All single crystal X-ray diffraction data (with the exception of 4-
aminobenzoic acid • phenazine cocrystal***) were collected on a Bruker AXS
SMART APEX CCD diffractometer using graphite monochromaticed Mo-K
radiation (λ = 0.71073 Å) and a Bruker AXS Kryoflex open flow cryostat. Unit cell
determinations and data sets were collected at 150 K. The Bruker SMART[33]
diffraction suite was used to control data collection. Data integration and final unit
cell parameters were obtained using the program SAINT+[34]. For all crystal
structures, semi-empirical absorption corrections were applied using the program
SADABS[35]. The structure of the cocrystals 4-aminobenzoic acid • antipyrine, 4-
aminobenzoic acid • phenazine and succinic acid • 2,2´-bipyridine were solved by
direct methods using the program SHELXS-97[36], whereas the structure of the
cocrystal succinic acid • diphenylcyclopropenone was solved using the program
SIR92[37]. All non-hydrogen atom positions were located using difference Fourier
methods as implemented in SHELXL-97[38].
For the cocrystals 4-aminobenzoic acid • phenazine, succinic acid • 2,2´-
bipyridine and succinic acid • diphenylcyclopropenone, all the hydrogen atom
positions were located from the difference Fourier map and freely refined. For the
cocrystal 4-aminobenzoic acid • antipyrine, the protons of N(1) and N(2) were fixed
in idealized positions and refined using the riding model, whilst all other hydrogen
atom positions were located from the difference Fourier map and freely refined.
***The single crystal X-ray diffraction experiment for the crystal 4-aminobenzoic acid • phenazine was
carried out by Dr. S. Barnett of Diamond Light Source Ltd. using a Crystal Logic diffractometer with a
Rigaku Saturn 724+CCD (silicon 111 monochromated radiation, λ=0.6889 Å; ω scans) at 120 K. The 
applied absorption correction is based on multi-scans using REQAB with the d*TREK program[32].
135
Details of crystallographic parameters for the novel solid forms are given in the
appendix (section 5.9) at the end of this chapter.
5.4 Validation of the screening strategy in stage I
To validate and test the efficacy of the stage I procedure, grinding and HSM
experiments were carried out on systems previously known to form cocrystals by
solution based experiments (table 5.2).
Table 5-2: The known cocrystals (bold) considered in stage I validation step.
Cocrystals
CSD code
Literature method of
cocrystallization
Stage I
experimental
method used
4-Aminobenzoic
acid•2,2-Bipyridyine DAQYUQ[39]
Slow solvent
evaporation using
methanol
Solvent (methanol)
assisted grinding
Succinic
acid•Phenazine WOQBOT[40]
Slow solvent
evaporation using
methanol
Solvent (methanol)
assisted grinding and
HSM
4-Aminobenzoic
acid•Nitrophenylacetic
acid
RILJOL[41] Slow solventevaporation using ethanol
Solvent (ethanol)
assisted grinding and
HSM
The X-ray powder diffraction patterns of the ground samples were collected
and compared with the simulated powder pattern of previously published cocrystal
structures, these were generated using the CSD program Mercury[42]. In all cases,
the comparison showed successful production of these cocrystals by grinding
techniques (figure 5.2).
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(a) 4-Aminobenzoic acid • 2,2-bipyridine.
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(b) Succinic acid • phenazine.
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(c) 4-Aminobenzoic acid • nitrophenylacetic acid.
Figure 5.2: Comparison of the powder patterns of the ground samples (navy) with the simulated
patterns of their corresponding cocrystals (red).
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HSM experiments could only be applied to the combinations succinic acid •
phenazine and 4-aminobenzoic acid • nitrophenylacetic acid due to the relative
melting points of the components. In both cases a new phase with a distinct
morphology and melting point was observed suggestive of cocrystal formation (figure
5.3).
(a)
(b)
Figure 5.3: HSM images of succinic acid • phenazine and 4-aminobenzoic acid •
nitrophenylacetic acid cocrystals. (a) Three unique melting points were observed at 184-
186°C, 172-176°C and 166-168°C, and were due to succinic acid, phenazine and the cocrystal
succinic acid • phenazine respectively. (b) Three unique melting points were observed at 187-
189°C, 150-155°C and 136-138°C and were due to 4-aminobenzoic acid, nitrophenylacetic
acid and the cocrystal 4-aminobenzoic acid • nitrophenylacetic acid respectively.
Succinic acid
Succinic acid • phenazine
Phenazine
4-Aminobenzoic acid •
4-nitrophenylacetic acid
4-Nitrophenylacetic acid
4-Aminobenzoic
acid
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Thus these validation experiments have demonstrated that stage I of the
experimental strategy is viable as the previously known cocrystals formed by the
slow solvent evaporation methods were producible in stage I as verified by the X-ray
powder patterns and HSM images.
5.5 Solubility test
To determine which of the available solvents are of practical use for the
cocrystal screens, solubility tests were carried out on both cocrystallization agents
and coformers. In these tests, attempts were made to dissolve 30 mg of compound in
10 cm3 of solvent at room temperature. By visual evaluation, the solvents were
classified into three categories:
 Soluble: the compound has fully dissolved
 Partially soluble: some or most of the compound dissolved
 Practically insoluble: little or none of the compound had
dissolved
The results are summarized in table 5.3.
For solvent assisted grinding (stage I) a solvent in which both components are
partially soluble in and that evaporates readily was selected. For the slow solvent
evaporation experiments (stage II) the solvents in which both components are
practically insoluble in were discounted, and the remaining solvents were used either
exclusively or in combination with other solvents.
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Table 5-3: Summary of the solubility screen results.
Compound Soluble Partially soluble Practically insoluble
4-Aminobenzoic acid
Acetone
Acetonitrile
Ethanol
Ethyl acetate
Methanol
Diethyl ether
Dioxane
Nitromethane
Water
Succinic acid
Ethanol
Ethyl acetate
Methanol
Acetone
Acetonitrile
Diethyl ether
Dioxane
Water
Nitromethane
Metyrapone
Acetone
Dioxane
Acetonitrile
Diethyl ether
Ethanol
Methanol
Nitromethane
Water
-Methyl--
nitrostyrene
Acetone
Ethanol
Ethyl Acetate
Methanol
Acetonitrile
Diethyl ether
Dioxane
Nitromethane
Water
Bifonazole
Acetone
Dioxane
Methanol
Acetonitrile
Diethyl ether
Ethanol
Ethyl acetate
Nitromethane
Water
1,4-Dicyanobenzene
Acetone
Acetonitrile
Methanol
Dioxane
Ethanol
Diethyl ether
Ethyl acetate
Nitromethane
Water
1-(5-Nitro-2-
pyridyl)benzotriazole
Acetone
Ethyl acetate
Nitromethane
Water
Acetonitrile
Diethyl ether
Ethanol
Methanol
1-(2-
Pyridyl)benzotriazole
Acetone
Ethyl Acetate
Acetonitrile
Diethyl ether
Ethanol
Methanol
Dioxane
Nitromethane
Water
Phenazine
Acetone
Diethyl ether
Dioxane
Acetonitrile
Ethanol
Ethyl acetate
Methanol
Nitromethane
Water
Diphenylcyclopropeone
Acetone
Acetonitrile
Dioxane
Ethanol
Ethyl acetate
Methanol
Diethyl ether
Nitromethane
Water
Antipyrine
Acetone
Diethyl ether
Dioxane
Ethanol
Ethyl acetate
Methanol
Nitromethane
Water
Acetonitrile
2,2´-Bipyridine
Acetone
Acetonitrile
Ethanol
Ethyl acetate
Methanol
Diethyl ether
Dioxane
Nitromethane
Water
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5.6 Results and discussion
Overview of experimental results
In total, eighteen novel combinations of cocrystallizing agents and biological
building blocks were investigated†††, results of which are summarized in table 5.4.
Stage I produced four multicomponent systems by solvent assisted grinding which
were identified as potential cocrystals following analysis of their IR spectra.
Whenever the HSM screens were possible, the results were consistent with those of
grinding experiments: systems suspected of forming cocrystals by grinding were the
only ones displaying a new phase with a unique melting point, thus providing further
evidence of potential cocrystallization. In stage II, the extensive slow solvent
evaporation screens performed on the four potential cocrystals of stage I gave single
crystals of the required dimensions and quality for X-ray diffraction structural
determination, and were subsequently confirmed to be cocrystals.
In some cases, the limited slow solvent evaporation screens performed on
combinations that displayed little evidence of cocrystallization managed to yield
single crystals, but these were invariably found to be due to one of the pure
components. The remaining cases either failed to give a precipitate or produced a
microcrystalline precipitate of a mixture.
††† The combinations 4-aminobenzoic acid • 2,2´-bipyridine and succinic acid • phenazine were not
included in the experimental screen as they have been previously studied and formed cocrystals by
slow solvent evaporation[39,40]. However these were considered in the validation of the stage I
screening strategy (section 5.4).
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Table 5-4: Summary of experimental screens.
Stage I
Indication of ocrystallization:
Stage II
Cocrystallizing
agent Biological building block Neat
grinding
Solvent
assisted
grinding
HSM Single crystals of:
Metyrapone   - 
-Methyl--Nitrostyrene   - -Methyl--Nitrostyrene
Bifonazole    Bifonazole
1,4-Dicyanobenzene    1,4-Dicyanobenzene
1-(5-Nitro-2-
Pyridyl)Benzotriazole    
1-(2-Pyridyl)Benzotriazole    
Diphenylcyclopropenone    Succinic acid •diphenylcycloprop-enone
Antipyrine    
Succinic acid
2,2´-Bipyridine   - Succinic acid • 2,2´-bipyridine
Metyrapone   - 
-Methyl--Nitrostyrene   - 
Bifonazole    Bifonazole
1,4-Dicyanobenzene    1,4-Dicyanobenzene
1-(5-Nitro-2-
Pyridyl)Benzotriazole    
1-(2-Pyridyl)Benzotriazole    
Phenazine    4-Aminobenzoic acid •phenazine
Diphenylcyclopropenone    
4-Aminobenzoic
acid
Antipyrine    4-Aminobenzoic acid •antipyrine
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5.6.1 Combinations that produced cocrystals
Succinic acid • Diphenylcyclopropenone
Analysis of succinic acid IR spectrum
Succinic acid has a carboxylic acid group at each end of the molecule, these
form carboxylic acid dimers with neighbouring succinic acid molecules in the solid
form (figure 5.4). The IR spectrum (figure 5.5) of succinic acid shows a broad band
centred around 2931 cm-1 which is characterized as O-H stretching. These vibrations
occur at a lower frequency than those caused by free O-H stretching due to the
formation of carboxylic acid dimers, which weaken the O-H bond and consequently
absorption at lower frequencies is observed[43]. There are also a series of peaks with
weak intensities superimposed on this band which are due to C-H stretching
vibrations[44]. At 1684 cm-1 a band of high intensity is found, which is attributed to
C=O stretching vibrations. This is found at a lower than typical frequency range due
to the influence of the carboxylic acid dimer formation.
Figure 5.4: Carboxylic acid dimer interaction found in both known polymorphic forms of
succinic acid
Analysis of diphenylcyclopropenone IR spectrum
At the high frequency region of the IR spectrum (figure 5.5), a sharp band of
weak intensity is found at 3057 cm-1, which is attributed to the =C-H (aromatic)
stretching vibrations. There are two very intense bands at 1837 cm-1 and 1615 cm-1,
characterization of which is ambiguous given the unusually strained cyclopropenone
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ring and highly conjugated nature of the molecule, however reports in the
literature[45] suggests assigning the former band to C=C stretching vibrations and the
latter to C=O stretching vibrations. The remaining bands between 1482 cm-1 and
1311 cm-1 are due to skeletal ring breathing modes.
Comparison of IR spectra of the components and the potential cocrystal sample
Comparison of the IR spectrum of the pure components and the succinic acid
• diphenylcyclopropenone solvent assisted ground sample (figure 5.5) shows two
major perturbations that indicate potential cocrystallization. The first is a considerable
shift of the succinic acid C=O stretching vibration band from a low frequency region
in the pure component spectrum to a higher one in the ground sample spectrum: 1684
cm-1 to 1712 cm-1 respectively. The second is a shift of the diphenylcyclopropenone
C=O stretching vibration band from a high frequency region in the pure component
spectrum to a lower region in the ground sample spectrum; 1615 cm-1 to 1601 cm-1
respectively. Such perturbations are not surprising, as in pure succinic acid the C=O
group is hydrogen bonded to an O-H group creating a carboxylic acid dimer, which is
probably affected upon cocrystallization as the C=O group of
diphenylcyclopropenone competes to hydrogen bond with the O-H group of succinic
acid. Consequently, this strengthens the C=O bond of succinic acid as it becomes
free, therefore, absorption at a higher frequency is observed.
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Figure 5.5: The IR spectrum of succinic acid (black), diphenylcyclopropenone (blue) and the
potential cocrystal produced by grinding (red).
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Results from the HSM screen
In the HSM experiment, a new phase with a unique morphology and
melting point (126-128 °C) was observed within the zone of mixing (figure 5.6).
Such observation supports the finding from the grinding screen as it further
illustrates the formation of a potential cocrystal.
Figure 5.6: H SM image for the potential cocrystal succinic acid•diphenylcyclopropenone.
Three distinct morphologies are shown whose melting points were observed at 184-186°C,
118-122°C and 126-128°C, and were due to succinic acid, diphenylcyclopropenone and the
potential cocrystal respectively.
Results from slow solvent evaporation screen
The extensive slow solvent evaporation screen only managed to yield
suitable crystals for structural determination by X-ray diffraction from the seeded
batch in the solvent mixture acetone: ethanol, which formed large crystals with a
block-like morphology (figure 5.7).
Potential cocrystal
Succinic acid
Diphenylcyclopropenone
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Figure 5.7: L arge colourless crystals of block like morphology produced from the seeded
batch of succinic acid•diphenylcyclopropenone in acetone: ethanol. These crystals had to be
cut down to size prior to X-ray diffraction studies.
The crystal structure was found to be that of a cocrystal, which crystallizes
in the monoclinic space group P21/c. The cocrystal stoichiometry is a discrete 1:2
adduct where two diphenylcyclopropenone molecules are bridged by one succinic
acid molecule via C=O···O-H interactions (figure 5.8a) with acceptor-donor
separation of 2.63 Å. The carbonyl (C=O) group of diphenylcyclopropenone is
involved in direct hydrogen bond interactions and has a bondlength of 1.2298(16)
Å, whereas the free carbonyl group of succinic acid has a bondlength of
1.2112(15) Å. Each succinic acid molecule lies on an inversion centre with only
half of it contained within the crystallographic asymmetric unit, along with a
whole diphenylcyclopropenone molecule. The extended packing of these discreet
adducts forms a herringbone type motif (figure 5.8b). These findings correlate
well with the results from the preliminary analysis in stage I, as the predicted
hydrogen bond interactions are found in the observed structure of the cocrystal.
Furthermore, the melting point of this cocrystal was found to be at 126 °C, which
is well within the melting point range of the new phase found in the HSM
experiment.
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(a)
(b)
Figure 5.8: The crystal structure of succinic acid • diphenylcyclopropenone cocrystal.
(a) The contents of the asymmetric unit are described by Arabic numerals alone.
Displacement ellipsoids are drawn at 50 % probability level and hydrogen atoms are shown
as spheres of arbitrary radii. (b) The packing, viewed along the a axis, is that of a
herringbone motif.
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Succinic acid • 2,2´-bipyridine
Analysis of 2,2´-bipyridine IR spectrum
The IR spectrum of 2,2´-bipyridine (figure 5.9) shows a sharp band of
weak intensity at the high frequency region of 3054 cm-1 which is characterized as
the =C-H (aromatic) stretching vibrations. Also, there are four very intense bands
at 1578 cm-1, 1557 cm-1, 1451 cm-1 and 1415 cm-1 attributed to skeletal ring
breathing modes. The nitrogen atom in the pyridine ring is isoelectronic with the
CH group, therefore no distinct C-N vibrational bands are detected[46].
Comparison of IR spectra of the pure components and the potential cocrystal
sample
Clear perturbations are observed between the three spectra (figure 5.9)
indicating potential cocrystallization. The most prominent is the shift of the C=O
stretching vibration band from 1684 cm-1 in the pure succinic acid spectrum to a
higher frequency: 1719 cm-1, in the potential cocrystal spectrum, thus the
carboxylic acid dimer is probably replaced by O-H···N interaction as the C=O
group becomes free.
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Figure 5.9: The IR spectrum of succinic acid (black), 2,2´-bipyridine (blue) and the potential
cocrystal produced by grinding (red).
Results from the HSM screen
During the course of the HSM experiment, 2,2´-bipyridine decomposed
given the large difference in melting points of the two components (the melting
point range of succinic acid and 2,2´-bipyridine is 184-186 °C and 70-73 °C
respectively), and so screening for cocrystals using this technique could not be
achieved.
Results from slow solvent evaporation screen
The extensive slow solvent evaporation screens produced colourless
crystals of needle-like morphology from the solvent mixture acetone: methanol:
water in both seeded and unseeded experiments (figure 5.10). Comparison of the
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IR spectra of the two samples confirms that they are of the same composition and
are indistinguishable from the sample obtained by grinding.
Figure 5.10: Crystals of needle-like morphology produced from the seeded batch of succinic
acid•2,2´-bipyridine in acetone:methanol:water.
The X-ray structure determination confirmed the formation of a 1:1
cocrystal which crystallizes in the monoclinic space group P21/c. The asymmetric
unit contains half of each component which are linked together by an R22(7)
heterodimer due to O-H···N and C-H···O=C interactions (figure 5.11a) with donor-
acceptor separation distances of 2.78 Å and 3.19 Å respectively. The R22(7)
heterodimer interaction gives rise to infinite chains of alternating succinic acid
and 2,2´-bipyridine molecules which run in two perpendicular directions through
the crystal (figure 5.11b).
(a) (b)
Figure 5.11: The crystal structure of succinic acid•2,2´-bipyridine cocrystal. (a) The R22(7)
heterodimer due to O-H···N and C-H···O=C interactions. The contents of the asymmetric
unit are described by Arabic numerals alone. Displacement ellipsoids are drawn at 50 %
probability level and hydrogen atoms are shown as spheres of arbitrary radii. (b) The
molecules pack in chains that are perpendicular to each other.
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4-Aminobenzoic acid • Phenazine
Analysis of 4-aminobenzoic acid IR spectrum
4-Aminobenzoic acid contains various hydrogen bond acceptor and donor
groups that are all involved in hydrogen bonding in the solid form (figure 5.12).
Consequently, its IR spectrum is a complex one (figure 5.13) with bands observed
at lower frequency regions than those typical of free vibrations.
Figure 5.12: Hydrogen bond interaction of the commercially available form of 4-
aminobenzoic acid.
At the high frequency region there are two sharp bands at 3460 cm-1 and
3362 cm-1 which correspond to NH stretching vibrations: asymmetric and
symmetric modes respectively. There is also a sharp band of low intensity at 3231
cm-1 and a broad band between 2975 cm-1 and 2547 cm-1 which are due to =C-H
(aromatic) and O-H stretching vibrations respectively. Other stretching vibrational
modes occur at 1657 cm-1 and 1342 cm-1 and are attributed to C=O and C-N
stretches respectively. The sharp band at 1596 cm-1 is due to NH deformations,
and those between 1574 cm-1 and 1420 cm-1 are due to skeletal ring breathing
modes.
Analysis of phenazine spectrum
The IR spectrum of phenazine (figure 5.13) has a sharp band of low
intensity in the high frequency region of 3058 cm-1 which is attributed to =C-H
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(aromatic) stretching vibrations. However, at lower vibrational frequencies the
spectrum becomes complicated, a series of bands with weak intensities are found
approximately between 2161 cm-1 and 1709 cm-1 and are caused by overtones[46].
There is also a series of sharp bands between 1626 cm-1 and 1324 cm-1 which are
due to skeletal ring breathing modes. These assignments correlate well with those
reported in the literature[46,47].
Comparison of IR spectra of the pure components and the potential cocrystal
sample
Although differences are observed between the three spectra (figure 5.13),
these are rather subtle with the majority of bands being shifted by less than
±5 cm-1. However, there is a reasonable shift in the band attributed to =C-H
(aromatic) stretching vibrations: from 3231 cm-1 in pure 4-aminobenzoic acid
spectrum to 3204 cm-1 in the cocrystal spectrum, which suggests potential
cocrystallization. The reason for this modest perturbation is probably because all
the hydrogen bond donor and acceptor groups of 4-aminobenzoic acid are
involved in some hydrogen bonding in both the cocrystal and pure homogenous
state. This implies that the regional environment around these functional groups
does not vary significantly. Consequently, small shifts associated with the
formation of new hydrogen bonds are observed.
The nitrogen atom in the aromatic ring of the phenazine molecule is isoelectronic
with the CH group, therefore there are no distinct CN vibrational bands[46], and
observation of peak shifts associated with this hydrogen bond donor group are not
possible.
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Figure 5.13: The IR spectrum of 4-aminobenzoic acid (black), phenazine (blue) and the
potential cocrystal produced by grinding (red).
Results from the HSM screen
The HSM experiment also showed strong signs of cocrystallization, as a
new phase with a unique morphology and melting point (168-170°C) was
observed within the zone of mixing (figure 5.14).
Figure 5.14: HSM image for the potential cocrystal 4-aminobenzoic acid•phenazine. Three
distinct morphologies are shown whose melting points were observed at 187-189°C, 172-
176°C and 168-170°C, and were due to 4-aminobenzoic acid, phenazine and the potential
cocrystal respectively.
Potential cocrystal
Phenazine
4-Aminobenzoic acid
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Results from slow solvent evaporation screen
The extensive slow solvent evaporation screen produced crystals of
different morphologies from the solvent mixture methanol: ethyl acetate: water, in
a 2: 2: 1 ratio (figure 5.15).
Figure 5.15: Crystals of fibrous needle and prism-like morphologies were produced from the
solvent mixture methanol: ethyl acetate: water
Crystals of fibrous needle-like morphology were found to be due to the  form of
4-aminobenzoic acid (AMBNAC03) as confirmed by infrared spectroscopy.
Crystals of prism-like morphology were also present in the same batch, and
following a single crystal X-ray diffraction study (by Dr Sarah Barnett of
Diamond Light Source Ltd.) the structure was found to be due to a complex
cocrystal which crystallizes in the triclinic space group P-1. The cocrystal
stoichiometry is a 1:2 (4-aminobenzoic acid: phenazine) with 12 symmetrically
inequivalent molecules in the asymmetric unit (figure 5.16a). All of the hydrogen
bond donor and acceptor groups of the components are used in forming this
complex hydrogen bonding system, which explains the small shift in peaks
observed in the IR spectra. There are two clusters each containing two molecules
of 4-aminobenzoic acid and four molecules of phenazine (figure 5.16b). Both
clusters have similar hydrogen bond interactions with subtle geometrical
differences. In all cases, each 4-aminobenzoic acid molecule forms hydrogen
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bonds with two different phenazine molecules via O-H···Nphenazine (donor-acceptor
separation distances: 2.687 Å, 2.711 Å, 2.706 Å and 2.704 Å) and N-H···Nphenazine
(donor-acceptor separation distances: 3.034 Å, 3.055 Å, 3.057 Å and 3.025 Å). In
addition, each 4-aminobenzoic acid molecules forms hydrogen bonds with another
4-aminobenzoic acid molecule via C=O···H-N (donor-acceptor separation: 2.894
Å, 2.919 Å, 2.883 Å and 2.902 Å). The packing of these two clusters allows for
interchanging layers of the components (figure 5.16c). The melting point of this
cocrystal and that of the new phase in the HSM experiment is found at 170°C.
(a) (b)
Figure 5.16: The crystal structure of 4-Aminobenzoic acid•phenazine cocrystal. (a) The
asymmetric unit contains 12 symmetrically inequivalent molecules. For simplicity, the
numerical values are only described for O and N atoms. Displacement ellipsoids are drawn
at 20 % probability level and hydrogen atoms are shown as spheres of arbitrary radii.
(b) The two clusters are presented by different colour codes. (c)The packing of the cocrystal
components is based on interchanging layers of 4-aminobenzoic acid (red) and phenazine
(grey) molecules.
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4-Aminobenzoic acid • Antipyrine
Analysis of antipyrine IR spectrum
In the IR spectrum (figure 5.17) there is a series of sharp bands with weak
intensity between 3093 cm-1 and 2917 cm-1. Those in the higher frequency range
are due to =C-H stretching vibrations, whereas those in the lower frequency range
are due to C-H stretching vibrations of the methyl groups. At 1659 cm-1 there is a
sharp band of high intensity that is characterized by C=O stretching vibrations.
Within the frequency range 1484-1374 cm-1, another series of sharp bands are
found, and these are attributed to the skeletal ring breathing modes of the phenyl
ring. The remaining bands at 1324 cm-1 and 1305 cm-1 are caused by the CH3
deformations.
Comparison of IR spectra of the pure components and the potential cocrystal
sample
Comparison of the IR spectra shows significant differences (figure 5.17),
suggestive of potential cocrystallization. The most prominent ones are shifts of the
bands due to the NH2 stretching vibrations of 4-aminobenzoic acid to a lower
frequency region: from 3460 cm-1 to 3402 cm-1 and 3362 cm-1 to 3346 cm-1 for
asymmetric and symmetric vibrations respectively. Such shifts imply a weakening
of the NH2 bond, most probably due to a new form of hydrogen bonding taking
place with antipyrine.
There are two C=O groups to account for in the potential cocrystal IR spectrum,
one for each coformer. Peaks at 1672 cm-1 and 1655 cm-1 are attributed to
stretching vibrations of these functional groups. Upon cocrystallization, the
carboxylic acid dimers between 4-aminobenzoic acid molecules are most likely to
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be broken as the C=O group of antipyrine competes with that of 4-aminobenzoic
acid to form hydrogen bonds. Therefore, the low frequency peak is probably due
to stretching vibrations of antipyrine C=O group and the high frequency peak is
due to 4-aminobenzoic acid free C=O stretching vibrations.
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Figure 5.17: The IR spectrum of 4-aminobenzoic acid (black), antipyrine (blue) and the
potential cocrystal produced by grinding (red).
Results from the HSM screen
In the HSM experiment, a new phase with a unique morphology and
melting point (100-102°C) to the pure components was observed within the zone
of mixing (figure 5.18). Such an observation complements the results from the
grinding screen as it further illustrates the formation of potential cocrystals.
1654.46
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Figure 5.18: HSM image for the potential cocrystal 4-aminobenzoic acid•antipyrine. Three
distinct morphologies are shown whose melting points were observed at 187-189°C, 109-
111°C and 100-102°C, and were due to 4-aminobenzoic acid, antipyrine and the potential
cocrystal respectively.
Results from the slow solvent evaporation screen
The extensive slow solvent evaporation screens yielded colourless crystals
of block-like morphology from both seeded and unseeded experiments using ethyl
acetate and the solvent mixture diethyl ether: methanol: water (figure 5.19).
Figure 5.19: Colorless crystals of block like morphology produced from the seeded batch of
4-aminobenzoic acid • antipyrine in diethyl ether: methanol: water
IR spectroscopy confirms that all crystals are of the same solid form and identical
to those obtained from grinding experiments. A single crystal was selected and the
results of X-ray diffraction experiments established the sample to be a cocrystal
which crystallized in the monoclinic space group P21, with four independent
molecules in the asymmetric unit and a 1:1 stoichiometry. The carbonyl group of
each antipyrine molecule is engaged in two hydrogen bonds: to the carboxylate
and amino groups of two different 4-aminobenzoic acid molecules (figure 5.20a).
4-Aminobenzoic acid
AntipyrinePotential cocrystal
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The donor-separation distances for C=O···H-N are 2.946 Å and 2.971 Å, and that
for C=O···H-O are 2.597 Å and 2.598 Å, these interactions form an 46R (26) graph
set (figure 5.20b). The molecules interdigitate as they pack forming a complex
herringbone motif (figure 5.20c). The melting point of this cocrystal was found to
be 102 °C, which is well within the melting point range of the new phase observed
during the HSM experiment in stage I.
(a) (b)
(c)
Figure 5.20: The complex structure of 4-aminobenzoic acid (navy/dark grey) • antipyrine
(red/light grey) cocrystals. (a) The asymmetric unit contains 4 symmetrically inequivalent
molecules. Displacement ellipsoids are drawn at 30 % probability level and hydrogen atoms
are shown as spheres of arbitrary radii. (b) The 46R (26) graph set motif. (c) The packing of
cocrystal components forms a herringbone type motif, for clarity the hydrogen atoms are
removed.
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5.6.2 Combinations that did not produce multicomponent systems
All stage I experimental screens on the remaining 14 combinations did not
show any signs of cocrystal formation. The IR spectra of samples prepared by
neat and solvent assisted grinding displayed no significant change with respect to
the spectra of their components, a typical example is shown in figure 5.21.
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Figure 5.21: The IR spectrum of succinic acid (black), 1,4-dicyanobenzene (blue) and the
ground sample (red).
Furthermore, whenever the HSM experiments were feasible, only two
phases with distinct morphologies and melting points were observed, thus
indicating the presence of the pure components only, a typical example is shown
in figure 5.22.
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Figure 5.22: HSM image of the binary system succinic acid:1,4-dicyanobenzene. Two distinct
morphologies are shown whose melting points were observed at 184-186°C (succinic acid)
and 224-226°C (1,4-dicyanobenzene).
The limited slow solvent evaporation screen in stage II managed to
produce single crystals in four different experiments, all of which were confirmed
by indexing to be one of the pure components (table 5.5).††† The crystallization
experiments between 1,4-dicyanobenzene and either cocrystallizing agent gave
the known triclinic form of 1,4-dicyanobenzene (TEPNIT11) [24], whereas that
between succinic acid and -methyl--nitrostyrene gave the known form of -
methyl--nitrostyrene (VESYOH) [22]. Crystals produced from succinic acid and
bifonazole in solution are probably due to a new form of bifonazole as the
monoclinic cell volume of 1642 Å3 is approximately four times the volume of
bifonazole molecule of 432 Å3 as estimated using the 18 Å3 rule. ‡‡‡ The quality of
these crystals was insufficient to perform a full crystal structure determination.
The remaining crystallization experiments either failed to give a precipitate or
produced a microcrystalline precipitate of a mixture.
††† Indexing was performed by Dr Royston Copley of GSK. The crystals were mounted in paratone
oil on MyTeGen 400/25 MicroMesh and flash frozen to 150 °C.
‡‡‡ The 18 Å3 rule was used to approximate the unit cell contents of the crystal produced from
succinic acid: bifonazole in methanol. This rule is based on the assumption that for organic
molecules each non-hydrogen atom in the unit cell requires an approximate volume of 18 Å3.
1,4-Dicyanobenzene
Succinic acid
162
Table 5-5: Indexed cell parameters of crystals and where possible their equivalent known
structures in bold.
a (Å) b (Å) c (Å) °) °) °) V (Å3)
Triclinic form of 1,4-
dicyanobenzene
(TEPNIT11)
3.843(1) 6.575(2) 7.313(2) 114.50(2) 93.53(3) 96.99(3) 165.606(1)
Crystal grown from 4-
aminobenzoic acid and
1,4-dicyanobenzene in
acetone
3.787(12) 6.51(2) 7.26(2) 114.1(3) 92.7(3) 98.2(3) 160.7(9)
Crystal grown from
succinic acid and 1,4-
dicyanobenzene in
methanol:acetone
3.817(2) 6.585(4) 7.333(2) 114.5(1) 93.6(1) 96.6(2) 166.156(8)
Orthorhombic of -
methyl--nitrostyrene
(VESYOH)
7.576(2) 19.452(5) 11.269(4) 90 90 90 1660.69(3)
Crystal grown from
succinic acid and -
methyl--nitrostyrene in
acetone
7.371(6) 19.366(9) 11.203(2) 90 90 90 1599(2)
Crystal grown from
succinic acid and
bifonazole in methanol
(possible new form of
bifonazole)
7.967(5) 6.233(2) 33.15(2) 90 93.81(5) 90 1642(2)
5.7 Comparison of calculated lattice energies
Lattice energy comparison were only possible for 4-aminobenzoic acid •
antipyrine and succinic acid • 2,2-bipyridine as these were the only cocrystals,
along with their pure components, that are computationally feasible and had fully
solved crystal structures with no disorder. Such calculations were performed using
the same methods describe in chapter 4 section 4.2.2. The structures and the
modelled conformational flexibility of their torsion angles are shown in table 5.6,
and the results of the lattice energy minimization are summarized in table 5.7.
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Table 5-6: Structures of the computationally feasible cocrystals used in the lattice energy
calculations. The intramolecular degrees of freedom that were optimized within the crystal
energy minimization are indicated, with double arrows representing the independent
rotation of two fragments around the same single bond.
O
O
H
N
H
H
4-aminobenzoic acid
(form
4-aminobenzoic acid
(form
N
N
CH3
CH3
O
Antipyrine
4-Aminobenzoic acid•antipyrine
O
O
O
O
H
H
Succinic acid (form
Succinic acid (form
N
N
2,2´-Bipyridine
Succinic acid•2,2-bipyridine
Comparison of the lattice energies of the cocrystals and the weighted sum
of their components show the cocrystals to be more stable when the least stable 
polymorphic form of either cocrystallization agents is considered. Neither
cocrystal is stable relative to the  polymorph of either cocrystallizing agent
(figure 5.23).
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Table 5-7: Results of the lattice energy calculations for the cocrystals 4-aminobenzoic
acid•antipyrine and succinic acid•2,2´-bipyridine along with their pure components.
Components Cocrystals
Z´ Crystalrmsd15 (Å)
Eintra
(kJ mol-1)
Elatt
(kJ mol-1) Ratio
‡ Crystal
rmsd15 (Å)
Eintra
(kJ mol-1)
Cocrystallizing
agent
Eintra
(kJ mol-1)
Compound
Elatt
(kJ mol-1)
-Succinic acid
-Succinic acid
2,2-Bipyridine
2
1
1
0.309
0.152
0.167
1.56; 0.49
0.85
0.00
-105.21
-111.90
-86.48
1:1 0.252 0.50 0.00 -195.34
-Aminobenzoic acid
-Aminobenzoic acid
Antipyrine
2
1
1
0.395
0.361
0.197
1.79; 1.55
1.97
0.64
-100.43
-120.52
-96.85
2:2 0.290 3.00; 0.62 6.49; 7.72 -407.14
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Figure 5.23: The relative stability of the cocrystals 4-aminobenzoic acid•antipyrine and
succinic acid•2,2´-bipyridine to the sum of their component energies. Blue bars correspond to
cocrystals that are more stable than their components, conversely red bars are used.
This is particularly surprising for the succinic acid • 2,2´-bipyridine cocrystal, as
in chapter 4, lattice energy comparisons on a number of succinic acid cocrystals
demonstrated a thermodynamic driving force for cocrystallization irrespective of
the succinic acid polymorphic form. In cases where the cocrystal contained a
coformer that lack a hydrogen bond donor group, these were often found to be
more stable than the weighted sum of their components by at least 10 kJ mol-1.
However, the difference in energy for the succinic acid • 2,2´-bipyridine cocrystal
and its components is about ±3 kJ mol-1, which is well within the polymorphic
‡ Stoichiometeric ratio in cocrystal
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energy difference and errors in the computational model. In this cocrystal, the
intramolecular energy penalty for conformational distortion (Eintra) of succinic
acid is less than in the pure polymorphs upon cocrystallizing, which means that it
now packs more easily than it did in its pure state with less strain thereby adding
to the overall stability of the cocrystal. There is a good overlay of the
experimental and computational cocrystal structures (figure 5.24) and the
RMSD15 value is reasonable in comparison to those noted in chapter 4.
Figure 5.24: Overlay of the experimental (grey) and theoretical (red) structures of the
cocrystal succinic acid • 2,2´-bipyridine
The energy difference of the two polymorphs of 4-aminobenzoic acid is
extremely large for a polymorphic system (about 20 kJ mol-1) as the stability of
the  polymorph is overestimated due to an artefact of the computational model
(as discussed in chapter 4 section 4.3.3). This drastically affects the relative
stability of the cocrystal 4-aminobenzoic acid • antipyrine, which is found to be
more stable when the  polymorph is considered, but significantly less so when
the polymorph is included. The intramolecular energy penalty for
conformational distortion (Eintra) contributed by the antipyrine molecules is very
high as they distort, particularly about the phenyl rings (figure 5.25a), to allow for
better hydrogen bonding interaction with 4-aminobenzoic acid, and consequently
lower the overall stability of the cocrystal. The overlay of the experimental and
computational structures of this cocrystal is a reasonable one with a satisfactory
RMSD15 value (figure 5.25b).
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(a) (b)
Figure 5.25: Overlay of computed and experimental structures for the 4-aminobenzoic
acid:antipyrine system. (a) Overlay of antipyrine in its pure state (grey) over the antipyrine
in the cocrystal environment (red) shows considerable distortion about the phenyl ring (b)
overlay of the experimental (grey) and theoretical (red) structures of the cocrystal 4-
aminobenzoic acid • antipyrine.
5.8 Conclusions
In this study both grinding and HSM experiments were combined in stage
I to provide a preliminary screen for cocrystals that is also environmentally
friendly. Analysis of the ground sample’s IR spectra and detection of a new phase
during the course of the HSM experiment provided indication of potential
cocrystallization. Systems that displayed strong signs of cocrystallization were
subsequently used in extensive slow solvent evaporation experiments, stage II, to
produce suitable single crystals for structural determination by X-ray diffraction.
To the best of our knowledge, this is the first study where both grinding and HSM
techniques are combined as preliminary screens for cocrystals prior to extensive
solution based crystallization experiments.
Overall this experimental strategy was a success, four novel cocrystals
were formed: succinic acid • 2,2´-bipyridine; succinic acid •
diphenylcyclopropenone; 4-aminobenzoic acid • antipyrine and 4-aminobenzoic
acid • phenazine, and their crystal structures were fully determined. Had the
cocrystals 4-aminobenzoic acid • 2,2´-bipyridine and succinic acid • phenazine not
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been produced in previous studies, they would have been found using this
approach as demonstrated by the experimental validation step in section 5.4.
The produced cocrystals had finite and infinite hydrogen bonding chains
as well as complicated ring patterns linking the component molecules. These
hydrogen bonds were of the expected type as suggested by the crystal engineering
guidelines (e.g. Figure 5.1). However, the limitation of designing cocrystals by
these simple hydrogen bonding rules is evident by 12 of the 18 combinations not
forming cocrystals (table 5.4).
5.8.1 Efficacy of screen
The preliminary screen in stage I proved to be very effective, as the results
were rapidly obtainable and systems that indicated potential cocrystallization were
the only ones to produce cocrystals in stage II. Unfortunately, in some cases
where there was a large difference in the melting point of the coformers, the
compound with the lower melting point decomposed, and so the use of the HSM
method was limited. However, whenever the HSM experiments were possible, the
results were equivalent to the grinding.
Analysis of the IR spectra of the ground samples proved very informative,
not only was it used to identify potential cocrystallization, it was also used to
predict which functional groups are directly involved in the hydrogen bonding
between the coformers. In most cases, there were significant peak shifts in the IR
spectra attributed by the formation of new hydrogen bonds upon cocrystallization.
However, in the case of 4-aminobenzoic acid•phenazine, only slight differences
between the IR spectrum of the pure components and that of the ground sample
were observed, providing unconvincing evidence of cocrystallization despite the
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sample being later confirmed to be a cocrystal. The reason for this is particular to
the cocrystal, as discussed in 5.6.1. In this case, the HSM screen offered a more
prominent indication of cocrystallization as a new phase was observed during the
course of the HSM experiment. This further demonstrates the complementary
benefit of combining the grinding and HSM techniques in the preliminary
screening stage.
Another advantage of stage I experiments is the reduced possibility of
solvate formation as there is little to no solvent involved. Such screens offer the
opportunity of exploring cocrystallization from experiments where nucleation is
predominantly influenced by milling (neat grinding), solvent (solvent assisted
grinding) as well as temperature (HSM).
A limited number of solution based experiments were carried out for
systems that displayed weak indications of cocrystallization in stage I (i.e. within
limits of the experimental methods) to investigate the possibility that
cocrystallization may only be induced under such conditions and to further test the
effectiveness of the preliminary screen in stage I. In all cases where single crystals
were formed, these were found to belong to either pure component, which include
a potentially new form of bifonazole, thereby illustrating the efficiency of stage I
screening approach for cocrystals.
The availability of some of the biological building blocks were limited,
therefore analysis by means of IR spectroscopy was considered the ideal choice
rather than the traditional approach of X-ray powder diffraction. This technique
required less sample, which was also reusable, and is cheaper. Furthermore,
collection of the IR spectra was obtained very rapidly in comparison to the
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collection of X-ray powder patterns, and offered more insight into the nature of
the hydrogen bonds involved.
5.8.2 Overview of lattice energy calculations
This study has targeted cocrystals comprising of either 4-aminobenzoic
acid or succinic acid and coformers that lack hydrogen bond donor functionalities.
This was motivated by findings made in chapter 4, where similar cocrystals were
calculated to be considerably lower in energy than the sum of their components,
typically by 10 kJ mol-1, and the majority contained the COOH···Naromatic synthon
(figure 5.1). Following experimental screens, four novel cocrystals were
produced, two of which (succinic acid • 2,2´-bipyridine and 4-aminobenzoic acid •
antipyrine) were computationally feasible. Although both cocrystals contained the
COOH···Naromatic synthon, their calculated relative stabilities were surprisingly low
in relation to the structurally similar cocrystals studied in chapter 4.
These disappointing stability values coupled by the poor production where only 4
out of 18 systems yielded cocrystals demonstrates the unreliability in the synthon
argument to predict cocrystals, and underlines the need for more sophisticated
methods to assist in the search of these multicomponent systems.
In the next chapter, an extensive computational procedure is used elucidate
theoretically why one of the experimentally investigated systems produced
cocrystals whilst another did not. Computed crystals structures and lattice energy
landscapes are generated and used to rationalize for these experimental
observations. This study also investigates whether crystal structure prediction can
provide viable means of screening for cocrystals more efficiently and effectively.
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5.9 Appendix
Table 5-8: Crystal structure summary for all novel cocrystals
Cocrystal Succinicacid•diphenylcyclopropenone Succinic acid•2,2´-bipyridine 4-Aminobenzoic acid•phenazine
§§§ 4-Aminobenzoic acid•antipyrine
Crystal data
Chemical formula C15H10O·0.5(C4H6O4) C10H8N2·C4H6O4 8(C12H8N2)·4(C7H7NO2) 2(C11H12N2O)·2(C7H7NO2)
Mr 265.27 274.27 1990.18 325.36
Crystal system, space group Monoclinic, P21/c Monoclinic, P21/c Triclinic, P¯1 Monoclinic, P21
Temperature (K) 150 150 120 150
a, b, c (Å) 14.654 (4), 5.5540 (14), 16.288 (4) 8.958 (3), 5.1788 (14), 14.357 (4) 15.557 (2), 17.056 (3), 19.782 (3) 9.5767 (12), 12.7646 (17), 13.9388(18)
 (°) 90.471 (4) 106.109 (4) 80.658 (5), 78.559 (7), 77.168 (6) 90.758 (2)
V (Å3) 1325.6 (6) 639.9 (3) 4977.6 (13) 1703.8 (4)
Z 4 2 24 4
Radiation type Mo K Mo K Synchrotron,  = 0.68890 Å Mo K
 (mm-1) 0.09 0.11 0.05 0.09
Crystal size (mm) 0.50 × 0.30 × 0.03 0.50 × 0.20 × 0.02 0.14 × 0.10 × 0.07 0.50 × 0.30 × 0.03
Data collection
Diffractometer Bruker SMART APEXdiffractometer Bruker SMART APEX
Crystal Logic goniometer Rigaku
Saturn724+ (2x2 bin mode)
Bruker SMART APEX
Absorption correction Multi-scanSADABS v2.10
Multi-scan
SADABS v2.03
Multi-scan
REQAB within D*TREK
Multi-scan
SADABS v2.10
Tmin, Tmax 0.844, 1.000 0.748, 0.982 0.704, 1.000 0.867, 1.000
No. of measured,
independent & observed
[I > 2(I)] reflections
10750, 3179, 2638 5107, 1523, 1316 76255, 29699, 22369 14769, 4240, 3175
Rint 0.030 0.042 0.046 0.045
Refinement
R[F2 > 2(F2)], wR(F2), S 0.047, 0.133, 1.05 0.039, 0.102, 1.07 0.071, 0.230, 1.11 0.048, 0.120, 1.01
No. of parameters 233 119 1737 455
No. of restraints 0 0 0 1
H-atom treatment All H-atom parameters refined freely All H-atom parameters refined freely All H-atom parameters refinedfreely
H-atoms of N1 and N2 were refined
using the riding model, all other H-
atoms were refined freely
max, min (e Å-3) 0.47, -0.22 0.28, -0.33 0.62, -0.39 0.18, -0.22
§§§ Data provided by Sarah Barnett of Diamond Light Source Ltd.
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Table 5-9: Succinic acid•diphenylcyclopropenone crystallographic parameters
Atomic coordinates and equivalent isotropic displacement parameters (Å2)
x y z Ueq
O1 0.30165(6) 1.02278(18) 0.43259(7) 0.0399(3)
C6 0.46878(8) 0.5467(2) 0.37606(7) 0.0231(3)
C5 0.53612(9) 0.6634(2) 0.42245(8) 0.0257(3)
C15 0.24017(9) 0.3504(2) 0.23722(8) 0.0283(3)
C9 0.29192(8) 0.6533(2) 0.34021(8) 0.0249(3)
C10 0.22375(8) 0.5558(2) 0.28423(7) 0.0244(3)
C1 0.48946(9) 0.3306(2) 0.33626(8) 0.0260(3)
C12 0.07719(9) 0.6017(3) 0.21802(8) 0.0319(3)
C8 0.31809(8) 0.8365(2) 0.39469(8) 0.0277(3)
C3 0.64261(9) 0.3500(2) 0.39048(8) 0.0295(3)
C11 0.14106(9) 0.6796(2) 0.27497(8) 0.0280(3)
C2 0.57633(9) 0.2332(2) 0.34391(8) 0.0297(3)
C4 0.62297(9) 0.5654(3) 0.42946(8) 0.0294(3)
C7 0.37861(8) 0.6530(2) 0.37155(7) 0.0246(3)
C14 0.17592(10) 0.2740(3) 0.18002(8) 0.0321(3)
C13 0.09518(10) 0.4008(3) 0.17016(8) 0.0330(3)
O3 0.16956(6) 0.02726(18) 0.99206(6) 0.0347(3)
O2 0.12665(7) 0.36814(19) 0.93026(7) 0.0389(3)
C16 0.11022(8) 0.1600(2) 0.96652(7) 0.0236(3)
C17 0.00964(8) 0.1067(2) 0.97251(8) 0.0269(3)
Selected bond lengths [Å]
O1—C8 1.2298 (16) C1—C2 1.3879 (18)
C6—C5 1.3974 (17) C12—C11 1.3818 (19)
C6—C1 1.3982 (17) C12—C13 1.387 (2)
C6—C7 1.4485 (17) C8—C7 1.4047 (17)
C5—C4 1.3881 (18) C3—C4 1.386 (2)
C15—C14 1.3857 (19) C3—C2 1.3884 (19)
C15—C10 1.3955 (18) C14—C13 1.385 (2)
C9—C7 1.3652 (18) O3—C16 1.2112 (15)
C9—C8 1.4012 (18) O2—C16 1.3210 (15)
C9—C10 1.4519 (17) C16—C17 1.5073 (17)
C10—C11 1.4006 (18) C17—C17 1.514 (3)
Selected bond angles [°]
C5—C6—C1 119.61 (11) C9—C8—C7 58.23 (9)
C5—C6—C7 118.56 (11) C4—C3—C2 120.45 (12)
C1—C6—C7 121.83 (11) C12—C11—C10 119.94 (12)
C4—C5—C6 120.37 (12) C1—C2—C3 120.26 (12)
C14—C15—C10 119.99 (12) C3—C4—C5 119.64 (12)
C7—C9—C8 61.01 (9) C9—C7—C8 60.76 (9)
C7—C9—C10 150.18 (12) C9—C7—C6 149.91 (12)
C8—C9—C10 148.42 (12) C8—C7—C6 149.30 (12)
C15—C10—C11 119.68 (12) C13—C14—C15 119.82 (13)
C15—C10—C9 121.92 (11) C14—C13—C12 120.64 (13)
C11—C10—C9 118.33 (12) O3—C16—O2 123.60 (12)
C2—C1—C6 119.67 (12) O3—C16—C17 123.90 (11)
C11—C12—C13 119.89 (13) O2—C16—C17 112.50 (11)
O1—C8—C9 151.05 (13) C16—C17—C17i 112.31 (13)
O1—C8—C7 150.69 (13)
Selected hydrogen-bond parameters
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°)
O2—H11···O1 0.96 (3) 1.68 (3) 2.6351 (15) 170 (2)
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Table 5-10 Succinic acid•2,2´-bipyridine crystallographic parameters
Atomic coordinates and equivalent isotropic displacement parameters (Å2)
x y z Ueq
O2 0.75702(10) 0.41419(17) 0.02628(6) 0.0273(2)
O1 0.93813(10) 0.32357(18) 0.11154(7) 0.0340(3)
N1 0.65570(11) 0.19736(18) 0.07493(7) 0.0195(2)
C1 0.54790(12) 0.0080(2) 0.05152(8) 0.0170(2)
C2 0.52830(14) 0.1661(2) 0.12124(8) 0.0223(3)
C3 0.62005(14) 0.1458(2) 0.21591(8) 0.0238(3)
C4 0.73021(14) 0.0468(2) 0.23972(8) 0.0224(3)
C5 0.74362(14) 0.2127(2) 0.16707(9) 0.0223(3)
C6 0.87875(13) 0.2821(2) 0.02707(8) 0.0194(3)
C7 0.93174(13) 0.0765(2) 0.03077(9) 0.0213(3)
Selected bond lengths [Å]
O2—C6 1.3342 (14) C2—C3 1.3835 (16)
O1—C6 1.2008 (14) C3—C4 1.3778 (17)
N1—C5 1.3411 (15) C4—C5 1.3821 (17)
N1—C1 1.3517 (14) C6—C7 1.5058 (15)
C1—C2 1.3941 (16) C7—C7 1.518 (2)
C1—C1 1.492 (2)
Selected bond angles [°]
C5—N1—C1 118.16 (10) C3—C4—C5 117.97 (11)
N1—C1—C2 120.95 (10) N1—C5—C4 123.87 (11)
N1—C1—C1 117.48 (12) O1—C6—O2 123.40 (11)
C2—C1—C1 121.56 (12) O1—C6—C7 124.36 (10)
C3—C2—C1 119.82 (11) O2—C6—C7 112.24 (10)
C4—C3—C2 119.23 (11) C6—C7—C7 111.99 (12)
Selected hydrogen-bond parameters
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°)
O2—H1···N1 0.91(2) 1.87(2) 2.7774(14) 177(2)
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Table 5-11: 4-Aminobenzoic acid•phenazine crystallographic parameters
Atomic coordinates and equivalent isotropic displacement parameters (Å2)
x y z Ueq
C1 0.53276(10) 0.22598(9) 0.27251(7) 0.0199(3)
C7 0.46522(10) 0.18427(9) 0.31718(7) 0.0212(3)
O1 0.39165(8) 0.18657(8) 0.30294(6) 0.0287(3)
O2 0.49105(8) 0.14410(8) 0.37541(6) 0.0298(3)
C2 0.50993(10) 0.28074(9) 0.21497(8) 0.0209(3)
C3 0.57182(10) 0.32136(10) 0.17245(8) 0.0215(3)
C4 0.66013(10) 0.30782(9) 0.18571(7) 0.0212(3)
N1 0.72169(10) 0.34598(10) 0.14240(8) 0.0295(3)
C5 0.68279(10) 0.25307(9) 0.24377(8) 0.0217(3)
C6 0.62015(10) 0.21317(9) 0.28643(7) 0.0201(3)
C11 0.96821(10) 0.72861(9) 0.77275(8) 0.0204(3)
C17 1.03453(11) 0.68634(9) 0.81646(8) 0.0221(3)
O11 1.11440(8) 0.68706(8) 0.80084(6) 0.0304(3)
O12 1.00001(8) 0.64652(8) 0.87576(6) 0.0299(3)
C12 0.87900(10) 0.71863(9) 0.78907(8) 0.0216(3)
C13 0.81840(11) 0.75758(10) 0.74610(8) 0.0228(3)
C14 0.84507(11) 0.80819(10) 0.68559(8) 0.0244(3)
N11 0.78725(11) 0.84561(11) 0.64169(9) 0.0354(4)
C15 0.93485(11) 0.81826(10) 0.66979(8) 0.0243(3)
C16 0.99488(10) 0.77872(9) 0.71268(8) 0.0217(3)
C21 0.03167(10) 0.27419(9) 0.73553(7) 0.0197(3)
C27 0.03878(10) 0.32144(9) 0.69782(8) 0.0212(3)
O21 0.11252(8) 0.30562(8) 0.70371(6) 0.0293(3)
O22 0.01560(9) 0.38590(8) 0.65684(7) 0.0378(3)
C22 0.11891(10) 0.28924(9) 0.72087(8) 0.0214(3)
C23 0.18382(10) 0.24296(10) 0.75698(8) 0.0218(3)
C24 0.16323(10) 0.18051(9) 0.80994(8) 0.0216(3)
N21 0.22659(10) 0.13422(10) 0.84591(8) 0.0310(3)
C25 0.07519(10) 0.16657(9) 0.82478(8) 0.0222(3)
C26 0.01109(10) 0.21230(9) 0.78779(8) 0.0209(3)
C31 0.46410(10) 0.77418(9) 0.22868(7) 0.0197(3)
C37 0.53115(10) 0.81775(9) 0.18576(8) 0.0216(3)
O31 0.60502(8) 0.81354(8) 0.19978(6) 0.0305(3)
O32 0.50492(9) 0.86173(8) 0.12913(7) 0.0335(3)
C32 0.48767(11) 0.71711(9) 0.28463(8) 0.0212(3)
C33 0.42641(11) 0.67470(10) 0.32516(8) 0.0228(3)
C34 0.33822(10) 0.68841(9) 0.31222(8) 0.0216(3)
N31 0.27741(10) 0.64739(10) 0.35309(8) 0.0312(3)
C35 0.31450(10) 0.74613(10) 0.25582(8) 0.0217(3)
C36 0.37675(10) 0.78773(9) 0.21468(7) 0.0201(3)
C101 0.14542(13) 1.11991(11) 0.03553(9) 0.0296(3)
C102 0.14030(13) 1.13987(12) 0.10003(10) 0.0354(4)
C103 0.11854(13) 1.08532(13) 0.16036(10) 0.0351(4)
C104 0.10273(12) 1.01160(12) 0.15490(9) 0.0319(4)
N105 0.09456(9) 0.91446(9) 0.08313(7) 0.0263(3)
C106 0.08852(12) 0.81754(11) 0.01021(10) 0.0303(4)
C107 0.09639(13) 0.79711(11) 0.05466(10) 0.0330(4)
C108 0.11554(13) 0.85281(11) 0.11473(9) 0.0313(4)
C109 0.12762(12) 0.92776(11) 0.10888(9) 0.0282(3)
N110 0.13599(9) 1.02452(8) 0.03664(7) 0.0232(3)
C111 0.10813(11) 0.98762(10) 0.08809(8) 0.0242(3)
C112 0.10076(11) 0.89583(10) 0.01873(8) 0.0237(3)
C113 0.12119(10) 0.95117(9) 0.04190(8) 0.0219(3)
C114 0.12960(11) 1.04346(10) 0.02761(8) 0.0230(3)
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C121 0.67986(11) 0.14832(10) 0.99811(9) 0.0261(3)
C122 0.66869(12) 0.16645(11) 1.06396(10) 0.0296(3)
C123 0.63765(12) 0.11278(11) 1.12156(9) 0.0302(4)
C124 0.61815(12) 0.04149(11) 1.11301(9) 0.0281(3)
N125 0.60864(9) 0.04951(8) 1.03561(7) 0.0248(3)
C126 0.59811(13) 0.13943(11) 0.95748(11) 0.0332(4)
C127 0.60679(15) 0.15533(13) 0.89095(12) 0.0409(5)
C128 0.63624(15) 0.10044(13) 0.83334(11) 0.0398(5)
C129 0.65717(13) 0.03045(12) 0.84347(9) 0.0333(4)
N130 0.67077(9) 0.05780(8) 0.92076(7) 0.0242(3)
C131 0.62840(10) 0.02042(9) 1.04467(8) 0.0223(3)
C132 0.61829(11) 0.06622(10) 0.96986(9) 0.0241(3)
C133 0.64966(11) 0.01114(10) 0.91202(8) 0.0257(3)
C134 0.65998(10) 0.07439(9) 0.98616(8) 0.0215(3)
C141 0.98438(12) 0.38133(10) 0.95040(9) 0.0282(3)
C142 1.01104(13) 0.37463(11) 0.88128(10) 0.0317(4)
C143 0.97419(14) 0.43523(11) 0.83052(9) 0.0347(4)
C144 0.91198(14) 0.50032(11) 0.85001(9) 0.0311(4)
N145 0.82547(10) 0.57732(8) 0.93931(7) 0.0259(3)
C146 0.74676(13) 0.65851(11) 1.02834(11) 0.0357(4)
C147 0.72487(15) 0.66799(13) 1.09688(13) 0.0445(5)
C148 0.75537(14) 0.60511(13) 1.14808(11) 0.0413(5)
C149 0.80884(13) 0.53422(12) 1.13054(9) 0.0330(4)
N150 0.89353(9) 0.45560(8) 1.04111(7) 0.0237(3)
C151 0.88303(11) 0.51041(9) 0.92163(8) 0.0235(3)
C152 0.80322(11) 0.58533(10) 1.00716(9) 0.0256(3)
C153 0.83599(11) 0.52325(10) 1.05908(8) 0.0249(3)
C154 0.91900(10) 0.44902(9) 0.97295(8) 0.0227(3)
C161 0.49176(12) 0.33540(10) 0.00265(10) 0.0294(3)
C162 0.52011(12) 0.32469(11) 0.07087(10) 0.0310(4)
C163 0.49252(13) 0.38638(11) 0.12449(9) 0.0310(4)
C164 0.43669(12) 0.45677(11) 0.10879(9) 0.0278(3)
N165 0.34989(9) 0.53970(8) 0.02299(7) 0.0236(3)
C166 0.26572(12) 0.62328(11) 0.06315(9) 0.0290(3)
C167 0.23992(13) 0.63451(12) 0.13139(10) 0.0333(4)
C168 0.27047(13) 0.57438(13) 0.18467(10) 0.0357(4)
C169 0.32441(13) 0.50351(12) 0.16888(9) 0.0315(4)
N170 0.40694(10) 0.41824(9) 0.08333(7) 0.0266(3)
C171 0.40513(11) 0.46987(9) 0.03802(8) 0.0218(3)
C172 0.32372(11) 0.55003(10) 0.04440(8) 0.0229(3)
C173 0.35309(11) 0.48831(10) 0.09799(8) 0.0241(3)
C174 0.43346(11) 0.40833(10) 0.01589(8) 0.0231(3)
C181 0.50731(12) 0.66439(11) 0.49847(10) 0.0301(3)
C182 0.47890(12) 0.67771(11) 0.56611(10) 0.0314(4)
C183 0.50651(12) 0.61912(11) 0.62124(9) 0.0314(4)
C184 0.56319(12) 0.54799(11) 0.60798(8) 0.0278(3)
N185 0.64990(9) 0.46098(8) 0.52573(7) 0.0233(3)
C186 0.73391(12) 0.37247(11) 0.44339(10) 0.0302(4)
C187 0.76004(13) 0.35794(13) 0.37579(11) 0.0379(4)
C188 0.73042(14) 0.41587(14) 0.32073(10) 0.0402(5)
C189 0.67613(14) 0.48744(13) 0.33373(9) 0.0349(4)
N190 0.59298(10) 0.57704(9) 0.41548(7) 0.0272(3)
C191 0.59447(10) 0.53130(9) 0.53814(8) 0.0217(3)
C192 0.67603(11) 0.44711(10) 0.45918(8) 0.0238(3)
C193 0.64679(11) 0.50599(10) 0.40356(8) 0.0258(3)
C194 0.56605(11) 0.59011(10) 0.48236(8) 0.0232(3)
C201 0.25407(12) 0.33600(11) 0.49347(10) 0.0312(4)
C202 0.28517(13) 0.31043(12) 0.43028(11) 0.0367(4)
C203 0.26270(13) 0.35953(13) 0.36871(10) 0.0362(4)
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C204 0.20793(12) 0.43411(12) 0.37144(9) 0.0314(4)
N205 0.11434(9) 0.53353(8) 0.44038(7) 0.0252(3)
C206 0.01426(13) 0.62951(11) 0.50921(11) 0.0342(4)
C207 0.02174(14) 0.65282(13) 0.57299(12) 0.0406(5)
C208 0.00527(15) 0.60686(13) 0.63339(11) 0.0418(5)
C209 0.06821(14) 0.53643(13) 0.63036(10) 0.0354(4)
N210 0.16505(10) 0.43704(9) 0.56201(7) 0.0261(3)
C211 0.17196(11) 0.46263(10) 0.43702(8) 0.0234(3)
C212 0.08002(11) 0.55665(10) 0.50371(9) 0.0261(3)
C213 0.10728(11) 0.50797(10) 0.56491(8) 0.0267(3)
C214 0.19653(11) 0.41323(10) 0.49889(8) 0.0235(3)
C221 0.32158(12) 0.85422(11) 0.49415(10) 0.0303(4)
C222 0.33160(13) 0.84074(12) 0.42714(11) 0.0369(4)
C223 0.36045(13) 0.89837(13) 0.37180(10) 0.0374(4)
C224 0.37904(12) 0.96898(12) 0.38410(9) 0.0311(4)
N225 0.38997(9) 1.05266(8) 0.46683(7) 0.0241(3)
C226 0.40346(13) 1.13488(11) 0.55004(10) 0.0310(4)
C227 0.39532(14) 1.14643(12) 0.61784(11) 0.0362(4)
C228 0.36560(14) 1.08861(13) 0.67283(10) 0.0387(4)
C229 0.34478(13) 1.02031(12) 0.65913(9) 0.0311(4)
N230 0.33103(9) 0.93837(8) 0.57647(7) 0.0245(3)
C231 0.37024(10) 0.98437(10) 0.45409(8) 0.0235(3)
C232 0.38194(11) 1.06423(10) 0.53384(8) 0.0231(3)
C233 0.35188(11) 1.00592(10) 0.58898(8) 0.0237(3)
C234 0.34091(11) 0.92649(10) 0.50980(8) 0.0234(3)
C241 0.90601(13) 0.17661(12) 0.51039(12) 0.0378(4)
C242 0.90011(14) 0.18496(14) 0.57826(13) 0.0450(5)
C243 0.88437(14) 0.12026(15) 0.63103(12) 0.0442(5)
C244 0.87459(14) 0.04831(13) 0.61511(10) 0.0363(4)
N245 0.86757(10) 0.03285(9) 0.52958(8) 0.0281(3)
C246 0.86043(14) 0.11137(13) 0.44159(14) 0.0447(5)
C247 0.86528(17) 0.1175(2) 0.37289(18) 0.0672(10)
C248 0.88287(17) 0.0526(2) 0.32074(14) 0.0606(8)
C249 0.89519(15) 0.01641(18) 0.33777(11) 0.0498(6)
N250 0.90097(10) 0.09625(10) 0.42404(8) 0.0315(3)
C251 0.87972(11) 0.03756(10) 0.54456(8) 0.0246(3)
C252 0.87293(11) 0.03930(11) 0.46183(9) 0.0292(3)
C253 0.89011(12) 0.02590(12) 0.40892(9) 0.0309(4)
C254 0.89594(11) 0.10222(10) 0.49118(9) 0.0264(3)
Selected bond lengths [Å]
C1—C2 1.401 (2) C168—C169 1.353 (3)
C1—C6 1.403 (2) C169—C173 1.432 (2)
C1—C7 1.466 (2) C171—C174 1.432 (2)
C2—C3 1.379 (2) C172—C173 1.434 (2)
C3—C4 1.411 (2) C181—C182 1.363 (3)
C4—C5 1.408 (2) C181—C194 1.429 (2)
C4—N1 1.358 (2) C182—C183 1.419 (3)
C5—C6 1.381 (2) C183—C184 1.362 (3)
C7—O1 1.2228 (19) C184—C191 1.423 (2)
C7—O2 1.3278 (19) C186—C187 1.365 (3)
C11—C12 1.403 (2) C186—C192 1.427 (2)
C11—C16 1.395 (2) C187—C188 1.422 (3)
C11—C17 1.467 (2) C188—C189 1.352 (3)
C12—C13 1.382 (2) C189—C193 1.430 (2)
C13—C14 1.406 (2) C191—C194 1.434 (2)
C14—C15 1.412 (2) C192—C193 1.436 (2)
C14—N11 1.359 (2) C201—C202 1.353 (3)
C15—C16 1.377 (2) C201—C214 1.426 (2)
C17—O11 1.2218 (19) C202—C203 1.419 (3)
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C17—O12 1.3338 (18) C203—C204 1.367 (3)
C21—C22 1.402 (2) C204—C211 1.424 (2)
C21—C26 1.396 (2) C206—C207 1.359 (3)
C21—C27 1.464 (2) C206—C212 1.427 (3)
C22—C23 1.379 (2) C207—C208 1.403 (3)
C23—C24 1.411 (2) C208—C209 1.372 (3)
C24—C25 1.408 (2) C209—C213 1.429 (2)
C24—N21 1.361 (2) C211—C214 1.436 (2)
C25—C26 1.377 (2) C212—C213 1.434 (2)
C27—O21 1.2151 (19) C221—C222 1.355 (3)
C27—O22 1.3293 (19) C221—C234 1.425 (2)
C31—C32 1.400 (2) C222—C223 1.420 (3)
C31—C36 1.402 (2) C223—C224 1.368 (3)
C31—C37 1.466 (2) C224—C231 1.425 (2)
C32—C33 1.374 (2) C226—C227 1.364 (3)
C33—C34 1.407 (2) C226—C232 1.419 (2)
C34—C35 1.413 (2) C227—C228 1.423 (3)
C34—N31 1.358 (2) C228—C229 1.357 (3)
C35—C36 1.382 (2) C229—C233 1.427 (2)
C37—O31 1.2189 (19) C231—C234 1.430 (2)
C37—O32 1.325 (2) C232—C233 1.432 (2)
C101—C102 1.356 (2) C241—C242 1.356 (3)
C101—C114 1.418 (2) C241—C254 1.431 (2)
C102—C103 1.423 (3) C242—C243 1.419 (4)
C103—C104 1.358 (3) C243—C244 1.362 (3)
C104—C111 1.427 (2) C244—C251 1.421 (2)
C106—C107 1.359 (3) C246—C247 1.366 (4)
C106—C112 1.431 (2) C246—C252 1.416 (3)
C107—C108 1.422 (3) C247—C248 1.420 (5)
C108—C109 1.359 (2) C248—C249 1.338 (4)
C109—C113 1.424 (2) C249—C253 1.427 (2)
C111—C114 1.436 (2) C251—C254 1.427 (2)
C112—C113 1.430 (2) C252—C253 1.431 (3)
C121—C122 1.356 (2) N105—C111 1.333 (2)
C121—C134 1.429 (2) N105—C112 1.342 (2)
C122—C123 1.417 (3) N110—C113 1.345 (2)
C123—C124 1.360 (3) N110—C114 1.3412 (19)
C124—C131 1.424 (2) N125—C131 1.343 (2)
C126—C127 1.361 (3) N125—C132 1.349 (2)
C126—C132 1.422 (2) N130—C133 1.334 (2)
C127—C128 1.422 (3) N130—C134 1.339 (2)
C128—C129 1.359 (3) N145—C151 1.333 (2)
C129—C133 1.424 (2) N145—C152 1.339 (2)
C131—C134 1.434 (2) N150—C153 1.344 (2)
C132—C133 1.436 (2) N150—C154 1.343 (2)
C141—C142 1.364 (2) N165—C171 1.343 (2)
C141—C154 1.426 (2) N165—C172 1.3427 (19)
C142—C143 1.426 (3) N170—C173 1.336 (2)
C143—C144 1.353 (3) N170—C174 1.342 (2)
C144—C151 1.425 (2) N185—C191 1.340 (2)
C146—C147 1.358 (3) N185—C192 1.342 (2)
C146—C152 1.429 (2) N190—C193 1.337 (2)
C147—C148 1.419 (3) N190—C194 1.345 (2)
C148—C149 1.360 (3) N205—C211 1.338 (2)
C149—C153 1.423 (2) N205—C212 1.346 (2)
C151—C154 1.435 (2) N210—C213 1.339 (2)
C152—C153 1.432 (2) N210—C214 1.341 (2)
C161—C162 1.363 (3) N225—C231 1.341 (2)
C161—C174 1.421 (2) N225—C232 1.349 (2)
C162—C163 1.426 (3) N230—C233 1.336 (2)
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C163—C164 1.358 (3) N230—C234 1.340 (2)
C164—C171 1.425 (2) N245—C251 1.343 (2)
C166—C167 1.362 (2) N245—C252 1.347 (2)
C166—C172 1.425 (2) N250—C253 1.336 (2)
C167—C168 1.421 (3) N250—C254 1.334 (2)
Selected bond angles [°]
C2—C1—C6 118.75 (13) C149—C153—C152 119.52 (16)
C2—C1—C7 119.72 (14) N150—C154—C141 120.11 (15)
C6—C1—C7 121.52 (13) N150—C154—C151 121.06 (14)
O1—C7—O2 122.78 (14) C141—C154—C151 118.81 (15)
O1—C7—C1 123.65 (14) C162—C161—C174 120.13 (16)
O2—C7—C1 113.56 (14) C161—C162—C163 120.74 (16)
C3—C2—C1 120.98 (14) C164—C163—C162 120.81 (16)
C2—C3—C4 120.45 (14) C163—C164—C171 120.03 (16)
N1—C4—C5 121.27 (14) C172—N165—C171 117.40 (14)
N1—C4—C3 120.26 (14) C167—C166—C172 119.87 (17)
C5—C4—C3 118.46 (14) C166—C167—C168 121.06 (17)
C6—C5—C4 120.70 (14) C169—C168—C167 120.70 (17)
C5—C6—C1 120.65 (14) C168—C169—C173 120.55 (17)
C16—C11—C12 119.12 (14) C173—N170—C174 117.02 (14)
C16—C11—C17 119.21 (14) N165—C171—C164 119.61 (14)
C12—C11—C17 121.66 (14) N165—C171—C174 121.14 (14)
O11—C17—O12 122.21 (15) C164—C171—C174 119.25 (15)
O11—C17—C11 123.81 (14) N165—C172—C166 119.64 (15)
O12—C17—C11 113.98 (14) N165—C172—C173 121.02 (14)
C13—C12—C11 120.49 (14) C166—C172—C173 119.34 (15)
C12—C13—C14 120.50 (15) N170—C173—C169 119.74 (15)
N11—C14—C13 121.57 (15) N170—C173—C172 121.80 (14)
N11—C14—C15 119.79 (15) C169—C173—C172 118.46 (15)
C13—C14—C15 118.63 (15) N170—C174—C161 119.35 (15)
C16—C15—C14 120.43 (14) N170—C174—C171 121.61 (14)
C15—C16—C11 120.83 (14) C161—C174—C171 119.04 (15)
C26—C21—C22 119.09 (14) C182—C181—C194 119.67 (16)
C26—C21—C27 118.82 (13) C181—C182—C183 121.27 (17)
C22—C21—C27 122.09 (13) C184—C183—C182 120.81 (16)
O21—C27—O22 122.06 (14) C183—C184—C191 119.93 (16)
O21—C27—C21 124.42 (14) C191—N185—C192 117.31 (14)
O22—C27—C21 113.50 (13) C187—C186—C192 119.52 (18)
C23—C22—C21 120.50 (14) C186—C187—C188 121.10 (18)
C22—C23—C24 120.57 (14) C189—C188—C187 120.97 (17)
N21—C24—C25 120.30 (14) C188—C189—C193 120.34 (18)
N21—C24—C23 121.26 (14) C193—N190—C194 116.68 (14)
C25—C24—C23 118.44 (14) N185—C191—C184 119.41 (14)
C26—C25—C24 120.61 (14) N185—C191—C194 121.23 (14)
C25—C26—C21 120.77 (14) C184—C191—C194 119.36 (15)
C32—C31—C36 118.96 (14) N185—C192—C186 119.39 (15)
C32—C31—C37 119.50 (14) N185—C192—C193 121.19 (15)
C36—C31—C37 121.54 (14) C186—C192—C193 119.41 (15)
O31—C37—O32 122.44 (14) N190—C193—C189 119.54 (16)
O31—C37—C31 123.64 (15) N190—C193—C192 121.82 (14)
O32—C37—C31 113.92 (14) C189—C193—C192 118.65 (16)
C33—C32—C31 120.67 (14) N190—C194—C181 119.30 (15)
C32—C33—C34 120.96 (14) N190—C194—C191 121.74 (15)
N31—C34—C33 120.82 (14) C181—C194—C191 118.96 (15)
N31—C34—C35 120.89 (15) C202—C201—C214 119.72 (17)
C33—C34—C35 118.29 (14) C201—C202—C203 121.32 (18)
C36—C35—C34 120.47 (14) C204—C203—C202 120.94 (17)
C35—C36—C31 120.64 (14) C203—C204—C211 119.62 (16)
C102—C101—C114 119.90 (17) C211—N205—C212 117.69 (14)
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C101—C102—C103 120.97 (18) C207—C206—C212 119.42 (19)
C104—C103—C102 120.86 (16) C206—C207—C208 121.1 (2)
C103—C104—C111 120.19 (17) C209—C208—C207 121.33 (18)
C111—N105—C112 116.70 (14) C208—C209—C213 120.20 (19)
C107—C106—C112 119.88 (16) C213—N210—C214 116.86 (14)
C106—C107—C108 121.08 (16) N205—C211—C204 119.92 (15)
C109—C108—C107 120.86 (16) N205—C211—C214 121.05 (14)
C108—C109—C113 119.85 (16) C204—C211—C214 119.01 (15)
C114—N110—C113 117.11 (13) N205—C212—C206 118.93 (16)
N105—C111—C104 119.82 (15) N205—C212—C213 120.67 (15)
N105—C111—C114 121.78 (14) C206—C212—C213 120.38 (16)
C104—C111—C114 118.39 (15) N210—C213—C209 120.40 (16)
N105—C112—C113 122.09 (14) N210—C213—C212 121.99 (15)
N105—C112—C106 119.14 (15) C209—C213—C212 117.57 (17)
C113—C112—C106 118.75 (15) N210—C214—C201 118.95 (15)
N110—C113—C109 119.44 (14) N210—C214—C211 121.67 (15)
N110—C113—C112 120.98 (14) C201—C214—C211 119.36 (15)
C109—C113—C112 119.56 (15) C222—C221—C234 120.02 (18)
N110—C114—C101 118.97 (15) C221—C222—C223 120.74 (18)
N110—C114—C111 121.34 (14) C224—C223—C222 121.46 (17)
C101—C114—C111 119.69 (14) C223—C224—C231 119.08 (18)
C122—C121—C134 119.93 (16) C231—N225—C232 117.66 (13)
C121—C122—C123 120.89 (16) C227—C226—C232 119.69 (17)
C124—C123—C122 121.48 (16) C226—C227—C228 121.04 (18)
C123—C124—C131 119.40 (16) C229—C228—C227 120.74 (17)
C131—N125—C132 117.66 (14) C228—C229—C233 120.14 (18)
C127—C126—C132 119.49 (18) C233—N230—C234 117.16 (14)
C126—C127—C128 121.40 (18) N225—C231—C224 119.63 (15)
C129—C128—C127 120.52 (18) N225—C231—C234 120.90 (14)
C128—C129—C133 120.30 (19) C224—C231—C234 119.46 (15)
C133—N130—C134 117.01 (14) N225—C232—C226 119.81 (15)
N125—C131—C124 119.89 (14) N225—C232—C233 120.70 (14)
N125—C131—C134 120.72 (14) C226—C232—C233 119.49 (15)
C124—C131—C134 119.39 (15) N230—C233—C229 119.31 (15)
N125—C132—C126 119.83 (15) N230—C233—C232 121.80 (14)
N125—C132—C133 120.68 (14) C229—C233—C232 118.89 (15)
C126—C132—C133 119.48 (16) N230—C234—C221 119.02 (15)
N130—C133—C129 119.29 (16) N230—C234—C231 121.76 (15)
N130—C133—C132 121.92 (14) C221—C234—C231 119.23 (15)
C129—C133—C132 118.78 (16) C242—C241—C254 120.2 (2)
N130—C134—C121 119.10 (14) C241—C242—C243 120.67 (19)
N130—C134—C131 122.00 (14) C244—C243—C242 121.13 (19)
C121—C134—C131 118.90 (14) C243—C244—C251 119.8 (2)
C142—C141—C154 120.39 (16) C251—N245—C252 116.52 (15)
C141—C142—C143 120.58 (17) C247—C246—C252 120.0 (3)
C144—C143—C142 120.67 (16) C246—C247—C248 121.1 (2)
C143—C144—C151 120.70 (17) C249—C248—C247 120.7 (2)
C151—N145—C152 117.13 (14) C248—C249—C253 120.2 (3)
C147—C146—C152 119.80 (19) C254—N250—C253 116.41 (15)
C146—C147—C148 120.79 (18) N245—C251—C244 119.28 (16)
C149—C148—C147 121.58 (18) N245—C251—C254 121.29 (15)
C148—C149—C153 119.25 (19) C244—C251—C254 119.42 (16)
C154—N150—C153 117.41 (14) N245—C252—C246 120.11 (19)
N145—C151—C144 119.52 (15) N245—C252—C253 121.44 (16)
N145—C151—C154 121.62 (14) C246—C252—C253 118.44 (18)
C144—C151—C154 118.83 (15) N250—C253—C249 118.6 (2)
N145—C152—C146 119.17 (16) N250—C253—C252 121.91 (15)
N145—C152—C153 121.83 (15) C249—C253—C252 119.53 (19)
C146—C152—C153 118.98 (16) N250—C254—C251 122.42 (16)
N150—C153—C149 119.63 (16) N250—C254—C241 118.76 (17)
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N150—C153—C152 120.84 (14) C251—C254—C241 118.82 (16)
Selected hydrogen-bond parameters
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°)
N1—H1B···O11 0.94 (2) 1.98 (2) 2.894 (2) 165 (2)
N1—H1A···N165 0.85 (2) 2.18 (2) 3.034 (2) 176 (2)
N11—H11A···O1 0.89 (2) 2.04 (2) 2.919 (2) 170 (2)
N11—H11B···N245 0.90 (2) 2.16 (2) 3.055 (2) 173 (2)
N21—H21A···O31 0.90 (2) 2.00 (2) 2.8827 (19) 167.4 (19)
N21—H21B···N110 0.93 (2) 2.15 (2) 3.057 (2) 166 (2)
N31—H31A···N185 0.86 (3) 2.17 (3) 3.025 (2) 173 (2)
N31—H31B···O21 0.92 (2) 2.00 (2) 2.902 (2) 165 (2)
O2—H2A···N225 0.96 (3) 1.76 (3) 2.6873 (18) 161 (2)
O12—H12A···N150 0.99 (3) 1.75 (3) 2.7112 (19) 161 (3)
O22—H22A···N205 1.02 (3) 1.71 (3) 2.7061 (19) 163 (3)
O32—H32A···N125 0.97 (3) 1.76 (3) 2.7036 (18) 163 (3)
Table 5-12: 4-Aminobenzoic acid•antipyrine crystallographic parameters
Atomic coordinates and equivalent isotropic displacement parameters (Å2)
x Y z Ueq
C1 0.9899(3) 0.0851(3) 0.7004(2) 0.0420(8)
C2 0.8836(3) 0.1220(2) 0.7668(2) 0.0327(7)
C3 0.8221(3) 0.2205(3) 0.7531(2) 0.0369(7)
C4 0.7201(3) 0.2580(3) 0.8125(2) 0.0381(8)
C5 0.6763(3) 0.1982(2) 0.8904(2) 0.0319(7)
C6 0.7370(3) 0.0998(3) 0.9048(2) 0.0369(7)
C7 0.8382(3) 0.0627(2) 0.8439(2) 0.0350(7)
C8 0.5914(3) 0.5925(3) 0.8058(2) 0.0331(7)
C9 0.6760(3) 0.6414(2) 0.7306(2) 0.0294(6)
C10 0.6759(3) 0.6046(3) 0.6368(2) 0.0354(7)
C11 0.7562(3) 0.6520(3) 0.5674(2) 0.0373(7)
C12 0.8401(3) 0.7377(2) 0.59050(19) 0.0283(6)
C13 0.8402(3) 0.7755(3) 0.6836(2) 0.0365(7)
C14 0.7593(3) 0.7281(3) 0.7519(2) 0.0374(7)
C15 0.0957(3) 0.4902(3) 0.9343(3) 0.0501(9)
C16 0.0548(4) 0.2985(3) 1.0583(2) 0.0491(9)
C17 0.0529(3) 0.3410(2) 0.9921(2) 0.0342(7)
C18 0.1922(3) 0.3184(2) 0.9871(2) 0.0312(7)
C19 0.2524(3) 0.3877(2) 0.91992(19) 0.0292(6)
C20 0.1449(3) 0.5089(2) 0.7997(2) 0.0333(7)
C21 0.2182(3) 0.6017(3) 0.7953(2) 0.0408(8)
C22 0.2205(4) 0.6557(3) 0.7092(3) 0.0567(11)
C23 0.1503(4) 0.6190(3) 0.6302(3) 0.0581(11)
C24 0.0755(5) 0.5279(4) 0.6349(3) 0.0616(11)
C25 0.0726(4) 0.4716(3) 0.7200(2) 0.0493(9)
C26 0.6497(3) 0.9936(3) 0.5615(3) 0.0465(9)
C27 0.5991(4) 0.8448(4) 0.3949(2) 0.0528(10)
C28 0.4944(3) 0.8691(3) 0.4701(2) 0.0354(7)
C29 0.3551(3) 0.8483(3) 0.4706(2) 0.0372(7)
C30 0.2963(3) 0.8971(2) 0.5518(2) 0.0313(6)
C31 0.4100(3) 0.9708(2) 0.6972(2) 0.0306(6)
C32 0.3511(4) 1.0607(3) 0.7314(3) 0.0477(9)
C33 0.3470(4) 1.0765(4) 0.8297(3) 0.0728(15)
C34 0.4039(5) 1.0036(6) 0.8913(3) 0.0814(18)
C35 0.4636(5) 0.9147(4) 0.8558(3) 0.0733(14)
C36 0.4664(4) 0.8973(3) 0.7593(2) 0.0486(9)
N1 0.5808(3) 0.2366(3) 0.9534(2) 0.0439(7)
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N2 0.9181(3) 0.7864(2) 0.5206(2) 0.0349(6)
N3 0.1452(2) 0.4511(2) 0.88752(17) 0.0323(6)
N4 0.0200(3) 0.4158(2) 0.92698(18) 0.0366(6)
N5 0.4059(2) 0.9498(2) 0.59673(17) 0.0312(6)
N6 0.5295(3) 0.9235(2) 0.54974(17) 0.0344(6)
O1 1.0357(2) 0.01053(18) 0.71894(16) 0.0421(5)
O2 1.0333(3) 0.1362(3) 0.6337(2) 0.0758(10)
O3 0.5788(3) 0.6274(2) 0.88588(15) 0.0522(7)
O4 0.5297(2) 0.50488(16) 0.77687(15) 0.0381(5)
O5 0.3753(2) 0.39525(19) 0.89115(15) 0.0398(5)
O6 0.1752(2) 0.8986(2) 0.58369(15) 0.0436(6)
Selected bondlengths [Å]
C1—O2 1.213 (4) C19—O5 1.252 (3)
C1—O1 1.321 (4) C19—O5 1.252 (3)
C1—C2 1.464 (4) C19—N3 1.378 (4)
C2—C7 1.389 (4) C20—C21 1.379 (5)
C2—C3 1.400 (4) C20—C25 1.385 (5)
C3—C4 1.375 (5) C20—N3 1.429 (4)
C4—C5 1.397 (4) C21—C22 1.385 (5)
C5—N1 1.367 (4) C22—C23 1.365 (6)
C5—C6 1.396 (4) C23—C24 1.368 (7)
C6—C7 1.380 (4) C24—C25 1.388 (5)
C8—O3 1.209 (4) C26—N6 1.465 (4)
C8—O4 1.325 (4) C27—C28 1.492 (4)
C8—C9 1.473 (4) C28—N6 1.348 (4)
C9—C10 1.389 (4) C28—C29 1.360 (5)
C9—C14 1.394 (4) C29—C30 1.415 (4)
C10—C11 1.382 (4) C30—O6 1.248 (4)
C11—C12 1.392 (4) C30—N5 1.389 (4)
C12—N2 1.383 (4) C31—C32 1.368 (5)
C12—C13 1.385 (4) C31—C36 1.382 (5)
C13—C14 1.375 (4) C31—N5 1.426 (4)
C15—N4 1.464 (4) C32—C33 1.386 (6)
C16—C17 1.494 (4) C33—C34 1.373 (8)
C17—N4 1.352 (4) C34—C35 1.366 (8)
C17—C18 1.367 (4) C35—C36 1.364 (5)
C18—C19 1.417 (4) N3—N4 1.400 (3)
C19—O5 1.252 (3) N5—N6 1.402 (3)
Selected bond angles [°]
O2—C1—O1 122.0 (3) N3—C19—C18 106.0 (2)
O2—C1—C2 124.0 (3) C21—C20—C25 120.6 (3)
O1—C1—C2 113.9 (3) C21—C20—N3 119.1 (3)
C7—C2—C3 117.4 (3) C25—C20—N3 120.3 (3)
C7—C2—C1 122.8 (3) C20—C21—C22 118.7 (3)
C3—C2—C1 119.8 (3) C23—C22—C21 121.0 (4)
C4—C3—C2 122.0 (3) C22—C23—C24 120.4 (4)
C3—C4—C5 120.1 (3) C23—C24—C25 119.8 (4)
N1—C5—C6 120.8 (3) C20—C25—C24 119.5 (4)
N1—C5—C4 120.9 (3) N6—C28—C29 109.3 (3)
C6—C5—C4 118.3 (3) N6—C28—C27 121.5 (3)
C7—C6—C5 121.0 (3) C29—C28—C27 129.1 (3)
C6—C7—C2 121.2 (3) C28—C29—C30 108.6 (3)
O3—C8—O4 122.8 (3) O6—C30—N5 122.1 (3)
O3—C8—C9 124.3 (3) O6—C30—C29 132.4 (3)
O4—C8—C9 112.8 (2) N5—C30—C29 105.5 (3)
C10—C9—C14 117.5 (3) C32—C31—C36 120.7 (3)
C10—C9—C8 122.3 (3) C32—C31—N5 119.6 (3)
C14—C9—C8 120.2 (3) C36—C31—N5 119.5 (3)
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C11—C10—C9 121.1 (3) C31—C32—C33 118.9 (4)
C10—C11—C12 120.5 (3) C34—C33—C32 120.2 (4)
N2—C12—C13 120.7 (3) C35—C34—C33 120.1 (4)
N2—C12—C11 120.4 (3) C36—C35—C34 120.4 (5)
C13—C12—C11 118.9 (3) C35—C36—C31 119.7 (4)
C14—C13—C12 120.2 (3) C19—N3—N4 108.7 (2)
C13—C14—C9 121.8 (3) C19—N3—C20 125.2 (2)
N4—C17—C18 109.4 (3) N4—N3—C20 120.7 (2)
N4—C17—C16 121.0 (3) C17—N4—N3 107.3 (2)
C18—C17—C16 129.5 (3) C17—N4—C15 125.5 (3)
C17—C18—C19 108.0 (3) N3—N4—C15 118.2 (3)
O5—C19—N3 123.3 (3) C30—N5—N6 108.1 (2)
O5—C19—N3 123.3 (3) C30—N5—C31 123.0 (2)
O5—C19—N3 123.3 (3) N6—N5—C31 119.4 (2)
O5—C19—C18 130.7 (3) C28—N6—N5 107.8 (2)
O5—C19—C18 130.7 (3) C28—N6—C26 126.4 (3)
O5—C19—C18 130.7 (3) N5—N6—C26 118.0 (3)
Selected hydrogen-bond parameters
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°)
N1—H4···O5 0.81 (4) 2.14 (4) 2.946 (4) 170 (3)
N1—H5···O3 0.92 (4) 2.18 (4) 3.065 (4) 163 (3)
N2—H11···O2 0.85 (3) 2.08 (3) 2.923 (4) 171 (3)
N2—H12···O6 0.89 (3) 2.09 (4) 2.971 (4) 173 (3)
O1—H1···O6 0.84 1.77 2.598 (3) 167.7
O4—H8···O5 0.84 1.79 2.597 (3) 161.2
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Chapter 6. Crystal Structure Prediction of Succinic Acid
Cocrystals
6.1 Introduction
It has been hypothesized that a combination of coformers which satisfy the
crystal engineering conventions are predisposed to cocrystallization. In practice,
however, very few experimental efforts targeting such multicomponent systems
are successful even when comprehensive screens with varied experimental
techniques are carried out, as observed in chapter 5. Also, in some cases, the
resulting cocrystals have been found to exhibit intermolecular interactions that are
not those expected from crystal engineering. These observations clearly
demonstrate the limitation of current approaches seeking cocrystals and
accentuate the need for more sophisticated screening methods with enhanced
efficiency and reliability.
This chapter, therefore, investigates whether computational modelling can
be complementary to experimental screening of cocrystals. Two binary systems:
succinic acid•2,2´bipyridine and succinic acid•1,4-dicyanobenzene, are used in
this study, of which, only succinic acid•2,2´bipyridine produced cocrystals
following the extensive screens in chapter 5. Lattice energy landscapes are
generated for both systems and their constituents to investigate whether the
computational models can (i) predict the crystal structure of the known forms (ii)
rationalize the experimental observations by comparing the relative stabilities of
the binary systems and their components, and (iii) to explore whether the
application of computational modeling can enhance the efficiency of cocrystal
screening.
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Generating these lattice energy landscapes for flexible molecules is
computationally challenging and expensive due to the potentially high volumes of
data produced. Hence, the coformers 2,2´-bipyridine and 1,4-dicyanobenzene
were deliberately chosen given their relatively rigid structures. However, succinic
acid is flexible, and a complete search involving all its conformations is
impractical. Thus, this study begins with part I where a conformational analysis of
succinic acid is performed to identify its most likely conformations. In part II,
lattice energy landscapes are generated for the binary systems and their
components, which includes the plausible conformations of succinic acid deduced
in part I.
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6.2 Part I. Conformational Analysis of Succinic Acid
Succinic acid has flexibility about five torsion angles (figure 6.1), where
1 and 5 as well as 2 and 4 are symmetry related in the gas phase and many
crystals. Taking all five torsion angles into account within the full angular range
0-360° in a multistage crystal structure prediction[1] is impractical. Hence to
reduce this range, we need to compare the conformations of succinic acid seen in
crystal structures with its low energy conformations and establish the most
plausible ones for use in the searches.
C1 C2
C3 C4
O4
O2
O3 H2
O1H1





Figure 6.1: The five torsion angles of succinic acid displayed at the planar conformation. The
displayed torsion angles correspond to 1=H1O1C1C2=180°, 2=O1C1C2C3=180°,
3=C1C2C3C4=180°, 4=O3C4C3C2=-180° and 5 =H2O3C4C3=-180°. For clarity the hydrogen
atoms on the carbon chain are not shown.
6.3 Methods
6.3.1 Analysis of experimental structures containing succinic acid
The CSD[2] (Version 1.11, Nov 08) was used to search for structures that
contained at least one neutral succinic acid molecule in its asymmetric unit, whose
coordinates are fully determined with no disorder and an R-factor ≤ 10 %. If
multiple entries of the same structure in the CSD existed, the one with the lowest
R-factor determined at the lowest temperature, with a preference for any neutron
determinations was used.
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In total 56 experimental structures containing succinic acid were found
that met these criteria, which includes the two polymorphic forms of succinic acid
( and . In cases where there was more than one succinic acid in the
asymmetric unit, both conformations were considered separately. In total 62
inequivalent neutral succinic acid structures were found. These structures were
further analyzed using the program Vista[5] to tabulate the values of the five
torsion angles as defined in figure 6.1.
6.3.2 Computational methodology
Molecular conformations of succinic acid were ab initio optimized to
obtain the energy minimized gas phase molecular conformation. This was
performed using the ab initio package Gaussian03[6], with the MP2 level of
theory and the 6-31G (d,p) basis set.
The optimization is comprised of two steps: the first involves scanning certain
torsion angles within a defined scanning range (table 6.1), results of which are
plotted on contour energy maps displaying regions of global and local minima.
The second step involves the free optimization of specific conformations related
to regions on the contour energy map that are heavily populated with experimental
structures and/or located within regions of low energy to obtain a more accurate
conformational description.
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Table 6-1: Defined parameters for the torsion angle scans.
Torsion angle(s) Scanning range Scanningstep
Scanning
increments Constraints
3 180° to -180° 18 20
All other torsion angles
were fixed as in figure 1
2, 4
(planar carbon
chain)
180° to -180° 18 20
3 was fixed at 180° and
the carboxylic acid groups
were set to a planar
geometry
2, 4
(non-planar
carbon chain)
180° to -180° 18 20
3 was fixed at -66.1° and
the carboxylic acid groups
were set to a planar
geometry
The hydroxyl group of succinic acid is nearly always found in the
synplanar conformation in the crystal structures (as in figure 6.1), therefore
optimization of the torsion angles 1 and 5 was unnecessary. And although the
conformation containing an intramolecular hydrogen bond is never found
experimentally (figure 6.2), it was considered in the free optimization stage (step
2), as it is conceivable that such interactions may lead to a low energy structure.
Figure 6.2: The hypothetical conformation of succinic acid with an intramolecular hydrogen
bond. The intramolecular hydrogen bond (dashed line) was manually created using the
program Molden[7] (1=2=60°, 3=90°, 4=5=-180°).
6.4 Results and discussion
6.4.1 Scan of the hydrocarbon torsion angle (3)
A relaxed scan for the hydrocarbon torsion angle was dominated by the
potential formation of an intramolecular hydrogen bonded structure, therefore the
carboxylic acid torsion angles were constrained at the values described in table
6.1. As shown in Figure 6.3a, there are two constrained minima; a global
minimum where succinic acid is non-planar and 3 is approximately ±70º, and a
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local one where succinic acid has a planar conformation and 3 is found at
approximately ±180º, this is higher in energy than the global minimum structure
by 3.76 kJ/mol.
Despite the observed stability of the non-planar conformation, it is the planar
conformation that succinic acid adopts more frequently in its experimental
structures (figure 6.3b). In fact, 52 out of the 62 experimental structures
containing succinic acid have this geometry, with the majority forming
)8(22R dimers. Although there are some succinic acid structures having the non-
planar conformation, in most cases this is a result of the partner molecule having a
more complex structure with multiple hydrogen bond donor/acceptor groups
located in regions that sterically restrict the formation of simple dimers, thereby
succinic acid is forced to distort as it forms hydrogen bonds with those functional
groups producing catemers. There is an energy penalty for such a distortion which
is more than compensated for by the intermolecular interactions[8], as observed in
the succinic acid cocrystal studies in chapter 4 section 4.3.2.
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Figure 6.3: A plot of succinic acid MP2 energy versus 3 and a plot of succinic acid
experimental structures verses 3. (a) MP2 energy versus 3 plot displaying a global minima
at approximately ±70º and a local minima at approximately ±180º that is higher in energy by
3.76 kJ/mol. (b) Number of experimental structures containing succinic acid structures
plotted against their 3 torsion angle values as defined in the CSD. The ranges between ±170º
- ±190º are heavily populated followed by ±50º - ±80º.
193
6.4.2 Scan of the carboxylic acid torsion angles ()
To account for the planar and non-planar conformations of succinic acid
about the hydrocarbon chain, two separate scans were performed: the first had the
hydrocarbon torsion angle (3) constrained at 180° (planar conformation);
whereas the latter was constrained at -66.1° (non-planar conformation)****. For
both scans the carboxylic acid group was constrained to a planar geometry (table
6.1).
The results of the planar conformation scan as a function of the carboxylic
acid torsion angles (2 and 4) shows a global minimum at approximately
2= -180° and 4= 180° (and their symmetrically related positions) (Conf A), as
displayed on the energy contour map figure 6-4a. This is also the most heavily
populated region with experimental structures containing succinic acid.
Surprisingly there are two structures: WOJHEI[9] and JAZBES[10], found at the
maximum where 2 and 4 are approximately zero (Conf B). In both structures,
the partner molecule only has hydrogen bond acceptor groups and lower
flexibility than succinic acid, consequently succinic acid is forced into such a
severe structural distortion as it forms hydrogen bonds.
The non-planar conformation results show two minima of close energy
wells (figure 6.4b), the global minimum has the conformation where the torsion
angle values for 2 and 4 are approximately -180° and 180° respectively
(including their symmetrically equivalent positions) (Conf C), this conformation
is found at slightly lower energy region as the O···O distance is longer than that
associated with the local minimum conformation (Conf E), 3.2Å and 3.1Å
**** The angular values used to define the non-planar and planar conformations correspond to the
global minimum and local minimum values respectively as determined from the 3 scan in figure
6.3a.
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respectively, thereby the repulsive forces of interaction are weaker. However, it is
the latter conformation that is more populated with experimental structures.
The experimental structure PEKQOM[11] has two symmetrically
inequivalent succinic acid molecules, one is found within the local minimum
whereas the other is located at a much higher energy region where 2 and 4 are
approximately zero (Conf D). In the latter conformation, succinic acid forms
hydrogen bonds with 4 partner molecules, thus compensating for the high
intramolecular energy penalty caused by such a severe distortion. Whereas in the
former conformation, succinic acid forms hydrogen bonds with only three partner
molecules and one of its carbonyl groups is free.
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(a) planar carbon chain
(b) non-planar carbon chain
Figure 6.4: MP2/6-31G(d,p) relaxed intramolecular energy (kJ mol-1) scans for succinic acid
as a function of rotation about the two carboxylic acid groups. (a) The contour energy plot
associated with the planar conformation was constructed by constraining the carbon chain
torsion (θ3=C1-C2-C3-C4) to 180° (planar). (b) The contour energy plot associated with the
non-planar conformation was constructed by constraining the carbon chain torsion (θ3=C1-
C2-C3-C4) to -66.1° (non-planar). For both scans the carboxylic acid groups were constrained
to planar geometry. The shaded areas were generated by molecular symmetry. The full
diamonds correspond to the CSD conformations as generated by the program Vista and the
open diamonds to their symmetry equivalent conformations.
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6.4.3 Comparison of fully optimized conformations
Conformations related to structures found at low energy regions and/or
those that are considerably populated were fully optimized, including a
hypothetical structure that contains an intramolecular hydrogen bond, results are
summarize in table 6.2. The majority of experimental structures containing
succinic acid are in the local minimum corresponding to Conf A. Despite this
minimum being heavily populated, it is not the global minimum with respect to
the MP2 energy as the non-planar Conf C is, which is found to be more stable by
6.37 kJ/mol. The other non-planar Conf E is found to be the second most stable
structure, higher in energy by 5.60 kJ/mol, as well as the second most populated
conformation. The hypothetical structure containing an intramolecular hydrogen
bond was found to be extremely high in energy; 15.77 kJ/mol above the global
minimum, this is despite the gain in energy contributed by the intramolecular
interaction.
Comparison with a similar conformation analysis[12] of succinic acid that
used the molecular mechanics force field MM+ approach[13] shows a different
ranking of conformation with respect to energy; most importantly Conf A was
found to be the global minimum structure, with Conf C and Conf E higher in
energy by 0.37 kJ/mol and 0.54 kJ/mol respectively. This demonstrates that the
difference and relative stability of isolated molecules is sensitive to the method
used. Obtaining definitive relative energies for organic compounds can require
very elaborate wavefunction and basis sets[14] and so definitive results are
beyond the scope of this work.
The minima were optimized at the MP2 level, but the relative MP2
energies differ significantly from the corresponding relative HF energies. Whilst
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the MP2 energies include some of the intramolecular dispersion energy, they are
also more susceptible to the intramolecular equivalent of basis set superposition
error[15]. The energies are certainly close, but it is likely that the global minimum
structure in the gas phase is non-planar.
Table 6-2: Freely optimized conformations of succinic acid and their occurrence in
experimental crystal structures. The difference in energies was calculated with respect to the
most stable conformation (Conf C).
Conformation MP2(kJ/mol)
HF
(kJ/mol) 3 2 4 1 5
Crystal
structures
Conf C - - -66.01 170.30 170.21 179.54 179.55 2
Conf E 5.60 8.10 -59.28 -178.64 -31.23 179.47 179.66 8
Conf A 6.37 1.86 177.29 177.13 177.06 179.56 179.56 50
Intramolecular
H-bond 15.77 20.06 -79.59 -168.66 69.02 -178.93 -1.47 0
Conf B 17.82 21.10 178.94 1.94 56.37 179.97 -179.92 2
6.5 Conclusion
Nearly all the experimental structures were found in energy wells on the
contour plots. However, highly populated regions did not coincide with the lowest
energy minimum. With respect to the torsion angle scan of 3, nearly all the
experimental structures populated the local minima associated with the planar
conformation, this is despite being higher in energy than the global minimum
associated with the non-planar conformation. This is not surprising as the
molecule is modelled in isolation (i.e. in the gas phase) where there is no
influence of nearby molecules to promote planarity by hydrogen bonding or by
other means of intermolecular interaction. Instead, the succinic acid molecule
adopts a conformation which is stabilized by electrostatic interactions between the
carbonyl groups at each end of the structure. However, in the solid state, succinic
acid is able to form hydrogen bond interactions with nearby molecules, which are
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more stabilizing, and consequently the planar conformation is preferred.
Furthermore, there are positions that are lower in energy than some
experimentally populated regions which are almost never populated, for example
in figure 6.4a a local minima is found at the approximate torsion angle values of
2=-60 and 4=180 (as well as their symmetrically related positions), but not a
single experimental structure contains succinic acid in this conformation. Yet at a
higher energy region where the torsion angles are approximately 2=4=0, two
experimental structures are found. Hence this study demonstrates strong
correlations between experimental structures and energy wells but not necessarily
in terms of energy positions. Only certain conformations can pack efficiently in a
crystal, and the preference for torsion angles at these conformations is not
necessary linked to their relative energy position on a contour plot.
Nearly all the cocrystals which contain succinic acid in a non-planar
conformation have relatively complex partner molecules with multiple hydrogen
bond donor/acceptor groups, these are located in regions which sterically restrict
the formation of simple dimers. However, the partner molecules chosen in this
study (2,2´-bipyridine and 1,4-dicyanobenzene see figure 6.5) are simple and
contain only hydrogen bond acceptor groups, which from a crystal engineering
perspective are likely to promote interactions with planar succinic acid molecules.
Despite the diversity of systems in the CSD, not one succinic acid
structure had a conformation that allowed for an internal hydrogen bond, and
computationally this was shown to be energetically unfavourable. Furthermore, as
this conformation engages both a hydrogen bond donor and acceptor groups it
would hinder any possible compensation contributed by a nearby molecule.
Therefore this conformation is to be excluded from the extensive calculations.
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This analysis makes it clear that a multistage CSP need only concentrate
on the planar conformation (Conf A) of succinic acid. Had more complex partner
molecules been chosen, then an extended search that includes the non-planar
conformations (Conf C and Conf E) would have been required to account for the
potential distortion of succinic acid.
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6.6 Part II. Crystal Structure Prediction
6.6.1 Method
In this section, lattice energy landscapes are generated for the binary
systems and their components (figure 6.5) using the multistage computational
methodology[1] described in chapter 3 sections 3.3.1-3.3.4. Only a limited
number of the most stable computed structures are carried forward to the next
subsequent stage where the accuracy of the calculation is improved. This is to
increase the efficiency of the search and to cut down on computational costs.
O
O
O
O
H
H
N
N
N
N
Succinic acid 2,2´-Bipyridine 1,4-Dicyanobenzene
Figure 6.5: Compounds considered in this study with the flexible torsion angles indicated.
The quality of the reproduction of known experimental structures was
evaluated by the optimal root mean square overlay of all non-hydrogen atoms in a
15 molecule coordination cluster[16] (RMSD15) calculated by the program
Mercury[17].
6.7 Results and discussion
Succinic acid has a number of low energy conformations as discussed in
part I, however, the near planar conformation; Conf A, is adopted in both known
polymorphs and most cocrystals. Therefore, a Z´=1 lattice energy landscape was
generated for succinic acid in this conformation and used for comparability with
searches of the binary systems. A Z´=2 search was also performed to investigate
the prediction of the  polymorph. Furthermore, to assess why the low energy
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conformations (Conf C and E) are so rarely observed, a limited MOLPAK[18]††††
search was carried out with succinic acid in these geometries. For the binary
systems, succinic acid was only modelled as planar, as justified by part I
conformational analysis results (section 6.5).
6.7.1 Planar succinic acid crystal structure prediction.
Stage II of the rigid body search generated 890 structures with Z´=1 and
7496 structures with Z´=2, these were reduced to 781 and 6641 respectively in
stage III following refinement with a more realistic electrostatic model and
clustering to remove equivalent structures. A selection of low energy structures
from the rigid body search were further refined in stage IV by simultaneous
relaxation of the flexible degrees of freedom and corresponding cell. The resulting
lattice energy landscapes are shown in figure 6.6.
The  form was identified in the lattice energy landscape containing Z´=2
structures and the  form in the Z´=1, as confirmed by the structure overlay of the
experimental and corresponding calculated structures and the low RMSD15 values,
these are presented in table 6.3 along with the cell parameters and calculated
lattice energy.
At room temperature, the  form has been reported to be the most stable
polymorph[19]. Our calculations also established this order stability: the  form
was lower in energy than the  form by 6.59 kJ/mol. In fact, it was
thermodynamically the most stable structure (global minimum) found in any of
the succinic acid searches.
†††† MOLPAK uses a simple search for densely packed crystal structures and is limited to Z´=1
structures.
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Figure 6.6: Lattice energy landscapes generated for the planar conformation of succinic acid.
(a) Results from Z´=1 search structures. (b) Results from Z´=2 search structures. The red
symbols indicate energy minima obtained after the rigid body search in stage III and the
blue symbols indicate energy minima obtained from the relaxed body search stage IV. The
dashed lines connect the low energy stage IV structures to their starting positions in stage
III. The open circles denote the known experimental structures.
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Table 6-3: Comparison of the known forms of succinic acid with the corresponding
structures found in the search.
Overlay of experimental
(red) and calculated
(grey) structures
RMSD15 (Å)= 0.196
-succinic acid (P21/c, Z´=1)
Experimental Calculated
a (Å) 5.526 5.147
b (Å) 8.881 8.707
c (Å) 5.105 5.392
 (°) 91.49 86.51
(g cm-3) 1.566 1.626
Lattice energy
(kJ mol-1) N/A -111.781
Overlay of experimental
(red) and calculated
(grey) structures
RMSD15 (Å)=0.302
-succinic acid (P-1, Z´=2)
Experimental Calculated
a (Å) 6.867 7.282
b (Å) 7.198 8.328
c (Å) 5.727 5.983
 (°) 109.10 106.97
 (°) 97.18 109.67
 (°) 101.84 118.21
(g cm-3) 1.531 1.551
Lattice energy
(kJ mol-1) N/A -105.193
In the Z´=1 lattice energy landscape (figure 6.6a), the global minimum
structure produced following the relaxed body search corresponds to the
experimental  form, this was 0.13 kJ/mol more stable than the second lowest
energy structure and the densest structure in the lattice energy landscape.
However in the preceding rigid body search, this order of stability was reversed,
the structure corresponding to the experimental  form was identified as the
second most stable structure but by a very small energy difference: 0.0019 kJ/mol
above the global minimum. This was the only observed structure re-ranking and is
a direct consequence of improved hydrogen bonding due to minor changes in the
flexible torsion angles which did not affect the packing motif of the molecules.
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All the low energy structures, including the  form, have chains of molecules
linked by the )8(22R carboxylic acid dimers, this motif is observed throughout the
147 lowest energy structures in the rigid body search (15.08 kJ/mol above the
global minimum), at higher energies some crystal structures are found to have
the )22(44R ring that packs forming a herringbone motif (figure 6.7).
Figure 6.7: The )8(22R carboxylic acid dimers packing motif observed throughout the 147
lowest energy structures (left) and the )22(44R packing motif observed for higher energy
structures (right).
In the Z´=2 lattice energy landscape (figure 6.6b), the experimental  form
was located as the 6th most stable structure, 6.17 kJ/mol above the global
minimum in the Z´=2 search, and 6.59 kJ/mol above the overall global minimum
in the Z´=1 search. There was some structure re-ranking as the order of stability
for the 2nd and 4th most stable structures in the rigid body search switched places
in the flexible body search. This was a result of improved hydrogen bonding
which did not change the packing motif of the molecules.
All the low energy structures, including the  form, have chains of
molecules linked by the )8(22R carboxylic acid dimers, similar to those observed
for the  form. This style of packing is observed up to the 24th most stable
structure (9.78 kJ/mol above the global minimum), beyond which a brick type
motif is observed (figure 6.8).
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Figure 6.8: The )8(22R packing motif observed throughout the 24 lowest energy structures
(left) and the brick type motif observed for higher energy structures (right).
Although both the  and  polymorphs contain the )8(22R carboxylic acid
dimers that form chains with a zigzag shape, the way these pack differs. In the 
form, the succinic acid molecules in the adjacent chains are stacked almost
perpendicularly to each other, whereas in the  form, they are stacked in a parallel
manner producing a more densely packed structure (figure 6.9).
Following refinements at stage III, 25 structures were found between the 
and the  forms in stability, all of which have a similar packing motif to the most
stable  form. Thus there is no apparent reason for these structures to occur.
Although the metastable  form has been produced in the past, all our attempts to
recrystallize it have resulted in the formation of the  polymorph.
Figure 6.9: The stacking of the zigzagging chains of succinic acid for the  form (left) and 
form (right). For clarity the hydrogen atoms have been omitted.
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6.7.2 Non-planar succinic acid crystal structure prediction.
The crystal energy landscape generated by the rigid body search for the
non-planar conformations of succinic acid is shown in figure 6.10. These
structures are considerably higher in energy than the planar conformation and
markedly less dense. The global minimum structure adopts the Conf C geometry
and is 7.01 kJ/mol higher in energy and 0.65 g cm-3 lower in density than the
global minimum structure with the planar conformation (figure 6.6a) following
rigid body calculation (stage III).
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Figure 6.10: Lattice energy landscape generated for the non-planar conformations of
succinic acid. In red are structures with Conf C and in grey are structures with Conf E.
All the low energy structures that are within 5 kJ/mol of the non-planar
global minimum fully utilize the hydrogen bond donor and acceptor groups
forming )8(22R dimers, the packing of which produces ribbon motifs that do not
pack densely (figure 6.11). Such inefficient packing makes this non-planar
geometry highly unlikely to be adopted by succinic acid unless it is in a complex
cocrystal as discussed in part I.
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Figure 6.11: The ribbon motifs of the global minimum structures with a non-planar
conformation of succinic acid. (a) Global minimum structure with Conf C geometry. (b)
Global minimum structure with Conf E geometry.
6.7.3 1,4-Dicyanobenzene crystal structure prediction.
Due to the rigidity of this compound, a rigid body search alone was
sufficient. Stage II of the search produced 1399 structures these were reduced to
790 in stage III. The resulting lattice energy landscapes are shown in figure 6.12.
Both known forms of 1,4-dicyanobenzene were identified in the search, with the
triclinic form[20] corresponding to the global minimum structure, and the
monoclinic form[21] corresponding to the 26th most stable structure: 1.79 kJ/mol
above the global minimum. This was confirmed by the structure overlay and low
RMSD15 values in table 6.4 which also contains the cell parameters and energy
values of both calculated forms along with their corresponding experimental
structure cell parameters.
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Figure 6.12: Lattice energy landscape for 1,4-dicyanobenzene. The red symbols indicate
energy minima obtained after the rigid body search in stage III and the open circles denote
the known experimental structures.
All the low energy 1,4-dicyanobenzene structures consist of of a network
of CH···N, π···π and aromatic-H···π interactions. For the triclinic polymorphy,
these interactions form a ribbon type motif, whereas the monoclinic polymorph
(and four other structures that are directly more stable) forms a ladder type motif
(figure 6.13).
Figure 6.13: Packing motifs of 1,4-dicyanobenzene polymorphs (left) ribbon type motif
observed for the triclinic structure and (right) ladder type motif observed for the monoclinic
structure.
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The lattice energy landscape is a congested one, with 31 structures within
2 kJ/mol of the global minimum, making it highly conceivable for potentially new
polymorphs or disordered structures to be discovered, particularly as there are
some structures well within the polymorphic energy range that can pack more
efficiently as evident by their higher density values.
Table 6-4: Comparison of the known forms of 1,4-dicyanobenzene with the corresponding
structures found in the search.
Overlay of experimental
(red) and calculated
(grey) monoclinic form
RMSD15 (Å) = 0.304
Monoclinic (P21)
Experimental Calculated
a (Å) 12.127 12.163
b (Å) 7.080 7.356
c (Å) 3.868 3.755
 (°) 97.210 79.735
(g cm-3) 1.291 1.287
Lattice energy per mol
(kJ mol-1) N/A -87.078
Overlay of experimental
(red) and calculated
(grey) triclinic form
RMSD15 (Å) = 0.344
Triclinic (P-1)
Experimental Calculated
a (Å) 13.944 13.616
b (Å) 3.847 3.654
c (Å) 7.322 8.146
 (°) 114.5 69.160
 (°) 93.6 88.515
 (°) 96.9 62.743
(g cm-3) 1.279 1.281
Lattice energy per mol
(kJ mol-1) N/A -88.866
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6.7.4 2,2´-Bipyridine crystal structure prediction.
Stage II of the rigid body search generated 419 structures, which were
reduced to 342 in stage III. A selection of low energy structures was refined
further in stage IV by simultaneous relaxation of the flexible degrees of freedom
and corresponding cell. The resulting lattice energy landscape is shown in figure
6.14.
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Figure 6.14: Lattice energy landscape for 2,2´-bipyridine. The red symbols indicate energy
minima obtained after the rigid body search in stage III and the blue symbols indicate
energy minima obtained from the relaxed body search stage IV. The dashed lines connect the
low energy stage IV structures to their starting positions in stage III. The open circles denote
the known experimental structures.
The second most stable structure corresponds to the known experimental form of
2,2´-bipyridine[22], as confirmed by both the structure overlay and low RMSD15
value (table 6.5), and is 0.81 kJ/mol above the global minimum. There is some
structure re-ranking going from the rigid body search to the flexible one which is
a consequence of improved intermolecular interactions caused by conformational
changes which do not alter the overall packing motif. However, the order of
stability of the three most stable structures remains consistent in both stages.
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Table 6-5: Comparison of the known form of 2,2´bipyridine with the corresponding
structure found in the search.
Overlay of experimental
(red) and calculated
(grey) monoclinic form
RMSD15 (Å) = 0.162
Monoclinic (P21)
Experimental Calculated
a (Å) 5.486 5.656
b (Å) 6.165 6.264
c (Å) 11.609 11.531
 (°) 95.276 84.180
(g cm-3) 1.326 1.276
Lattice energy
(kJ mol-1) N/A -86.476
Given that 2,2´-bipyridine does not have any hydrogen-bond donor
groups, all the low energy structures contain both π···π and (aromatic)-H···π
interactions, and the pyridine rings are coplanar. The hypothetical structure at the
global minimum exhibits a tilted edge-to-face (T-shaped) arrangement of the
molecular planes (figure 6.15). The remaining three most stable structures,
including the experimental one, pack forming a herringbone type motif.
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Figure 6.15: The observed motifs for the global minimum and experimental structure of
2,2´bipyridine generated in the search. (a) The tilted edge-to-face (T-shape) motif found in
the global minimum structure. (b) The herringbone type motif found in the known
experimental structure and other low energy structures.
These observed motifs, including the structure energy ranking, correlates well
with a previous study[1] that used a different set of dispersion-repulsion potential
parameters[23]. The potentials used in this study resulted in an overall lowering of
the lattice energies typically by ~5kJ/mol.
A potentially new polymorph of 2,2´-bipyridine that is thermodynamically
more stable than the known monoclinic form and which corresponds to the global
minimum structure could be found in future experimental work. This
hypothetically denser polymorph is most likely to be produced under extreme
experimental conditions, such as high pressure crystallization, as crystals of
2,2´bipyridine produced under normal laboratory conditions have all
corresponded to the monoclinic form[22,24-26].
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6.7.5 1,4-Dicyanobenzene • Succinic acid crystal structure
prediction.
Stage II of the rigid body search produced 28276 structures, from which
the most stable 7500 structures were considered in stage III. These were reduced
to 6286 following the use of a more realistic model and clustering.
A selection of low energy structures from the rigid body search were further
refined in a stage IV by simultaneous relaxation of the flexible degrees of freedom
and corresponding cell. The resulting lattice energy landscape is shown in figure
6.16, with notable structure re-ranking, a result of improved hydrogen bonding
geometries.
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Figure 6.16: Lattice energy landscape for the hypothetical cocrystal of succinic acid•1,4-
dicyanobenzene. The red symbols indicate energy minima obtained after the rigid body
search in stage III and the blue symbols indicate energy minima obtained from the relaxed
body search stage IV. The dashed lines connect the low energy stage IV structures to their
starting positions in stage III. The red dashed lines indicate the lattice energy range for the
sum of the pure components.
Lattice energy comparisons of the hypothetical cocrystal at the global
minimum with the sum of its experimentally known pure components shows the
hypothetical cocrystal to be very high in energy: 9.44 kJ/mol higher in energy
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than the most stable coformer combination ( form of succinic acid and the
triclinic form of 1,4-dicyanobenzene) and 1.07 kJ/mol higher than the least stable
coformer combination ( form of succinic acid and the monoclinic form of 1,4-
dicyanobenzene). This prediction shows that on ground of thermodynamics there
is no reason for cocrystallization. This supports the unsuccessful experimental
attempts targeting these cocrystals in chapter 5.
In all the low energy structures, there is no hydrogen bonding between
succinic acid and 1,4-dicyanobenzene molecules. Instead, succinic acid molecules
form homogenous )8(22R dimers that extend in chains that pack in layers above the
1,4-dicyanobenzene molecules, which in turn, have ribbon type motifs that stack
in sheets above one another, similar to those in figure 6.17.
The three most stable structures have the succinic acid chains
perpendicular to the 1,4-dicyanobenzene sheets, whereas the following three most
stable structures have them parallel to one another.
It is notable that the most energetically favoured cocrystals have the
compounds segregated in layers. If hydrogen bonds were formed between
succinic acid and 1,4-dicyanobenzene, i.e. (succinic acid)-OH···N≡C-(1,4-
dicyanobenzene), then both the succinic acid carbonyl group and the benzene ring
of 1,4-dicyanobenzene will be sterically less accessible to other interactions.
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(a) (b)
Figure 6.17: Packing motifs of the six lowest energy structures generated in the search for
the binary system succinic acid:1,4-dicyanobenzene. Succinic acid forms )8(22R dimers that
extend in chains, these are separated by layers of ribbon type motifs of 1,4-dicyanobenzene
that stack in a perpendicular fashion; as observed in the three most stable structures (a), or
parallel (b); as in the case of the following three most stable structures.
6.7.6 2,2´-Bipyridine • Succinic acid crystal structure prediction.
Stage II of the rigid body search produced 21166 structures, from which
the most stable 7500 structures were considered in stage III. These were reduced
to 6554 following the use of a more realistic model and clustering.
A selection of low energy structures from the rigid body search were
further refined in stage IV by simultaneous relaxation of the flexible degrees of
freedom and corresponding cell. The resulting lattice energy landscape is shown
in figure 6.18.
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Figure 6.18: Lattice energy landscape for the hypothetical cocrystal of succinic
acid•2,2´bipyridine. The red symbols indicate energy minima obtained after the rigid body
search in stage III and the blue symbols indicate energy minima obtained from the relaxed
body search stage IV. The dashed lines connect the low energy stage IV structures to their
starting positions in stage III. The open circles denote the known experimental structures.
The red dashed lines indicate the lattice energy range for the sum of the pure components.
The global minimum structure was identified as the experimental cocrystal
as confirmed by the structure overlay and low RMSD15 value presented in table
6.6. The observed motif is that of chains that stack perpendicularly to one another
figure 6.19.
Comparisons of the lattice energy between the experimentally known
cocrystal and the sum of energies of the  form of succinic acid and 2,2´-
bipyridine shows the cocrystal to be more stable by 3.56 kJ/mol. However, when
the  form is considered, the cocrystal is found higher in energy by 3.03 kJ/mol,
i.e. the cocrystal is calculated to be unstable.
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Table 6-6: Comparison of the experimental and computed structure of 2,2´bipyridine •
succinic acid cocrystal.
Overlay of experimental
(red) and calculated
(grey) monoclinic form
RMSD15 (Å) = 0.255
Monoclinic (P21)
Experimental Calculated
a (Å) 8.958 8.422
b (Å) 5.178 5.132
c (Å) 14.357 14.774
 (°) 106.109 113.05
(g cm-3) 1.423 1.385
Lattice energy
(kJ mol-1) N/A -195.230
A hypothetical cocrystal, 3.19 kJ/mol above the known cocrystal, is also found to
be more stable than the sum of lattice energy of its components with respect to the
 form of succinic acid but not so when the form is considered. However, there
is no apparent reason to suggest it is experimentally accessible given its motif
packing similarity to known form.
Figure 6.19: The observed motif of the computed structure of succinic acid•2,2´bipyridine
cocrystal is based on sheets of chains (left) that pack perpendicular to one another (right).
6.8 Conclusion
The extensive crystal structure predictions in this study have been a
success in that all the known experimental structures were found at or near the
global minimum on their lattice energy landscape. It also rationalized why the
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binary system 2,2'-bipyridine • succinic acid produced cocrystals whereas that
between 1,4-dicyanobenzene and succinic do not, as found in chapter 5.
The study also predicts the formation of potentially new forms of 2,2'-
bipyridine and 1,4-dicyanobenzene. Crystals of 1,4-dicyanobenzene may be
susceptible to disorder given the congested lattice energy landscape about the
global minimum where structures of higher density and similar packing motifs to
the known forms are present. A new denser form of 2,2'-bipyridine was found at
the global minimum in this and a previously related study[1]. This form is most
likely to be produced under severe experimental conditions such as high pressure
crystallization, as despite the frequent crystallization attempts conducted under
normal laboratory conditions, only the monoclinic form has been found[22,24-
26].
The computed hypothetical cocrystals of 1,4-dicyanobenzene • succinic
acid were found to be unstable relative to the sum of lattice energies of their pure
components. This is reasonable as all the predicted low energy cocrystals
consisted of alternating homogenous layers of the two coformers, showing that
1,4-dicyanobenzene is ineffective in displacing the )8(22R dimers between the
succinic acid molecules and give a well packed structure.
The cocrystal 2,2'-bipyridine • succinic acid, was identified as the global
minimum structure. However, its lattice energy was unstable relative to the  form
of succinic acid, but stable with respect to the  form, with energy differences of
3.03 kJ/mol and -3.56 kJ/mol respectively. Such differences in lattice energy are
comparable to errors in the computational model and polymorphic energy
differences.
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Calculations of the lattice energies are likely to be insufficiently accurate
given the intrinsic approximations in the model, for example the induction effects
have been ignored, which has been demonstrated to influence the relative stability
of different hydrogen motifs[8]. Furthermore, the assumption that the relative free
energies of the cocrystals and their components will be similar to the relative
lattice energies may well be an even poorer approximation than it is for
comparing energies of one component crystals[27].
Another possibility is that the cocrystallization process for the system 2,2'-
bipyridine • succinic acid is kinetically driven[28]: i.e crystallization of the
cocrystal occurs more rapidly than that of the pure components. This would imply
that the stability order of the cocrystal with respect to its components as
represented in the lattice energy landscape is realistic.
6.9 Overall chapter conclusion
This study has confirmed the viability of computational modeling in
predicting the crystal structures of cocrystals as well as their components. Unlike
crystal engineering, which relies on a small set of chemically intuitive synthons to
forecast the cocrystal structure (albeit in a 1-dimensional representation),
computational modeling accounts for the much larger set of secondary but
collectively significant interactions, thus allowing for more credible structure
predictions.
With regards to predicting the formation of cocrystals on the basis of their
relative stabilities with respect to their components, the results were less
convincing. In few cases the calculations did not appear to reflect reality, and it
was deemed that either the approximations of the model were insufficiently
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accurate or kinetic factors were at play. Without further investigations, factors that
contribute most to this uncertainty cannot be identified, and more research is
required in this field.
On average the calculations took 3-5 weeks per binary systems, which is
comparable to extensive experimental screens targeting cocrystals. As a result, our
current computational models cannot be considered as effective means of
enhancing the efficiency of cocrystal screens. If, however, the emphasis is on
saving chemical resources rather than labour and time, then these computational
methods can have beneficial applications.
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Chapter 7. Conclusions and Recommendations for Future Work
Computational modelling of the organic solid state is a powerful discipline
that has been expanding rapidly in recent years. Its utility as a complementary tool
to experimental methods in the search for cocrystals has been investigated in this
thesis. Computer methods have an advantage over qualitative crystal engineering
guidelines as they model all the interactions between coformers in a cocrystal
rather than focus on a small set of chemically intuitive synthons.
7.1 Limitation of the model-comparison of the calculated lattice energies
In chapter 4, a contemporary computational methodology was tested for its
ability to account for the formation of a series of known cocrystals by comparing
their calculated lattice energies to those of their components, with the assumption
that cocrystallization is a thermodynamically driven process. In most cases the
cocrystals were found to be more stable than their components. However, the
magnitude of thermodynamic stabilization was often comparable to polymorphic
energy differences and errors in the modeling approximations. Furthermore, for a
few crystal structures there was a clear indication that the computer modeling was
not realistic, as discussed below.
7.1.1 Problems with the empirical potentials
The empirical FIT potentials[1] used to model the repulsion-dispersion
contribution had been fitted to a modest sample of crystal structures, and so the
limited range of intermolecular contacts sampled are unlikely to include the
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unusual hydrogen bonding observed in some of the crystals studied. One key
example is that of the 4-aminobenzoic acid polymorphs, where the polymorphic
energy difference calculated with the FIT potentials was found to be very high (20
kJ/mol) as the stability of the  polymorph was severely overestimated.
Recently a new set of potentials (W99 potentials [2]) has been developed,
which was fitted to a more diverse sample of crystal structures. In the future, some
calculations could benefit from these potentials. This have already been applied to
4-aminobenozic acid in a separate related study[3], resulting in a more realistic
polymorphic energy difference (7 kJ/mol) which is within the expected
polymorphic energy difference of organic molecules (i.e. below 8-10 kJ/mol) [4].
7.1.2 Thermodynamics vs. kinetics
The assumption that cocrystallization is a thermodynamically driven
process may not always be valid, as kinetically stable cocrystals can be formed, as
evidenced by the existence of polymorphic cocrystals[5-7]. Thus the rationale
behind some cocrystals being calculated to be more stable relative to their
kinetically stable components, but less stable relative to their thermodynamic
stable components could be due to kinetic factors rather than inaccurate
calculation of relative stability. Many of the 4-aminobenzoic acid cocrystals
studied in chapter 4 displayed this relationship. 4-Aminobenzoic acid has two
known forms: the kinetically stable  polymorph which crystallizes with relative
ease from a range of solvents and is commercially available; and the
thermodynamically stable  polymorph which has only been reported to
crystallize from water or ethyl acetate, often concomitantly with the  form.
Nearly all the investigated 4-aminobenzoic acid cocrystals were produced from
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solvents that do not nucleate the  polymorph, thus it is tempting to speculate that
cocrystallization is in direct competition with the formation of the  polymorph.
In that case, lattice energy comparisons should have only been made relative to
this  polymorph.
To examine this hypothesis, in the future two parallel experiments should
be performed investigating the ability to reproduce these cocrystals: (i)
exclusively from the  polymorph; and (ii) exclusively from the  polymorph.
These experiments should utilize neat grinding or HSM methods to avoid solvent
effects during the nucleation process. It is also necessary to conduct some
validation experiments, such as calorimetry measurements, to obtain the enthalpy
of sublimation of the cocrystals and their components, and to establish the true
order of their stability. Although such experiments are performed at elevated
temperatures and the minimizations nominally correspond to 0 K, the results
should be comparable to the calculated lattice energies.
7.1.3 Calculation of free energy instead of lattice energy
As the calculated lattice energies nominally correspond to 0 K, the
temperature and pressure effects which give rise to entropic factors are neglected.
Generally this is a good approximation of the relative stability, as for a pair of
polymorphs the difference in entropy is rarely equal or greater than the difference
in enthalpy[8]. However, when the difference in the lattice energy is small,
consideration of the entropy can change the stability order. Thus a more realistic
calculation would be that of the free energies at the specific crystallization
temperature and pressure.
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Currently, calculating the free energy is extremely challenging and
computationally expensive, even for small and rigid single component
molecules[9]. Research in this field of computational chemistry is still
growing[10], but it will be some time before such calculations can be practically
utilized for cocrystal studies.
7.2 Experimental screening strategy targeting cocrystals
In chapter 5, a two stage experimental strategy was designed targeting
cocrystals of 4-aminobenzoic acid and succinic acid with coformers of
pharmaceutical relevance. In their pure state, these pharmaceutical coformers are
incapable of forming hydrogen bonds as they only have hydrogen bond acceptors
and no donor functional groups. However, hydrogen bonds are likely to form
upon cocrystallizing with either succinic acid or 4-aminobenzoic acid. This
coformer selection was motivated by results in chapter 4, where a greater relative
thermodynamic stability was calculated for such cocrystals driven by the
formation of hydrogen bonds.
Stage I included simple experimental techniques such as grinding and hot
stage microscopy to provide a preliminary indication of potential cocrystal
formation. Such techniques are environmentally friendly and rapidly produced
results that were relatively easy to analyze. Systems displaying signs of potential
cocrystallization were forwarded to stage II, where extensive solution based
experiments were carried out to grow good quality single crystals for X-ray
structure determination. In addition, a few solution based experiments were
performed on all systems that displayed no signs of cocrystallization to test the
effectiveness of stage I screens.
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Overall this experimental strategy was successful. Complementary results were
observed between the two stages: systems that indicated potential
cocrystallization in stage I were the only ones to produce cocrystals in stage II.
However, only four novel cocrystals were produced out of the 18 combinations
investigated. Two of these were suitable for relative lattice energy calculations,
for which their results did not reflect those found in chapter 4 as their magnitude
of stability was within polymorphic energy differences and errors in the model.
These results demonstrate further the limitation of crystal engineering concepts
and the need for more accurate modeling of the relative energies of cocrystals and
their components.
7.3 Computational rationalization of experimental observations
In chapter 6, an extensive multistage computational methodology was used
to rationalize the experimental observations for the binary systems: 2,2´-
bipyridine with succinic acid and 1,4-dicyanobenzene with succinic acid, which
had been experimentally investigated in chapter 5. The former produced a
cocrystal whereas the latter did not. The computational methodology was used to
generate and minimize the lattice energy of putative crystal structures for the
binary systems (which assumed a 1:1 stoichiometry) and their components. The
search was successful in generating all the known experimental structures, the
majority of which were identified at the global minimum. Had this study been part
of the CCDC international blind test (where for successful prediction, the blind
test molecule should correspond to any of the three most stable structures on the
lattice energy landscape) the search would have successfully predicted all the
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known experimental structures with the exceptions of the metastable  form of
succinic acid and the monoclinic form of 1,4-dicyanobenzene.
The computed hypothetical cocrystals of 1,4-dicyanobenzene•succinic
acid were calculated to be very unstable relative to their pure components,
consistent with the experimental observations that no cocrystal was formed.
Furthermore, all the low energy hypothetical cocrystals consisted of alternating
homogenous layers of the two components with no direct hydrogen bonding
between them. This implies that the molecules prefer a ‘like for like’ form of
interaction, rather than forming O-H···N≡C hydrogen bonds.
The observed cocrystal 2,2´-bipyridine•succinic acid was identified as the
global minimum structure on the lattice energy landscape. However, it was less
stable than its pure components with respect to the  polymorph of succinic acid,
but more so when the  polymorph was considered. This could be attributed to
inadequacies in the modelling or kinetic factors, as suggested for some cases in
chapter 4.
This study showed that reasonable predictions can be made for cocrystal
structures. However, calculation of the relative stability of cocrystals and their
components was less convincing. It cannot be assumed that errors associated with
the calculated lattice energy of the cocrystals and their components will cancel
out. This is reasonable as the coformers and the cocrystals contain different
intermolecular interactions and they may not be equally accurately calculated with
the empirical FIT potential. Hence more research is needed to develop sufficiently
accurate models for the calculations of absolute lattice energies.
In none of the lattice energy landscapes was there a large energy gap
between the experimental structures and the hypothetical ones, implying that the
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discovery of further polymorphs may be possible. This is particularly apparent for
the coformers 2,2´-bipyridine and 1,4-dicyanobenzene, with the latter likely to be
susceptible to disorder given its congested lattice energy landscape about the
global minimum with structures having similar packing motifs. For 2,2´-
bipyridine, a crystal structure more stable than the experimentally known form
was found at the global minimum. This structure is most likely to be produced
under extreme experimental conditions, such as under high pressure given the
structure’s high density.
7.4 Final conclusion
This thesis has developed a speedier method for the screening of cocrystals
experimentally which comprises of a preliminary screen (stage I) prior to solution
based crystallization experiments (stage II). In contrast to practices when this
work began, this approach has enhanced efficiency and effectiveness. Not only is
the use of grinding and HSM in stage I simple to setup, both appear to be reliable
in detecting potential cocrystal formation. Furthermore, the need for little or no
solvent makes these techniques environmentally friendly.
This study has provided considerable evidence that computational modeling
can be used to give more insight into the formation of cocrystals, and serve as
complementary tools to experimental efforts targeting these multicomponent
systems. However, this study has also illustrated the need for further
improvements in the accuracy of the modeling and the need to gain more
understanding of the kinetic factors that dictate the crystallization pathways
during nucleation. Currently, the high computational costs limit the practical use
of these calculations. The cocrystals investigated in this study are considered
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‘simple’ given their small stoichiometric ratio and low degree of flexibility, yet
the calculations typically lasted for 2-3 months per binary system. This length of
time is comparable to that of extensive screens of cocrystals by solution based
experiments. Performing these calculations on pharmaceutical cocrystals is
expected to last considerably longer given the complexity of common APIs.
A more practical approach would be to predict the formation of cocrystals
using crystal engineering concepts along with an integrated quantitative
approach[11,12] of estimating their free energies. Coformers displaying a high
propensity to cocrystallize would then undergo a similar experimental setup as
described in chapter 5, where grinding and HSM methods were used as
preliminary indicators of potential cocrystallization prior to the extensive solution
based experiments aimed at producing quality crystals for X-ray structure
determination. Once a cocrystal of pharmaceutical relevance is produced,
computational modeling could be utilized for characterization purposes, to
identify, for example, potential polymorphs and their relative stabilities. Such
information could be crucial during the due diligence process to avoid a Ritonavir
like scenario[13].
Nevertheless, with the continuous advances being made in computational
technology and modeling, it is inevitable that computational methods will become
more routinely exploited in the future prior to laboratory based studies on the
crystallization of cocrystals. This has the potential of streamlining research by
narrowing down the experimental investigations to the most promising candidates,
thereby saving time, labor and chemical resources.
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